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Abstract
The age distribution of the naturally occurring transmissible spongiform encephalopathies (TSEs) or
prion diseases, including scrapie in sheep, bovine spongiform encephalopathy (BSE) in cattle and
variant Creutzfeldt-Jakob disease in humans (vCJD) may be explained by age-dependent
susceptibility to infection. Epidemiological studies have shown that exposure to BSE-contaminated
meat and meat products alone cannot fully account for the young age distribution of vCJD cases, and
that changes in susceptibility may also play a role. Oral exposure has been implicated as the most
likely route of natural transmission of TSEs. Peyer's patches (PPs), part of the gut-associated
lymphoid tissue (GALT), may represent a portal of entry for orally transmitted prions and appear to be
the most likely sites of prion accumulation in the gastrointestinal tract. The main aim of this project
was to determine whether the observed age-susceptibility relationship of scrapie, BSE and vCJD could
be explained by the development of PPs in the gut. Statistical analyses were performed on an
experimental scrapie dataset to determine whether there was an effect of age at exposure on scrapie
outcome and incubation period of the disease, taking into consideration other potentially important
factors related to susceptibility. PP tissue was quantified in the distal ileum of NPU Cheviot sheep,
and data on measures of PP development in cattle and humans were extracted from previous studies.
Anatomical PP data and estimates of age-related risks of infection, derived from mathematical
models, were used to determine a potential link between age-related risk of natural TSE infection and
the development of PP tissue in the three species. Because follicular dendritic cells (FDCs) have been
implicated as the likely sites of prion replication in lymphoid tissues, immunocytochemistry was
carried out to investigate the ontogeny of PrP-associated FDCs in ileal PP tissue in both mice and
sheep. Results showed that age at exposure to the TSE agent is a potentially important factor in
determining disease outcome as well as the incubation period of disease. Younger sheep were found to
have shorter incubation periods than older animals following subcutaneous inoculation of the
infectious agent, a finding which may be attributed to the development of peripheral nerves and which
warrants further investigation. For sheep, cattle and humans, measures of PP development peaked in
adolescent years followed by a decline, thereafter. There was a significant correlation between
measures of PP development and estimated risks of natural TSE infection, with the two age-related
distributions peaking in the same age group for all three species. Immunocytochemistry studies
showed that PrP-associated FDCs can first be detected in 7 day-old mice, and provided further
evidence for the presence of mature FDC networks in GALT of postnatal sheep. These findings imply
that, in the absence of FDCs, mice younger than 7 days old may be less susceptible to oral scrapie
challenge. The presence of FDCs in newborn sheep suggests that these animals may be susceptible to
TSE infection in early postnatal life particularly at lambing when an infected placenta could act as a
source of scrapie infection to the young lamb. Age-dependent susceptibility to oral TSE infection in
mice and sheep may offer a convenient experimental framework with which to explore the reasons for




1.1 Transmissible spongiform encephalopathies
Bovine spongiform encephalopathy (BSE) was first recognised in dairy cattle in the United
Kingdom (UK) in 1985 but burst in on public awareness as "Mad Cow Disease" in 1986
(Wilesmith et al., 1988). BSE belongs to a group of fatal, neurodegenerative disorders called
the transmissible spongiform encephalopathies (TSEs) or prion diseases, which are widely
recognised for their transmissibility. The terms TSE and prion disease have been used
interchangeably throughout this thesis. Prion diseases involve modification of the normal,
cellular host prion protein (PrPc) into the abnormal, pathogenic isoform (PrPSc) (Prusiner et
al., 1998). The TSEs include, in animals, scrapie in sheep and goats, feline spongiform
encephalopathy (FSE), transmissible mink encephalopathy (TME) and chronic wasting
disease (CWD) in mule deer, white-tailed deer and elk (see Table 1.1). In humans, TSEs
include kuru, fatal familial insomnia (FFI), Gerstmann-Straussler-Scheinker syndrome
(GSS) and Creutzfeldt-Jakob disease (CJD), of which there are sporadic, iatrogenic, familial
and new variant forms (see Table 1.2).
The risk to humans from BSE fuelled much concern when, in 1996, a novel human disease
affecting mainly young adults and then known as new variant CJD (nvCJD, now simply
vCJD) was identified (Will et al., 1996). During this time, previously unknown TSEs were
also recognised in several other animal species including domestic cats (Wyatt et al., 1991)
and captive wild animals (Kirkwood and Cunningham, 1994; Willoughby et al., 1992).
Investigation of early cases of BSE suggested that protein supplements (meat and bone meal
(MBM)) which were derived primarily from rendered cattle and which were fed to calves
from 2 weeks to 6 months old, were a likely source of the disease (Wilesmith et al., 1991). In
the late 1970s there was a change in the rendering process used to produce MBM for
livestock and feeding of this material to very young calves may have triggered the BSE
epidemic (Horn, 2001). The MBM product, which was widely distributed throughout the
UK, was infecting not only cattle but also other animals that were habitually being given this
feed. These findings prompted speculation that the agent had crossed the species barrier
(Bruce et al., 1997). It has been recently shown that vCJD and BSE are caused by the same
strain of agent (Bruce et al., 1997), and that the outbreak of vCJD is almost certainly due to
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Although vCJD cases are tragic at the individual level, the number of victims has remained
reassuringly small from a public health perspective. However, since more than a million
cattle with BSE may have entered the human food chain (Anderson et al., 1996) and the
incubation period may be as long as 40 years for vCJD (Baker et al., 1998), the possibility of
a significant epidemic of vCJD over the next 10-15 years exists. However, if the mean
incubation period is short, with little variation from person to person, then most cases of
vCJD may have already emerged.
What is most striking about the TSEs and what makes these diseases the subject of
widespread interest is the apparent age distribution of cases (Figure 1.1). For instance, 80 per
cent of scrapie cases die at age 2-4 years of age compared to only 3 per cent of cases that die
at 7 or 8 years (Figure 1.1C) (Baylis et al., 2004), and it is unclear as to why youth should be
a risk factor for acquiring vCJD (Figure 1.1 A). However, one explanation is related to the
immune system of the young (Bosque, 2002). Various authors have shown, following
experimental oral infection of rodents and mule deer fawns, that the initial stages of vCJD
prion infection occur in the gut-associated lymphoid tissue (GALT) (Beekes and McBride,
2000; Sigurdson et al., 1999). Whether the normal variation in the GALT bears any relation
to susceptibility to TSE infection has so far remained unexplored, but it is tempting to
speculate that such variations may predispose to (or protect from) TSE infection that is
known to target these structures.
1.1.1 Characteristics of the TSEs
The TSEs are an unconventional group of diseases and share in common several unique
characteristics, which distinguish them from other diseases. Prion diseases are known
collectively as spongiform encephalopathies (SEs) because of the characteristic pathology
they display in the central nervous system (CNS). Pathological changes include spongiform
(vacuolar) degeneration, loss of neurons, astrocytosis, gliosis and in most TSEs, variable
amyloid plaque formation (Brown et al., 2000a; DeArmond, 1993; Detweiler and Baylis,
2003). Scrapie-associated fibrils (SAF) are consistently found in detergent-treated extracts of
infected brain tissue examined by negative stain electron microscopy (Merz et al., 1981).
SAF have been observed only in scrapie and related SE diseases (Merz et al., 1984;
Somerville, 1985) and have never been found in diseases with other causes (Merz et al.,
1981). Unlike other infectious diseases, the TSEs are not accompanied by a detectable
classical immune or inflammatory response (Carp et al., 1985).
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Figure 1.1 Age distribution of the naturally acquired TSEs. A. Age distribution of vCJD cases in
British people. Data include 129 cases with onset of clinical disease before November, 2001 and
comprises 71 men and 58 women (taken from Boelle et al., 2004). B. Age at clinical onset of BSE in
British cattle as of October, 2005 (taken from Defra, 2004). C. The frequency distribution of ages at
death for scrapie cases (taken from Baylis et al., 2004). D. Age distribution of CWD cases in captive
mule deer in Colorado (data provided by M. Miller, 2005).
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A striking feature of the causative agent is its extraordinary resistance to inactivation by
physical and chemical treatments. The resistance of the causative agent was revealed when
ten per cent of a group of Scottish sheep acquired scrapie after having been vaccinated
against louping ill. The vaccine was prepared from a formalin-treated suspension of sheep
brain extract, which was unknowingly contaminated with the scrapie agent (Gordon, 1946).
The resistance of the agent is further exemplified by its ability to withstand ultraviolet
irradiation, a finding, which suggests that the agent may be devoid of nucleic acid (Alper,
1992).
Sigurdsson (1954) first applied the term, slow viral infections, to the TSEs. This was based
on the recognition that these diseases have unconventional characteristics, and prolonged
incubation periods ranging from months to years (for example, one year for a mouse and
four to six years for a cow). In humans, the disease type determines the age at onset of
symptoms. For example, in sCJD and vCJD, symptoms become apparent at a mean age of 60
and 29 years, respectively. Prion diseases are progressive and debilitating with neurological
symptoms, which inevitably lead to death (Lasmezas, 2003).
However, one characteristic, which distinguishes this group, whether sporadic, dominantly
inherited or acquired by infection, is that most of the diseases listed (Table 1.1 and Table
1.2) have been successfully transmitted to experimental animals. Infectivity, for example,
has been demonstrated by transmission of disease to experimental animals (typically mice or
hamsters) by intracerebral (i/c) injection of infected material and subsequent serial passage
to further mice and hamsters (Bruce et ai, 2002; Chandler and Fisher, 1963; Kimberlin et
al., 1989). Transmission via natural routes also occurs; in sheep and goats, scrapie can be
naturally transmitted by infected dams to their offspring or from infected to uninfected
members of a flock (Detweiler and Baylis, 2003). Because of their ability to be transmitted
experimentally and/or naturally, these diseases have been appropriately termed the TSEs.
It is evident that from these unusual properties, the causative agent is very different from all
other known plant and animal viruses, and also viroids. Because of the uncertainty
surrounding the nature of the transmissible agent, several unorthodox hypotheses have been
proposed.
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1.1.2 The nature of the scrapie agent
Several hypotheses on the nature of the agent that causes TSEs have been proposed,
involving every major class of macromolecules as possible components. Examples include: a
"naked" nucleic acid genome without a protective protein coat (Diener, 1972); a small DNA
virus (Kimberlin and Millson, 1967); a replicating polysaccharide (Field et al., 1967);
nucleic acid surrounded and stabilised by a polysaccharide coat (Adams and Field, 1967); a
"holoprotein" which comprises a PrPSc component ("apoprion") and a nucleic acid
component ("coprion") (the "unified theory") (Weissmann, 1991). The two fields of thought
which have gained most credibility are the virino hypothesis (Bruce and Dickinson, 1987;
Weissmann, 1991) and the prion or "protein only" hypothesis (Prusiner, 1991). Evidence for
both is compelling and strongly defended.
The virino hypothesis is based on the concept of an unusual "sub-virus" particle, called a
virino, which is composed of a non-coding nucleic acid genome that determines strain
characteristics in tight association with a protective "structural" host-encoded protein
(Dickinson and Outram, 1988) to which the infective agent would imprint an abnormal
conformation through interference with normal metabolism.
The hypothesis explains many of the unconventional properties of the infectious agent, such
as the difficulty in purifying the agent, its resistance to ultra-violet radiation and an absence
of an immunological response in infected animals. The host origin of the protein may explain
the difficulties which arise when trying to separate the infectious agent from the host
material (Hunter, 1972; Millson and Manning, 1979; Prusiner et al., 1981). The low
molecular weight of the nucleic acid could also contribute to difficulties in isolating and
detecting nucleic acid in partially purified preparations (Carp et al., 1985), and may offer an
explanation for the remarkable resistance of the scrapie agent to irradiation (Alper et al.,
1978). Binding of the agent genome to host protein would provide the resistance to
inactivation for which the agent is renowned, and render it "immunologically invisible" to
the host (Dickinson and Outram, 1988). The infectious nature of such a particle may be
dependent on the continued interaction between the nucleic acid and the protein coat. Hence,
if the genome exists as an unprotected nucleic acid, infectivity could be lost (Bennett et al.,
1992) or could become difficult to detect.
The hypothesis attempts to explain the variability of scrapie isolates when passaged in
rodents (Dickinson and Fraser, 1977), and the occasional strain phenotypic changes
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(mutations) which occur spontaneously during passage (Bruce and Dickinson, 1987;
Kimberlin et al., 1989). Such phenotypic features have also been observed with isolates from
other TSEs, such as CJD and Kuru (Gibbs et al., 1979).
Aiken and Marsh (1990) have reviewed several techniques used to identify nucleic acids
unique to the scrapie agent. Hence, although the idea of a virion remains intellectually
attractive, no credible evidence for an agent-specific nucleic acid has yet been forthcoming.
Griffith (1967), in light of the previous finding that the infectious agent was too small to
possibly be a virus or any other known type of infectious agent, proposed that the
transmissible agent was a protein that had the ability to self-replicate in the host. This
marked the beginning of the so-called "protein-only" or "prion" hypothesis of TSE
propagation, and represented the first clash with the biological dogma that conventional
pathogens are unable to replicate in the absence of nucleic acid.
1.1.3 Prion protein (PrPSc)
Since the 1980s, Stanley Prusiner's group has led research supporting the "protein only"
hypothesis of TSE transmissibility. Prusiner's prion hypothesis is based on two major points:
(i) there is no demonstrable nucleic acid in infectious PrPSc preparations and (ii) the scrapie
agent is highly resistant to harsh procedures (Bolton et al., 1984). He first coined the term
"prion" (to distinguish the scrapie agent from viruses and viroids), which he defined as, "a
small proteinaceous infectious particle that resist inactivation by procedures which modify
nucleic acids", and suggested that PrPSc (or scrapie-associated prion protein) is the sole
component of the prion (Prusiner, 1982). It was proposed that PrPSc, when introduced into a
normal cell, causes the conversion of PrPc (or normal host cellular prion protein) or its
precursor into PrPSc (Prusiner, 1991).
PrPSc is the only characterized macromolecule found in purified preparations of scrapie agent
(Diringer et al., 1983; Prusiner, 1991); no specific nucleic acid has been detected in highly
purified PrPSc preparations (Kellings et al., 1992; Meyer et al., 1991) despite long-standing
efforts. Furthermore, infectivity was convincingly neutralised by agents that destroy protein
structure and, more importantly, by anti-PrP antibodies (Prusiner, 1982). The prion
hypothesis is also supported by genetic studies, which have shown that most, if not all, cases
of human familial SEs are linked to mutations in the PrP gene (Hsiao et al., 1989; Ironside,
1996), and that mice expressing PrP genes with point mutations linked to GSS spontaneously
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develop neurological dysfunction, spongiform brain degeneration and astrocytic gliosis
(Hsiao and Prusiner, 1991; Kaneko et al., 2000). Other studies have shown that transgenic
mice devoid of the PrP gene and lacking PrPc, are resistant to scrapie infection, developing
neither symptoms of scrapie nor allowing propagation of the infectious agent (Biieler et al.,
1992). The latter result demonstrated that PrPc was required for disease propagation.
Another strong argument in favour of the prion hypothesis was based on a seminal
experiment by Prusiner and his colleagues, which showed that the species barrier can be
overcome by introducing a Syrian hamster (SHa) PrP transgene into the recipient mouse line
(Prusiner et al., 1990; Scott et al., 1989). Hence, when inoculated with hamster prions, some
strains of mice containing SHa PrP transgenes had a short incubation period of 75 days,
whereas, in the non-transgenic controls, the incubation period was about 500 days (Scott et
al., 1989). Furthermore, prions generated from such transgenic mice are highly infectious to
the hamster but not to the mouse. The same transgenic mouse strain, infected with mouse-
derived prions, yields preparations highly infectious for mice but not for hamsters (Prusiner
et al., 1990). These experiments show that hamster PrPc and not murine PrPc is a suitable
substrate for conversion to hamster PrPSc by hamster prions and vice versa.
The prion concept has been largely developed from the fact that infectivity in hamster brain
homogenates is resistant to a variety of treatments expected to destroy nucleic acid but some
of the infectivity is abolished only by certain protein-specific agents (Prusiner et al., 1984).
All conventional viruses normally depend on a protein coat for their integrity and infectivity.
Interference with the protein coat will consequently lead to destruction of the virus. Hence, it
is accurate to assume that the TSE genomic material is protected by a protein coat as is
observed in viruses.
The idea that scrapie could be caused solely by an infectious protein still remains far-fetched
and unconvincing for many scientists. The most common arguments used against the
protein-only hypothesis of prion transmissibility are the existence of several strains of the
agent (Bruce and Dickinson, 1987), and the fact that infectivity is not strictly associated with
PrPSc in some situations (Lasmezas et al., 1997). However, it has been suggested, based on
accumulated evidence, that "prion strains" are the result of the existence of multiple PrPSc
conformations, which provide a specific template for the faithful conversion of the host
protein into the disease-inducing conformer. Furthermore, conformation-dependent assay is
one PrP-based method used to distinguish between different "prion strains", and exploits the
9
fact that discrete PrP epitopes can be differentially recognised by the antibodies used in the
assay depending upon the conformation of the abnormally folded protein (Safar et al., 1998).
Under certain experimental conditions, wild-type mice inoculated with BSE (Lasmezas et
al., 1997) and transgenic mice inoculated with human TSEs (Collinge et al., 1995; Manson
et al., 1999) developed a TSE-like disease but PrPRes (abnormal disease-associated or
protease resistant prion protein) was not detected. The interpretations that stem from these
observations are that the pathogenic, misfolded PrP is not necessarily protease-resistant, or
that the infectious agent comprises a hitherto undiscovered molecule (presumably but not
necessarily a nucleic acid) in addition to PrP (Lasmezas, 2003).
1.1.3.1 Prion protein is encoded by the PrP gene
In 1982, Stanley B. Prusiner achieved a 100-fold purification of the scrapie agent from SHa
brains and for the first time, showed that infectivity of the agent depended upon PrP
(Prusiner, 1982), an evolutionary conserved glycoprotein (Bosque, 2002). The PrP gene is
expressed in both normal and scrapie-infected brain tissue, but can also be found in other
tissues both within and outside the CNS (Bendheim et al., 1992). In hamsters and mice, PrP
messenger ribonucleic acid (mRNA) is most abundant in brain tissue (Chesebro et al., 1985)
especially in neurons (Prusiner, 1991). The cognate complementary deoxyribonucleic acid
(DNA) and gene were cloned, based on the partial sequences of PrP and were found to be
encoded by a single, host gene, PrP (Basler et al., 1986; Oesch et al., 1985) on the short arm
of chromosome 20 in humans (Sparkes et al., 1986).
This led to the recognition of two isoforms of PrP, the normal cellular form (PrPc) and the
abnormal disease-associated or resistant form (PrPRes), which represents an abnormal
structural conformation of PrPc (Pan et al., 1993). The amino acid chain of PrP, which, in
the hamster, is composed of 254 amino acid residues (Bennett et al., 1992) folds into a
specific three-dimensional structure that is presumably essential to PrP function (Oesch et
al., 1985). The entire open reading frame, that part of a gene coding for a protein, is in a
single exon, ruling out the possibility that PrPc and PrPSc differ as a result of alternative
mRNA splicing (Stahl and Prusiner, 1991).
PrPc and PrPRes are distinguished by their physical properties. PrPc is a 33-35 kilodalton
(kDa) glycoprotein anchored to the cell surface by a glycosylphosphatidyl inositol (GPI)
moiety (Aguzzi and Weissmann, 1997; Oesch et al., 1985; Prusiner, 1991) and its structure
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comprises approximately 43% a-helix and 3% P-sheet (Riek et al., 1997). On proteinase K
treatment, it was found that while 33-35 kDa PrP from an uninfected animal was completely
hydrolysed, the 33-35 kDa PrP derived from infected animals was partially degraded to
PrPRes that corresponded to 27-30 kDa PrP, without loss of infectivity (Oesch et al., 1985).
PrPSc retains 34% a-helix but incorporates a greatly increased amount of p-sheet (Pan et al.,
1993). Due to its sensitivity to protease digestion, PrPc it is also known as PrPSen. On the
other hand, due to its partial resistance to protease treatment, PrPSc is sometimes referred to
as PrPRes. PrP*™ is usually represented as PrP with a superscript, which indicates the disease
in question, for example, PrPSc for scrapie in sheep and PrPBSE for BSE in cattle. In vitro, PrP
27-30 forms into rod-like particles (unlike PrPc), and is able to bind to Congo red dye, which
reveals green birefringence in polarized light. PrP 27-30 specific antibodies indicate that the
amyloid plaques, which develop in scrapie-infected brains, also contain protease-resistant
PrP (Bendheim et al., 1984; DeArmond et al., 1987), as do the amyloid plaques seen in cases
of CJD, GSS and kuru (Guiroy et al., 1994).
1.1.4 The role of PrP in uninfected animals
PrPc plays a pivotal role in the acquisition of prion diseases in animals and humans, although
its exact physiological role has not yet been elucidated. The molecule is expressed
predominantly within the CNS (Aguzzi and Weissmann, 1997; Prusiner, 1991), but is also
found in several non-neuronal tissues as demonstrated by the use of antisera to the protein
and ribonucleic acid (RNA) detection methods (Chesebro et al., 1985; Robakis et al., 1986).
PrPc has been shown to be present in various regions of the hamster brain, including the
cortex, hippocampus, striatum, olfactory bulb, hypothalamus, midbrain, cerebellum and
brainstem (Bendheim et al., 1992), although various authors have found some regional
differences in the abundance and localization of PrPc (DeArmond et al., 1987). The cellular
isoform of PrP has also been detected on the surface of lymphocytes and activated T-
lymphocytes in humans and mice (Cashman et al., 1990; Mabbott et al., 1997) and at higher
levels on follicular dendritic cells (FDCs) of lymphoid tissues (McBride et al., 1992).
Northern blot and/or Western blot have been used to detect PrPc in a number of peripheral
tissues including heart, lung, pancreas, testes and kidney in the rodent (Oesch et al., 1985;
Robakis et al., 1986) as well as skeletal muscle and uterus in sheep (Horiuchi et al., 1995).
PrPc has been detected on epithelial cells of skin and mucous membranes suggesting that
these cells may well represent possible first targets for peripheral infection with the agent
(Pammer et al., 1998). In peripheral organs, the identification of PrPc-expressing cells is
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much less documented than in the brain. The association with various cell types exhibiting
different physiological functions suggests that PrPc may have several different roles.
In an attempt to unveil the function of PrPc, PrPc knock-out mice (variously termed PrP
nulls, PrP0/0 or PrP7" mice) were used but no obvious phenotypic deficits were observed
(Biieler et al., 1992). Although PrP null mice breed and behave normally, they exhibit a lack
of fine tuning of neuronal functions including aberrant sleep patterns (Tobler et al., 1996)
and increased locomotor activity (Roesler et al., 1999) as well as a reduced T-lymphocyte
response (Mabbott et al., 1997). One study showed that, although PrP null mice grew
normally after birth, at about 70 weeks of age all began to show progressive signs of ataxia
(Sakaguchi et al., 1996). However, alternative explanations have been offered for this ataxia,
which appears to be due to up-regulation of a related gene or the Doppel gene (Moore et al.,
1999), rather than a lack of PrP expression. PrP null mice were found to harbour lower
copper concentrations in synaptosomal fractions than their PrPc expressing counterparts.
This suggests that PrPc could regulate copper concentration in the synaptic region of the
neuron and may play a role in the re-uptake of copper into the presynaptic cell (Kretzschmar
et al., 2000).
Several experimental findings suggest that PrPc may play a role in signalling, cell survival
and differentiation. Binding of PrPcto signalling molecules suggests a role as a transmitter of
information from the extracellular environment to the cell and a trigger for a molecular
cascade (Mouillet-Richard et al., 2000). Moreover, the presence of the protein in fibre tracts
of elongating axons of hamster brain, as well as at the surface of elongating retinal axons
(Sales et al., 2002), is suggestive of a signalling role of PrPc during axonal growth. PrPc may
play a major role in neuroprotective signalling. Mice expressing N-terminally truncated PrPc
in a PrP0/0 genetic background suffered from neurodegeneration, and the normal phenotype
was rescued by the expression of the full-length protein (Shmerling et al., 1998). In contrast
to these findings, some studies have shown that over-expression of PrPc sensitizes cultured
cells to apoptotic death (Paitel et al., 2002), and abnormal accumulation of cystolic PrPc
results in neurodegeneration and acute toxicity (Ma and Lindquist, 2002; Ma et al., 2002). In
the light of present knowledge, it seems that although PrPc is involved in cell survival, any
abnormal deviation from its steady state concentration and compartmentalization in the cell
results in the protein exerting adverse cytotoxic effects. In summary, although the role of
PrPc remains unclear, its importance lies in providing useful insight into the pathogenesis of
TSE disease.
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1.1.5 The role of PrP in TSE pathogenesis
PrP plays a pivotal role in control of development of TSEs. Natural prion infection may
result through ritualistic cannibalism as in kuru, or through the ingestion of prion-
contaminated meat and bone meal as in BSE. However, the exact size and physical nature of
the TSE agent is not known, and this hampers understanding of the likely mechanisms and
rate of uptake of the agent following oral infection. Furthermore, it is not known whether
infectious particles of a different size are required to cause disease when administered by the
oral compared with the i/c routes. Although the pathological form of PrP is usually found in
multimeric fibrillar aggregates in the brain of TSE-affected individuals, it is not known
whether food preparation and subsequent processing during digestion may release a
monomeric form of PrPSc (Shmakov and Ghosh, 2001). The infectious prion particle is
generated through the conversion of endogenous PrPc to PrPSc, the latter providing a
template that promotes the conversion of PrPc and the conversion being catalysed by the
pathogenic agent (Prusiner, 1991). In the heterodimerisation model, the activation energy
barrier at each new structural transformation is lowered promoting the conversion of PrPc to
PrPSc. In the case of familial human SEs, PrP mutations would destabilise PrPc thereby,
lowering the barrier and facilitating the conversion of PrPc to PrPSc. In sporadic prion
diseases, somatic mutations might destabilise PrPc promoting its conversion into PrPSc
(Huang et al., 1996). The PrPSc molecules would eventually aggregate, a process which may
be facilitated by an unidentified molecular chaperon, referred to as Factor X (Telling et al.,
1995). Whether or not PrPSc itself is responsible for disease manifestation remains a major
subject of controversy.
1.1.5.1 Experiments using knock-out and transgenic mouse models
PrP knockout and transgenic mouse models have been used extensively to study TSE
pathogenesis. Mice have been experimentally produced in which the PrP gene has been
deleted. The advent of these so-called "knock-out" mice (PrP0/0 or mice homozygous for the
disrupted PrP gene) and inoculation experiments in these hosts have supported the concept
that PrP is indispensable for disease induction by TSE agents. Biieller et al. (1993) have
shown that when PrP0/0 and PrP+/+ (wild-type counterpart) mice were inoculated
intracerebrally with a high dose of the Chandler isolate of mouse-adapted prions (Chandler,
1961), PrP+/+ controls died within about 180 days, while PrP0/0 mice, devoid of PrPc, were
completely protected against scrapie and showed normal development and behaviour up to
13 months after inoculation. Although PrP0/0 mice were shown to harbour small amounts of
infectivity for up to two days post-inoculation, the most likely explanation for these findings
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was the persistence of inoculum (Sailer et al., 1994). Manson and colleagues (1994) have
also shown that inoculation of PrP0/0 mice with TSE-infected tissue failed to produce any
signs of disease either clinically or pathologically.
Various authors (Brandner et al., 1996; Blatter et al., 1997) have re-introduced PrP into
PrP0/0 mice in the form of brain grafts from transgenic mice over-expressing PrP. After i/c
inoculation (Brandner et al., 1996), grafts were found to have accumulated high levels of
PrPSc and infectivity. Furthermore, grafts showed the severe histopathological changes
characteristic of scrapie, and substantial amounts of graft-derived PrPSc had migrated into the
host brain. Despite this, the adjacent host brain tissue (devoid of PrPc) underwent no
pathological changes after a 16-month period.
Blattler et al. (1997) showed that PrP-expressing neurografts in PrP0/0 mice do not exhibit
histopathological changes after intraperitoneal (i/p) or intravenous (i/v) inoculation with
scrapie prions. Furthermore, peripheral (i/p or i/v) inoculation did not produce scrapie
pathology in mice with reconstituted lymphohaemopoietic systems with PrP-expressing
cells. The results of these two studies show that PrP is essential for the development of
pathology and spread of infection both within the CNS, and from the peripheral tissues to the
CNS.
Experiments with transgenic mice expressing various levels of homologous or heterologous
PrP have shown that the level of expression of the PrP gene influences susceptibility to the
prion diseases (Biieler et al., 1993). Mice carrying a single PrP allele (heterozygous PrP0/+
mice) are found to be partially protected from scrapie when inoculated with mouse-adapted
prions (Btieler et al., 1993). Furthermore, disease incubation period in PrP0/+ mice was found
to be noticeably longer than wild-type (PrP+/+J mice. The fact that PrP0/+ heterozygous mice
exhibit considerably longer incubation times compared to their wild-type counterparts (and
PrP expression appears to be positively correlated with disease susceptibility) suggests that
PrPc concentration may be an important rate-limiting factor in determining the progression
of the disease (Biieler et al., 1993).
Because transgenic "null" mice are resistant to TSE infection and appear to be clinically
normal, this has led to the suggestion of breeding animals without PrP genes (through
ablative gene therapy, or the use of anti-sense oligonucleotides to "switch off' PrP
production) in order to produce prion-disease-resistant animal strains which are safe for
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human consumption (WHO, 1999). The possibility of gene therapy for human prion diseases
also exists (WHO, 1999). However, the dilemma lies in determining the normal function of
PrPc and whether or not critical cell functions are dependent on it. Until the role of PrPc
becomes established, this possibility will remain a likely conjecture.
1.1.6 TSE susceptibility in animals and man
The primary risk factor associated with scrapie is explicitly the PrP genotype. However,
genetic analyses of scrapie incubation period and susceptibility to natural scrapie are
complex because of uncontrolled variables such as the time and extent of exposure and the
strains of scrapie agent involved. The genetic control of TSEs in different species and the
complexity arising as a result of host-strain interactions and other risk factors associated with
the incubation period and susceptibility to TSEs are described in this section.
1.1.6.1 Genetic control of TSEs
1.1.6.1.1 Genetic control ofscrapie in sheep
The susceptibility/resistance of sheep to scrapie is largely under genetic control (Hunter et
al, 1997), and this has formed the basis for the National Scrapie Plan in which sheep are
specifically bred to prevent scrapie developing (Eglin et al., 2005). The Cheviot sheep flock
(Neuropathogenesis Unit (NPU) Cheviots), which was founded by Alan Dickinson in 1960,
has made a considerable contribution to the understanding of host genetic factors involved in
scrapie susceptibility. Dickinson (1976) selected two lines of sheep, a positive and a negative
line, depending on the incubation period in the animals following injection with a source of
scrapie called SSBP/1. Cheviots that developed disease from subcutaneous (s/c) inoculation
in 150-400 days were bred as the positive line and those, which showed no clinical signs of
disease within their normal lifetime, were grouped in the negative line. The gene, which
controls the experimental scrapie incubation period in these sheep, was called Sip (for
scrapie incubation period), and has two alleles sA and pA (Dickinson and Outram, 1988).
Negative-line Cheviots were described as SippApA homozygotes whilst positive-line Cheviots
were SipsAsA homozygotes or SipsApA heterozygotes (Dickinson, 1976) (5ipsApA being partially
dominant (Foster and Hunter, 1991)). The behaviour of SipsA and SippA incubation period
alleles can only be defined in terms of infecting strain of scrapie agent and the recipient
breed of sheep. For example, SSBP/1 has shorter incubations in SipsA carriers (positive-line)
than in SippApA (negative-line) Cheviots. However, for CH1641 and BSE strains, the
incubation phenotypes of the Sip alleles are reversed, with SippApA homozygous sheep having
shorter incubations than positive-line animals (Foster and Dickinson, 1988a; Foster and
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Dickinson, 1988b; Foster et al., 1993). CH1641 and BSE differ from each other in many
respects and are not related (Hunter, 2003).
The Sip gene is very closely linked and most probably identical to the PrP gene (Hunter,
1997a). Molecular techniques, including the use of polymerase chain reaction, restriction
enzyme digestion, allele specific amplification, denaturing gradient gel electrophoresis and
sequencing have led to the discovery of many polymorphisms in the PrP gene of sheep. The
three main amino acid substitutions that play a significant role in both experimental and
natural scrapie onset are at codons 136, 154 and 171 of the PrP gene (Hunter, 1997a). At
codon 136, the amino acid specified can be either valine (V) or alanine (A); at codon 154, it
is arginine (R) or histidine (H); and, at codon 171, arginine (R), glutamine (Q) or histidine
(H). These three amino acid substitutions define five major PrP alleles, namely, Ai36, Rl54>
Qi7i, VRQ, ARH, AHQ and ARR (Table 1.3). A genotype can be written simply as VRQ/
ARQ. As many as 12 different sheep PrP allelic variants based on the three codons have
been described (Hunter, 2003). However, only 5 alleles (mentioned above) are
predominantly seen in sheep in many studies worldwide (Belt et al., 1995). The frequency
and distribution of the PrP allelic variants differ from breed to breed. For example, the VRQ
allele is rare in Suffolk sheep but not in Texel, Swifter and NPU Cheviot sheep, and the
ARH allele is common in Texel sheep but rare in most other breeds (Hunter, 1997a).
Table 1.3 PrP polymorphisms in sheep
Allele" Nucleotide sequences Phenotypic effect
ARQ GCC...CGT...CAG Associated with susceptibility in some breeds0
VRQ GTC...CGT...CAG Associated with susceptibility
ARR GCC.. .CGT...CGG Associated with resistance
ARH GCC.. .CGT.. .CAT Usually associated with resistance
AHQ GCC.. .CAT.. .CAG Usually associated with resistance
"Amino acids specified by codons 136, 154 and 171, respectively.
bBold type indicates nucleotide sequence difference from ARQ.
CARQ homozygotes are normally susceptible in Suffolks (which lack the VRQ allele) and in Ro¬
manovs and Icelandics (which have the VRQ allele) but not normally in Cheviots (which also have
the VRQ allele).
(Taken fromWoolhouse et al., 2001).
In general, polymorphisms at codons 136, 154 and 171 are associated with scrapie
susceptibility. In many breeds, such as Cheviot, susceptibility to scrapie is linked to valine at
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codon 136, with VRQ/VRQ homozygotes being the most susceptible genotype (Hunter et
al., 2000). For example, affected NPU Cheviots with a gene/dose effect where 77% of the
natural scrapie cases were VRQ/VRQ and 23% were ARQ/ARQ, died at a mean age of 907
and 1462 days, respectively (Hunter et al., 1996). Certain PrP gene alleles offer a protective
effect, for example, ARR, so that animals with the VRQ/ARR genotype have only marginal
susceptibility and rarely develop natural scrapie (Hunter et al., 1996; Hunter et al., 1997).
ARR sheep are generally considered to be clinically resistant to natural scrapie with the
exception of one reported case in Japan (Ikeda et al., 1995), and recently reported cases in
Norwegian sheep (Le Dur, 2005).
This observation may mean that these so-called atypical cases might be genetically different
and that scrapie strains different from those in Western Europe may exist (Laplanche, 1999).
Although it has been reported that three ARR/ARR sheep became infected (all with
extensive incubation periods) after being injected intracerebrally with BSE-infected bovine
brain homogenate (Houston and Gravenor, 2003), this result does not necessarily imply that
ARR/ARR sheep are naturally susceptible to BSE. However, recent evidence indicates that
ARR/ARR sheep may harbour subclinical infection (Gonzalez et al., 2005). Although the
National Scrapie Plan was initiated to eventually eradicate scrapie (as well as any BSE in
sheep) by increasing the frequency of the ARR allele and decreasing the frequency of the
VRQ allele (Houston et al., 2003) on the basis of initial observations, these new findings
may call for a reappraisal of this strategy in the long term.
The present view is that although the PrP genotype is the primary risk factor associated with
scrapie, it is not a purely genetic disease. Hunter and colleagues (1997) have described two
healthy Cheviot sheep, aged 36 and 96 months, carrying the VRQ allele in Australia, a
scrapie-free country. This observation implies that scrapie is not necessarily a spontaneous
genetic disease but most likely results from an exogenous pathogenic agent (Hunter et al.,
1997). ARR/ARR sheep are susceptible to i/c injection with BSE, which suggests that these
animals do not have complete genetic resistance to prion infection (Houston and Gravenor,
2003). Foster and colleagues (1996) have shown that transmission of scrapie can be
prevented or development of the disease delayed in some genetically susceptible sheep. It is
possible that other polymorphisms in the PrP gene and other undefined genes could modulate
sheep susceptibility to scrapie and explain perhaps why some animals with susceptible
genotypes do not develop disease (Diaz et al., 2005; Laplanche et al., 1999). During the
perinatal period, lambs in a flock with a high incidence of natural scrapie are exposed to
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greater levels of infectivity. Studies should take into account that several biological factors
such as development and physiology of an animal's immune system and age at exposure
may also come into play when determining susceptibility to prion infection. This possibility
should not be overlooked. In natural scrapie other uncontrolled variables including time of
exposure, different levels of infectivity pressure in contaminated environments and scrapie
strain appear to be necessary for development of scrapie and make genetic analysis of
scrapie incubation and/or susceptibility complex (Foster and Dickinson, 1988a). These
variables will be discussed later.
The incubation time for the same prion isolate may be different in distinct mouse strains and
is determined predominantly by the PrP gene (Carlson et al., 1986; Hunter et al., 1987).
Short and long incubation periods are associated with two distinct PrP alleles, Prn-pa (which
produces the PrP A allotype) and Prn-pb (which produces the PrP B allotype), respectively.
The a and b alleles of PrP differ at codons 108 (Leu/Phe) and 189 (Thr/Val) (Carlson et al.,
1986). These PrP alleles are analogous to the two alleles of the Sine gene, s7 and p7,
identified by Dickinson and others (1968). The host PrP genotype does not account for all of
the variation seen in the incubation period, indicating that other genes are probably involved
in the control of the disease (Manolakou et al., 2001; Moreno et al., 2002), although little is
known of their nature and function.
1.1.6.1.2 Cattle and elk PrP gene polymorphisms
In cattle, only one specific polymorphism (a 23-bp insertion/deletion polymorphism in the
putative PrP promoter region) in the bovine PrP gene has so far, been associated with BSE
susceptibility (Sander et al., 2004). Although a variable number of octarepeats has been
reported in bovine PrP with the majority of cattle having five octarepeats instead of six
(Goldmann et al., 1991), it is unlikely that the repeats affect the incidence of BSE (Hunter et
al., 1994; Neibergs et al., 1994).
In Rocky Mountain elk, MM 132 homozygosity appears to predispose exposed elk to CWD
(O'Rourke et al., 1999). The elk is the first non-human species with a reported
polymorphism at the corresponding site (O'Rourke et al., 1998). Heterozygosity does not
appear to be associated with prolonged incubation time since two of the CWD-affected
methionine/leucine elk were diagnosed at 2 years of age (O'Rourke et al., 1999).
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1.1.6.1.3 PrPpolymorphisms in human TSEs
Susceptibility of humans to vCJD is also linked to PrP polymorphisms. All patients with
vCJD reported so far, are homozygous for the amino acid methionine (M) at position 129
(Will, 2003), with the exception of one patient with the MV (methionine/valine) genotype
thought to be infected via blood transfusion (Peden and Ironside, 2004). Molecular genetic
studies have also shown that multiple mutations in the PrP gene on chromosome 20p, which
codes for the prion protein, are associated with familial CJD, GSS disease, and fatal familial
insomnia (Goldfarb and Brown, 1995). Studies have shown that the MV polymorphic
variation at position 129 of the PrP gene affects the age at onset and duration of illness in
familial TSE (Baker et al., 1991; Dlouhy et al., 1992) and influences susceptibility to the
sporadic and iatrogenic forms (Brown et al., 2000b; Collinge et al., 1991). Kuru, which has
some phenotypic similarity to vCJD (Lantos et al., 1997) and a common mode of
transmission (kuru and vCJD are the only human TSEs transmitted naturally), preferentially
affects individuals with the PrP 129 MM genotype (Lee et al., 2001), and homozygosity
(MM) appears to be associated with an earlier age at onset and a shorter duration of illness
(Cervenakova et al., 1998; Lee et al., 2001). Since the codon 129 genotype has a marked
influence on susceptibility to kuru and vCJD, cases of human BSE infection with a valine
homozygous (VV) or heterozygous (MV) codon 129 genotype may yet occur (Will, 2003)
and could have longer incubation periods, as suggested by recent studies of kuru (Goldfarb et
al., 2004; Huillard d'Aignaux et al., 2002). Hence, further cases of vCJD may occur in older
individuals with alternative 129 genotypes, signalling a maturing evolution of the vCJD
"epidemic" (Lee et al., 2001). Three large-scale studies testing tonsil and appendix tissues
are currently underway in the UK to determine the prevalence of asymptomatic infection
(Hilton et al., 2002), however, the unknown sensitivity and specificity of the tests at different
stages of the incubation period will necessitate careful interpretation of any results (Ghani et
al., 2003).
Like scrapie, the PrP gene may not solely explain susceptibility to vCJD since about 38 per
cent of the UK population carry the high-risk methionine 129. One study investigated the
distribution of codon 129 polymorphisms in patients in France and the UK who had acquired
CJD iatrogenically by human growth hormone (Brandel et al., 2003). UK patients had a low
proportion (4%) of the MM genotype compared to French patients (62%) and this
discrepancy was attributed to probable infection with different strains of the CJD agent in
human growth hormone in France and the UK. This is possible since different host-strain
interactions exist under experimental conditions. For example, ARR/ARR sheep have never
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been orally infected with BSE (Kao et al., 2003), and humans with MV or VV codon 129
genotypes appear to be so far, resistant to oral infection of the BSE strain of prion (Brandel
et al., 2003).
The relatively small number of vCJD cases diagnosed to date and the many biological and
epidemiological uncertainties surrounding this novel disease make future projections of the
epidemic difficult. Recent results from a study to detect abnormal prion protein in UK tonsil
and appendix specimens (Hilton et al., 2004) suggest a prevalence of 237 cases per million
for prion infection, which implies that the extent of vCJD infection in the UK population is
far greater than current clinical cases of vCJD would suggest. A number of subclincial or
preclinical infections owing to the effect of different genotypes may be the cause of this
discrepancy (Clarke and Ghani, 2004). While all clinical cases to date have been identified
as MM, it is possible that other genotypes of individuals exposed orally to BSE, will develop
disease with longer incubation periods. Support for this hypothesis comes from the recent
identification of infection in the spleen of a patient with the MV genotype believed to be
infected via blood transfusion (Peden and Ironside, 2004). A high incidence of subclinical
infection has been identified in animal experiments using MM transgenic mice that have
been inoculated with the BSE agent (Asante et al., 2002). If there are two subpopulations of
vCJD patients, one with "short" incubation times and methionine homozygosity, the other
with "long" incubation times and valine homozygosity or heterozygosity, one would expect
that in the next couple of years, the age distribution of vCJD cases will become bimodal and
the proportion of older patients will increase (Valleron et al., 2001). So far, the age-
distribution of vCJD cases has not shifted.
1.1.6.2 Strain ofagent, dose and route of infection
Host PrP genotype does not account for all of the variation seen in the incubation period, and
not all genetically susceptible sheep develop scrapie when orally challenged or when
residing in naturally infected flocks (Foster et al., 2001; O'Rourke et al., 1997). Scrapie
occurs occasionally in animals which have one ARR allele (in the genotype ARQ/ARR or
VRQ/ARR) (Hunter, 1997a), and naturally infected Suffolk sheep flocks do not demonstrate
100 percent scrapie infection of susceptible genotypes (Jeffrey et al., 2001b). One study
showed that in field outbreaks of scrapie or following oral dosing, between 12 and 20
percent of susceptible genotypes do not develop the disease (Jeffrey et al., 2001b). These
observations imply that there may be other factors involved in the control of the disease such
as additional genetic factors (Hunter et al., 1996), environmental factors (Healy et al., 2004),
20
variable conditions for oral exposure (such as rumen contents) (O'Rourke et al., 1997), age at
infection (Diaz et al., 2005) and agent strain (Goldmann et al., 1994).
Host strain interactions are well documented in TSE infections. Humans with MV or VV
codon 129 genotypes appear to be resistant (so far) to the BSE strain of prion (Brandel et al.,
2003), and inocula prepared from the brains of scapie-infected sheep target the challenged
sheep differently according to PrP genotype (Goldmann et al., 1994). For example, in the
NPU Cheviot flock, although sheep of the ARQ/ARQ genotype appear to be resistant to
scrapie following inoculation of the SSBP/1 scrapie strain (Goldmann et al., 1994), and
natural scrapie that circulates in the flock (Hunter et al., 1996), they are susceptible to an
experimental isolate of scrapie termed CH1641 and also to BSE (Foster et al., 2001).
Studies in mice show that the incubation period of the disease depends not only on PrP
genotype, but that the size and direction of this effect differ according to the prion strain
(Bruce et al., 1991; Carlson et al., 1994). Pattison and Millson (1961) reported the
occurrence of multiple scrapie strains over 30 years ago. Two experimentally passaged
scrapie isolates produced dramatically different clinical signs in goats, labelled "nervous" or
"drowsy", and syndromes were reproducible through subsequent i/c inoculations, implying
that "true breeding" variants of the scrapie agent existed (Carlson, 1996). Over 20
phenotypically distinct TSE strains have been isolated in mice by serially passaging scrapie
or BSE from a number of sheep, goat and cattle sources (Bruce, 2003). It has been suggested
that each TSE strain represents a specific self-propagating PrP conformation (Safar et al.,
1998). Studies in mice indicate that TSE strains interact with genetic elements in the host
and have a strong influence particularly on incubation period (and hence susceptibility to
prion disease) and neuropathology. Experiments using panels of inbred mouse strains have
shown that the BSE agent is indistinguishable from the agent causing vCJD, but differs from
isolates of sCJD, reinforcing the idea that the vCJD epidemic in Britain is the result of
consumption of contaminated beef products (Manolakou et al., 2001). Incubation periods
differ markedly for different TSE strains tested in the same mouse strain. Incubation periods
are highly repeatable when equivalent doses of a specific TSE strain is administered to
different groups of genetically uniform mice, but when different TSE strains are tested in the
same mouse strain, the resulting incubation periods are clearly different (Bruce et al., 1991).
The incubation period is influenced largely by PrP genotype of the mouse and on the scrapie
strain that is inoculated, with Prn-pa showing the shortest incubation period for some TSE
strains and Prn-pb for other strains (Bruce, 2003). For example, when infected with the ME7
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strain, Prn-pa mice have a shorter incubation period than Prn-pb mice. The reverse is true for
the 22A strain whereby incubation times are shorter in Prn-pb mice than in Prn-pa animals.
Incubation time, however, shortens through subsequent passage in mice expressing Prn-pb
(Bruce and Dickinson, 1987), reflecting perhaps host selection for more rapidly replicating
prion mutants present in the 22A isolate (Carlson, 1996). For the ME7 and 22A strains, the
incubation period in the Fi heterozygote (Prn-pab) lies between those of the two parental
phenotypes, and beyond the parental range, respectively (Bruce, 2003).
TSE strains differ in their ability to recognise and replicate in different neuronal populations
in mice (Bruce, 1993), giving rise to characteristic "lesion profiles" (whereby strains are
identified based on the distribution and severity of vacuolation in different areas of the brain
and the presence or absence of amyloid plaques) (Bruce et al., 1991; Fraser and Dickinson,
1968). Each combination of scrapie strain and mouse genotype has a characteristic lesion
profile (Bruce and Fraser, 1991; Bruce et al., 1991). The lesion profile stabilises on
subsequent serial mouse-to-mouse transmissions; the same holds true for the incubation
period, which also shortens after a few passages to produce a strain with characteristic
properties (Bruce, 2003). However, it is possible that the major strain will be passaged
together with minor variants. Hence, it is inappropriate to assume that the isolate contains
only a single strain (Bruce, 1993) unless it is cloned (i.e. serially passaged several times at
the minimum infective dose, to remove minor strains from the isolate) (Bruce, 2003).
Whether or not the strains isolated in mice are representative of field strains in cases of
natural scrapie is not known (Bruce and Fraser, 1991). However, since multiple strains have
been isolated from most primary sources, this may be suggestive that mixed infections are
common under natural conditions (Dickinson, 1976).
Although experimental TSE transmissions in mice have proved to be invaluable for our
understanding of prion biology and disease pathogenesis, additional complexity arises
because occurrence and development of disease depends not only on host genetics and agent
characteristics, but also on the level of infectious challenge, route of exposure and age at
exposure (Jeffrey et al., 2001b). Furthermore, each combination of inbred mouse strains used
in transmission studies contains only limited genetic variability compared with natural
populations, and it is unlikely that all genes affecting the incubation period in natural
populations are accounted for (Manolakou et al., 2001).
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Evidence from experimental infections in mice indicates that the incubation period is a
function of the route of infection and the infective dose (Bruce et al., 1991; McLean and
Bostock, 2000). In general, the incubation period is lengthened when a smaller dose of agent
is given or when a peripheral route of injection is employed instead of an i/c route.
Experiments in mice have shown that the average incubation period increases linearly with
logarithmic decrease in dose, and that the variability in incubation period increases linearly
as the dose decreases (McLean and Bostock, 2000). Other authors have shown that the risk
of infection depends not only on the total dose, but whether the dose was given as one or a
series of challenges (Gravenor et al., 2003). In hamsters infected orally with scrapie-infected
brain homogenate, the attack rate was found to decrease with dilutions of homogenate, and
subclinical infections were identified among the healthy survivors at 520 days post-infection
(Baier et al., 2003). An increase in the incidence of scrapie in sheep and a decline in the age
at which the disease begins have been reported within affected flocks, and have been
attributed to increasing levels of environmental contamination (Foster and Dickinson, 1989;
Sigurdarson, 1991). In kuru, human females had shorter incubation periods compared to
males, which may reflect a higher level of exposure among females rather than any
difference in susceptibility (Huillard d'Aignaux et al., 2002).
Hamir and others (2005) described the experimental transmission of scrapie to genetically
susceptible Suffolk sheep by i/c and oral routes. The oral route resulted in longer incubation
periods (956 ± 196 days) than i/c routes (570 ± 133 days). This is in agreement with findings
from other studies involving the transmission of BSE to NPU Cheviot sheep via the same
routes (Goldmann et al., 1994). Although oral inoculation of PrPSc can lead to disease, this
route is relatively inefficient when compared with direct inoculation of infectivity into the
CNS (Tyler, 2004). Studies on the transmission of scrapie in hamsters suggest that oral
inoculation was nearly a billion times less efficient in transmitting scrapie than was i/c
inoculation and that the oral route of infection is associated with greater variability in
incubation periods compared with parenteral ones (Prusiner et al., 1985).
The survival of a proportion of sheep of susceptible genotypes following oral inoculation
implies that factors other than PrP genotype may also govern the risk of infection by the oral
route, and that uptake of infectivity may vary with factors such as rumen contents or
maturity (Foster et al., 2001). If the immune system of the gut plays a role in susceptibility to
oral infection, it is possible that age will influence susceptibility to TSE infection since the
amount of Peyer's patch (PP) tissue, part of the GALT (or number of lymphoid follicles in
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these structures), decreases with age. Hence, the decreased amount of PP tissue may well
contribute to reduced susceptibility to oral TSE infection in older individuals (Shmakov and
Ghosh, 2001). Although oral exposure appears to be the most likely route of transmission for
natural TSE infections, including vCJD, BSE and scrapie, the majority of published studies
have carried out i/c inoculation of TSE-infected brain homogenates in experimental animals.
In light of current epidemiological data, it appears that multiple oral-exposure events to
BSE-contaminated beef and beef products that seemed likely in the UK, and the occurrence
of vCJD mainly in young adults raise the possibility of age-related susceptibility or exposure
to natural TSE infection (Head and Ironside, 2005).
1.1.6.3 Age ofaffected individuals
A striking feature of the vCJD epidemic has been the young age of most victims and the lack
of any trend toward older ages in patients dying later in the epidemic (Figure 1.1 A). The
median age of onset of vCJD patients was 29 years three years ago (Will, 2003). Analyses,
based on the assumptions that the incidence of vCJD is correlated with exposure to BSE-
infected tissues, and that the incubation period distribution is unimodal for the PrP codon
129 methionine homozygous genotype (MM), show that the current age distribution of vCJD
cases can only arise if younger individuals were either exposed to a greater extent to BSE
through consumption of particular foodstuffs, were more susceptible to infection because of
yet to be identified biological factors, or have shorter incubation periods (Ghani et al, 1998).
It is unlikely that the stable age distribution of cases arose from an age-dependent incubation
period alone. This is because, under the latter hypothesis, we would expect an increasing age
distribution over time, and models without age-dependent susceptibility or exposure do not
provide good fits to the data (Ghani et al., 2003). Furthermore, there is evidence that the
incubation period is not linked to age, as has been found in kuru in humans (Huillard
d'Aignaux et al., 2002). Results demonstrate that individuals between 10 and 20 years of age
are most susceptible to vCJD infection, with those over 40 years old being much less
susceptible (Ghani et al., 2003). However, it has been shown that differential dietary
exposure alone to potential BSE- infected products does not decrease rapidly enough with
age to reduce the risk of infection with vCJD in older adults, and that decreasing
susceptibility with age is required to reproduce the characteristics of the age distribution of
vCJD cases (Boelle et al., 2004).
Although some parallels can be drawn with other human TSEs such as kuru, direct
comparison cannot be made since oral transmission and the species barrier (which is absent
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for kuru) have been shown to lengthen and increase variability in the incubation period in
animal experiments (Diringer et al., 1998; Kimberlin and Walker, 1978). The occurrence and
development of acquired TSEs like vCJD is complex, depending not only upon host
genetics, but also on the level of exposure to the infectious agent, age at exposure and the
species barrier. Hence, it is worth emphasising that extrapolations to acquired human TSEs
need to carefully consider all of these limitations. Although recent data raise the possibility
that the epidemic has peaked (Andrews et al., 2003), models rely on a range of assumptions
including important determinants like the incubation period of BSE in humans or the
infectious dose of BSE for humans, and there remains uncertainty about the likely size of the
total vCJD epidemic.
For BSE, there is an apparent age-dependent risk of infection with calves having a higher
risk of infection than adult cattle (Arnold and Wilesmith, 2004). Cases of BSE typically peak
in cattle at 5-7 years (Defra, 2004) (Figure 1. IB). The majority of clinical cases of scrapie
occur in sheep between 2 and 4 years of age (Baylis et al., 2004; Redman et al., 2002)
(Figure 1.1C). However, cases have been reported in sheep as young as 7 months
(Sigurdarson, 1991) and in animals as old as 11 years (Parry, 1962). In captive cervids, most
cases of CWD occur in animals 2-3 years of age (Figure 1.ID); however, the disease has
been reported in cervids as young as 17 months and as old as >15 years of age (Williams et
al., 2002). Why the peak incidence is in young adults must be a matter of conjecture in the
present state of knowledge. Nonetheless, the age distribution of scrapie is consistent with the
hypothesis that most victims probably encounter the pathogen either prenatally or in early
post-natal life and that the long incubation period of the disease results in a peak incidence at
2 or 3 years old (Dickinson et al., 1964). As mentioned previously, some studies indicate that
in field outbreaks of scrapie (Hunter et al., 1997) or following oral dosing (O'Rourke et al.,
1997), between 12 and 20% of susceptible genotypes do not develop the disease. Other
authors have shown that naturally infected Suffolk sheep flocks do not demonstrate 100%
scrapie disease in susceptible genotypes (Jeffrey et al., 2001b). This implies that other
factors may be involved in determining susceptibility to the disease. Diaz et al. (2005) have
shown that animals first exposed to infection at older ages seemed to be less susceptible to
scrapie than animals encountering infection for the first time early in life. Although this age
effect may be explained by a higher susceptibility of younger animals to scrapie infection
(Matthews et al., 2001), a relationship between age at infection and age at which symptoms
appear also exists (Woolhouse et al., 1998). Therefore, animals exposed at older ages may
have been culled or died for other reasons, resulting in insufficient time to develop scrapie
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symptoms, although available data suggest that the average incubation period for all
susceptible genotypes is unlikely to be significantly greater than 2 years (Woolhouse et al.,
1998). Another complication arises in understanding how the age-incidence curve for scrapie
interacts with the background survivorship (or the natural mortality of sheep). This is
reflected in one study (Chase-Topping et al., 2005), which found that the peak in scrapie
deaths approximates the point at which 50% of the susceptible animals in the flock, in which
scrapie was not diagnosed, were being removed. Whether these removals were the result of
susceptible genotypes being in poorer condition and consequently removed at younger ages,
or whether they developed pre-clinical scrapie is not known.
Due to the age range considered and the route of transmission, biological factors involved in
the maturation of the immune system of the gut and peaking in adolescent years may
promote prion replication and consequent development of disease. Previous studies suggest
that the incidence of scrapie infection decreases with the age at which animals are exposed
and infection is thought to occur in young sheep less than 9 months of age and (Hourrigan et
al., 1979). During this period of high susceptibility to infection, the ileal PP is the major
GALT possessing an extensive bed of FDCs and specialized epithelium (follicle-associated
epithelium or FAE) actively engaged in the transport of antigens and macromolecules from
the gut to the underlying lymphoid tissue (Press et al., 2004). In humans, the number of PPs
was found to be higher in the small intestine of teenagers than in young children and adults
(Cornes, 1965). The same holds true for sheep (Reynolds and Morris, 1983) and cattle
(Carlens, 1928) whereby the amount of PP tissue decreases with age, with a peak occurring
in adolescent years. Assuming that particle uptake capacity is a function of the area occupied
by FAE overlying PPs, these differences may explain susceptibility of young people and
lambs to vCJD and scrapie, respectively (Shmakov and Ghosh, 2001). There is some
variation between different individuals (sheep, cattle and humans) in all age groups (Carlens,
1928; Cornes, 1965; Reynolds and Morris, 1983), and this variation may well contribute to
individual susceptibility to prion diseases.
In experimental studies of mice, the age at time of peripheral injection with scrapie is known
to influence the length of the incubation period and susceptibility to scrapie (Outram et al.,
1973). I/p injections of ME7 scrapie were found to be 100% lethal in young adult mice and
killed only about 80% of neonatal mice, which also showed significantly prolonged
incubation periods (Outram et al., 1973). Paradoxically, a proportion of the neonatal mice
injected subcutaneously with ME7 developed scrapie after shorter incubation periods
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compared to weanlings, and if neonatal mice were challenged with higher scrapie doses, the
proportion of mice with shorter incubation periods increased. Survivors only occurred in the
newborn group given the lowest titre (Outram et al., 1973). Based on these findings, it was
proposed that neonatal mice that survive peripheral scrapie challenge and those with
prolonged incubation periods have an impaired ability to replicate scrapie and may lack a
mature cell population that could be undergoing differentiation after birth and required for
the initiation of scrapie pathogenesis (Outram et al., 1973). Hence, the outcome would
ultimately depend on the balance of an individual's developmental state and the dose of
agent used (Outram et al, 1973). Other work has shown neonatal mice to be very susceptible
to agent injected by various s/c routes (Ierna, 2001; Outram, 1976). After s/c challenge of
neonatal severe combined immunodeficient (SCID) and CB20 mice with the ME7 strain, a
very high proportion developed scrapie with short incubation periods (Ierna, 2001). SCID
mice inoculated at 14 days or older did not develop scrapie with short incubation periods and
were relatively resistant to infection. These results imply that neonatal mice may possess an
efficient mechanism by which infectivity can quickly gain access to the CNS following s/c
challenge with scrapie. Since similar proportions of neonatally challenged SCID and CB20
mice succumbed to scrapie after short incubation periods, similar pathogenic mechanisms
(following s/c inoculation) may be involved and may not necessarily be FDC-dependent
(Ierna, 2001).
Although studies in mice demonstrate an age-effect, direct comparisons cannot be made to
other species because of differences in development of the lymphoreticular system (LRS) in
mice and the route of inoculation used in these experiments. Humans, sheep and cattle for
example, are more immunologically mature at birth than mice. In mice, the lymphoreticular
system and in particular FDCs are still undergoing development during the first two
postnatal weeks (van den Berg and Dijkistra, 1995) and therefore, may be unable to replicate
the scrapie agent. Splenic FDCs do not become fully mature until about 2-4 weeks after birth
and the time at which FDCs mature coincides with the normalisation of the scrapie
incubation period to that of the adult (Ierna, 2001). Furthermore, unlike i/p infection, oral
exposure to the scrapie agent appears to be less or not dependent on the spleen (Kimberlin
and Walker, 1989a). This has been suggested by Kimberlin and Walker (Kimberlin and
Walker, 1989a; Kimberlin and Walker, 1989b) who observed that splenectomy does not
prolong the incubation period after intragastric infection as opposed to the prolongation
observed following infection via the i/p route.
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So far, there is no clear biological explanation for the apparent age distribution of TSEs.
Although a relation with puberty may be hypothesized, evidence should be sought to support
such a possibility since the age-susceptibility relationship is crucial in determining whether
or not the age of vCJD cases is increasing and, if not, whether it should be expected to do so.
1.1.7 Pathogenesis of the TSEs
Oral exposure appears to be the most likely route of transmission for natural TSE infections
including natural scrapie, BSE, CWD, TME, Kuru and vCJD (Gajdusek, 1977; Hadlow et
al., 1982; Marsh and Bessen, 1993; Shmakov and Ghosh, 2001; Williams and Young, 1980).
For example, it is believed that kuru was spread through cannibalism, which was associated
with ritual mourning among the Fore people in New Guinea (Gajdusek, 1977). A more
recent example was the emergence of a number of cases of vCJD in 1996, which suggested
that these cases might be causally linked to the BSE epidemic in UK cattle (Will et al., 1996)
and was almost certainly due to the consumption of BSE-infected meat products (Bruce et
al., 1997). In sheep, other potential sources of natural infection which have been shown to be
effective experimentally, are scarification (Taylor et al., 1996) and horizontal transmission
(Andreoletti et al., 2002a) by consumption of foetal membranes from scrapie-infected sheep
(Pattison et al., 1972). Several studies have been carried out on the transmission of scrapie in
sheep by embryo transfer. In one study, scrapie was found not to be transmitted to offspring
via the embryo nor was the infective agent transmitted to recipient ewes during embryo
transfer procedures (Foote et al., 1993). Another study showed that scrapie was transmitted
via embryo transfer (Foster et al., 1996). These experiments have revealed conflicting results
and do not provide an adequate basis to confirm that embryo transfer is a truly safe method
of preventing the transmission of scrapie (Foote et al., 1993; Foster et al., 1996; Foster et al.,
1992). Further work is required to provide a definitive answer to embryo transfer and scrapie
transmission. Work to date argues against the transmission of scrapie in utero. No infectivity
was detected in foetal tissues from naturally infected dams (Hadlow et al., 1982; Hourrigan
et al., 1979) and no apparent PrPSc was detected within the foetus (Andreoletti et al., 2002b).
Epidemiological evidence suggests that if vertical transmission occurs at all, it does not
account for the majority of cases in heavily infected flocks (Elsen et al., 1999; Woolhouse et
al., 1998).
Many studies have used experimental mice and hamster scrapie models in an attempt to
elucidate the pathogenesis of TSEs. It is important to note that several factors determine the
course of TSE infection including the infecting TSE strain, the host PrP genotype and the
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route and dose of infection (Farquhar et al., 1994). For example, comparatively different
ranges of incubation period have been obtained using many mouse scrapie models, which
vary mainly in agent strain and Sine genotype of the mouse (Kimberlin and Walker, 1988).
Although the i/c route of infection is used extensively for bioassays of infectivity, it does not
represent a clinically relevant model for scrapie. Eklund et al. (1967) performed a major
study on "Chandler" scrapie in which the agent was injected s/c. It was established that
extraneural events of scrapie pathogenesis (which were bypassed by the i/c route) were
involved after peripheral challenge. This finding was confirmed by Hadlow et al. (1982) who
showed that after peripheral exposure, pathogenesis necessarily involves the LRS before the
CNS. The importance of the immune system in the pathogenesis of TSEs is further
exemplified by alteration of the immune cell repertoire, either by splenectomy (Fraser et al.,
1996; Kimberlin and Walker, 1989a), disease (Lasmezas et al., 1996) or genetic
manipulation (Brandner et al., 2000), which can alter the progression of prion disease. Since
oral exposure has been incriminated as one of the most probable routes of transmission
leading ultimately to neuroinvasion, it seems appropriate to investigate this route of infection
and to identify potential target cells of scrapie infectivity for purposes of prophylaxis and
therapy.
1.1.7.1 The role ofGALT in oral TSE Pathogenesis
The appearance of vCJD and evidence suggesting that this new human prion disease resulted
from interspecies transmission of BSE (Bruce et al., 1997) has renewed scientific interest in
the pathogenesis of oral transmission of TSEs, as this represents the most obvious route of
human exposure to BSE-infected material.
Although lesions are restricted to the CNS, the pathogenesis of infection implies an initial
replicative phase of the infectious agent in the lymphoid tissues prior to invasion of the CNS
and development of clinical disease (Hadlow et al., 1982; Sigurdson et al., 1999). The
lymphoid system is essential for transport of prions from the periphery to the CNS as
evidenced by the impairment of CNS disease in immune deficient mice (like SCID, RAG ' or
pMT mice) after i/p inoculation, and development of CNS disease after i/c inoculation
(Fraser et al., 1996; Klein et al., 1997; Lasmezas et al., 1996). When rodents were orally
exposed to scrapie, PrPSc accumulation occurred first in PPs and ganglia of the enteric
nervous system (Beekes and McBride, 2000) long before detection in the CNS (Farquhar et
al., 1994). PrPSc was also first detected in lymphoid tissues (including the retropharyngeal
lymph node, tonsil, PPs and ileocaecal lymph node) following experimental oral infection of
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Figure 1.2 PP structures in sheep and mice. A. Lymphoid follicle of the ileal PP in a 6 year-old
Cheviot sheep B. PP in a 35 day-old C57 BL mouse containing two germinal centres. LZ=light zone
of lymphoid follicle; DZ=dark zone of lymphoid follicle; D=dome; L=lumen; GC=germinal centre.
mule deer fawns with CWD (Sigurdson et al., 1999). In one study (Kimberlin and Walker,
1989a) it has been shown that mice infected intragastrically with scrapie had detectable
infectivity in PPs and cervical lymph nodes as early as one week post-inoculation. Other
authors (Wells et al., 1994) have shown that BSE can be transmitted orally to cattle with
infectivity detectable in the ileum of calves at 26 weeks post-inoculation. Kuru, Creutzfeldt-
Jakob disease and scrapie have been transmitted to squirrel monkeys (Saimiri sciureus) after
oral exposure to infectious tissue (Gibbs et al., 1980). These findings support oral exposure
as a natural route of infection for TSEs.
1.1.7.1.1 PPs: What makes these structures so interesting?
PPs are collections of lymphoid follicles, located along the anti-mesenteric border
throughout the small intestine, and present in a wide variety of animals including birds,
rodents, ruminants and man (Griebel and Hein, 1996; Poskitt et al., 1984) (see Figure 1.2).
Historically, butchers expressed concern (more so than physicians) over PPs which appeared
as thimble-shaped structures on the surface of intestines and as casings for sausages, making
them less marketable (Carlson and Owen, 1987).
PPs of the small intestine were first described in 1677 by a Swiss physician, Johann Conrad
Peyer (Griebel and Hein, 1996), although patches may actually have been discovered by
Marco Aurelio Severino in 1645 who may not have proclaimed his findings sooner (Heel et
al., 1997). These organs form a major part of the GALT, which plays a critical role in the
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induction and dissemination of immune responses at mucosal surfaces (Griebel and Hein,
1996), and which also consists of colonic and caecal patches, appendix and isolated
lymphoid follicles throughout the intestine from the oesophagus to the rectum (MacDonald
and Spencer, 1994).
PPs occur with increased frequency in the ileum, especially the terminal ileum (Cornes,
1965; van Kruiningen et al., 2002). It has been theorised that intestinal contents progress at a
relatively slower pace near the ileocaecal junction thus resulting in increased contact time
between antigens and mucosa and consequently, leading to the development of PPs in
response to this increased contact (Carlson and Owen, 1987).
The amount of PP tissue in the distal ileum bears clinical relevance. With respect to vCJD,
the quantity of lymphoid tissue encountered during some clinical procedures for example,
lower gastrointestinal endoscopy, may contribute to the risk of transmitting PrP to the next
patient. Axon et al. (2001) have indicated that the greatest risk arises from biopsy of the
terminal ileum, where PPs are highly concentrated and may contain significant levels of PrP
for a patient incubating vCJD. Because these lymphoid organs are undoubtedly an inherent
part of natural TSE pathogenesis, it is important to examine briefly the comparative aspects
of the structure and function of PPs in the different species. Furthermore, the variation in PP
number, size and area in different individuals is greater than is often appreciated and whether
this variation is related to susceptibility to TSE infection raises an intriguing possibility.
1.1.7.1.2 Heterogeneity ofPPs in the different species
Two distinct groupings are observed with respect to the anatomical and developmental
patterns of the amount of PP tissue found in various regions of the intestine. In ruminants,
pigs, horses, dogs and humans (group I species) the PP tissue is unequally distributed along
the small intestine with 80% to 90% of the total mass of PP tissue occurring in the ileum
(HogenEsch et al., 1987; Pabst et al., 1988; Reynolds and Morris, 1983). In sheep, the total
weight of PP tissue is greater than any other single lymphoid tissue by around 6 weeks after
birth, accounting for about 1.2% of the body weight (Reynolds and Morris, 1983). The ileal
PP forms a single continuous aggregation of lymphoid follicles that can extend up to 2.5 m
(in 6 week-old lambs) from the ileocaecal junction, proximally, accounting for about 90% of
the total mass of PP tissue (Reynolds and Morris, 1983; Reynolds and Pabst, 1984). The ileal
PP in a lamb contains about 100,000 follicles (Reynolds, 1987). In young pigs, the ileal PP
may extend up to 2 m in length (Pabst et al., 1988). In humans, PPs are distributed in small
clusters throughout the gastrointestinal tract, and as in sheep, are most concentrated in the
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terminal ileum (Cornes, 1965; van Kruiningen et al., 2002). The number of follicles per
patch vary from as few as 5 to several hundred (Cornes, 1965)). Although a similar bias
seems to exists for horses, the amount of PP tissue occurring in the ileum has not been
accurately measured (Carlens, 1928). A continuous ileal PP is also found in young
carnivores, such as blue foxes and mink (Landsverk et al., 1991).
In rabbits, rodents and chickens (Group II species), PPs occur at random intervals along the
jejunum and ileum (Abe and Ito, 1978; Befus et al., 1980; Waksman, 1973). In rats, there are
approximately 18 to 26 PPs, the number of macroscopically visible PPs and their sizes
increasing with age in young rats up to 6 weeks postpartum (Hummel, 1935). The number of
follicles in each patch varies from as few as 4 to 6 to about 20 in the largest patch near the
ileocaecal junction. Mice have approximately 9 PPs in the small intestine (Mayrhofer, 1984).
In rabbits, PP number ranges from 2 to 10 per animal, consisting of approximately 40 to 50
follicles (Faulk et al., 1970). In rabbits and chickens, specialized GALTs are also present in
other areas of the small intestine. These include the sacculus rotundus and an exaggerated
appendix in rabbits, and the bursa of Fabricius in chickens (Griebel and Hein, 1996).
Histologically, the rabbit appendix and the bursa of Fabricius resemble the sheep ileal PP,
while the PPs in the rabbit resemble the sheep jejunal PPs (Reynolds et al., 1985).
The PPs develop differently between species of these two groups. In Group I, PPs develop
well before birth in the ileum (by 110 days gestation in lambs) and jejunum (by 75 days
gestation in lambs) (Reynolds et al., 1985). The only other lymphoid organs which are
histologically mature before birth are the thymus and avian bursa of Fabricius (Archer et al.,
1963; Cooper and Lawton, 1973). Since external antigen is not required for the development
of jejunal and ileal PPs, the follicles in PPs are not comparable to germinal centres
(Reynolds and Morris, 1983). The jejunal and ileal PPs, however, develop differently after
birth. The ileal PPs reach their maximum size early in life and then involute in a manner
similar to that of the thymus. For example, in sheep, the ileal PP begins to involute from
about 12 weeks after birth with only a few follicles remaining in the ileum by 18 months of
age (Reynolds and Morris, 1983). In humans, the number of PPs increases to a maximum in
the entire small intestine by late adolescence and then decreases with increasing age (Cornes,
1965). Van Kruiningen et al. (2002) studied the distal ileum of humans and concluded that a
greater amount of lymphoid tissue was present in 21 to 30 year-olds than in older age groups,
and that the area of PP tissue declines progressively with age. However, the study included
few young subjects (none within the age category, 0-15 years) and different criteria were
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used (from Cornes, 1965) in defining a PP. The ileal PP in minks and blue foxes is thought
to regress early, probably at about one year of age (Landsverk et al., 1991). The jejunal PPs,
by contrast, persist throughout the life of the animal, although the density of follicles may
decrease with increasing age (Griebel and Hein, 1996).
In Group II species, PPs develop post-natally, usually in the first 2-4 weeks after birth (Abe
and Ito, 1978; Befus et al., 1980; Sminia et al., 1983; Waksman, 1973) and, as for the jejunal
PPs of Group I species, also persist into old age (Griebel and Hein, 1996). The development
of PPs in Group II species depends on antigenic stimulation since they remain small and
poorly developed in germ-free mice.
1.1.7.1.3 Function ofPPs
The two types of sheep PPs (ileal and jejunal) can be distinguished by their microanatomy
and cellular composition of follicles (Hein et al., 1989; Larsen and Landsverk, 1986;
Reynolds et al., 1985). The ileal PP of sheep consists of densely packed, long, sac-like
lymphoid follicles, each separated by a connective tissue sheath. The follicles contain mostly
B cells (95% sIgM+) and few T cells (<0.5% CD4+). Jejunal PPs on the other hand, have
small, pear-shaped follicles separated by large interfollicular areas, and contain up to 15% T
cells (Griebel and Hein, 1996). Studies investigating the functions of PPs have been
performed mostly on rodents and based on interpretation of the data obtained, various
authors have cast PPs as secondary lymphoid organs (where mature lymphocytes become
stimulated to respond to invading pathogens). In rats, PPs were recognised as a site of
generation of antigen-specific IgA precursors, which then migrate to other regions of the gut
lamina propria (Husband et al., 1977). In another study, rabbit PPs were found to contain an
enriched population of IgA precursors that seeded into other areas of the gut (Craig and
Cebra, 1971). Microfold cells (or M cells), which have been described (Nicoletti, 2000),
present a possible route for transport of macromolecules and micro-organisms from the gut
lumen to the underlying mucosal tissue. The concept of PPs as secondary lymphoid organs
contains the element that antigen uptake (including prion uptake) occurs in these specialized
cells or M cells (Heppner et al., 2001; Nicoletti, 2000). Reynolds (1987) conducted a series
of experiments in sheep, which ultimately classified sheep ileal PPs as primary lymphoid
organs (or organs where immune cells develop and mature to the stage at which they are able
to respond to a pathogen). In sheep, the ileal PP is the most significant source of B cells for
export to other tissues (unlike laboratory rodents where the major source is the bone
marrow), and antigen does not have to be present for lymphopoiesis to occur (Reynolds,
1987). Removal of the ileal PP in sheep foetuses near to term or shortly after birth resulted in
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lambs remaining B-cell deficient for at least one year and failing to produce antibodies
(Gerber et al., 1986). Most PPs in sheep have stopped producing B cells by the time the
animal is fully grown (Reynolds, 1987). Other more recent studies have also supported the
role of the ileal PP as a primary lymphoid organ (Reynaud et al., 1995; Reynaud et al.,
1991).
1.1.7.1.4 Role ofPPs in TSE Pathogenesis
PrPSc has been widely accepted as a marker of TSE infectivity and used to investigate the
pathogenesis of the TSE agent. Following peripheral inoculation, abnormal PrP usually
accumulates in a variety of lymphoid tissues well before the CNS is involved (Sigurdson et
al., 1999; Williams and Miller, 2002). PPs show early presence of infectivity (Kimberlin and
Walker, 1989a) and PrPSc (Beekes and McBride, 2000) after oral exposure to the TSE
infectious material, and are the most probable sites for the intestinal uptake of prions
(Shmakov and Ghosh, 2001) (Figure 1.3). Andreoletti et al., (2000) have suggested that
natural scrapie infection occurs via the oral route and that the ileal PP acts as a likely primary
entry site of the scrapie agent. In one study (Terry et al., 2003), PrPSc staining was
demonstrated in the follicles of PPs of the distal ileum of cattle orally exposed to the BSE
agent. This finding supports the suggestion that, in common with some other models of
TSEs, the distal ileum is a probable route of entry of the agent. However, in the same study,
no immunostaining was detected in the lymphoid tissue of the distal ileum of naturally
occurring clinical cases of BSE; this finding has been attributed to the possibility of natural
field cases of BSE having been exposed to lower doses of the agent or the inability to detect
decreased infectivity after an incubation period of 5 years (Terry et al., 2003). It is likely,
therefore, that the importance of lymphoreticular amplification varies with the dose and
possibly the strain of the infecting agent. PrPSc staining has also been reported in PPs and
tonsils in non-human primates after natural and experimental infection by the BSE agent
(Bons et al., 1999). Additional evidence supporting a key role for PPs in oral infection with
the TSE agent comes from the fact that mice with genetic defects resulting in decreased
numbers of PPs are resistant to oral challenge with prions (Prinz et al., 2003).
Following oral exposure of hamsters to scrapie, pathological PrP accumulations were
detected in PPs within cells of the FAE which have M cell morphology (Beekes and
McBride, 2000). M cells are specialized epithelial cells of the FAE and occur only over
mucosal lymphoid follicles (Kucharzik et al., 2000). They are the key sites of antigen
sampling in the gut mucosa and play a central role in the initiation of gut immune responses
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by transporting enteric pathogens from the gut lumen to the underlying lymphoid tissue
(Nicoletti, 2000). Experiments using an in vitro cell culture model suggest that M cells have
the ability to transcytose the TSE agent across the gut epithelium (Heppner et al., 2001).
Oral inoculation with prions in mice deficient in enteric lymphocytes but with preserved M
cells indicates that it is the M cells and not the enteric lymphocytes that are critical in initial




Figure 1.3 Possible spread of scrapie infectivity from the gut lumen to the nervous system following
oral infection (route indicated by dotted line). Soon after ingestion, PrPSc is detected readily within
Peyer's patches upon FDCs, within macrophages, within cells with morphology consistent with that of
M cells and within ganglia of the enteric nervous system (ENS). These observations suggest that
following uptake of scrapie infectivity from the gut lumen infectivity accumulates upon FDCs in
Peyer's patches and subsequently spreads via the ENS to the CNS. DC=Dendritic cell; FAE=follicle-
associated epithelium (taken from Mabbott and Bruce, 2001).
It has also been suggested that intestinal mucosal epithelial cells may provide a route for
entry of PrPSc. This is based on immunoreactivity found in intestinal cells of the small and
large intestine and a laminin receptor found on human small intestinal mucosa which can
bind PrPSc (Rieger et al., 1997; Shmakov et al., 2000). It is important to note that M cells
differ in their ability to "sample" specific pathogens depending on species and location in the
gut. For example, the FAE overlying the ileal PP in ruminants does not constitute a
population of typical M cells, but instead comprises an homogenous population of epithelial
cells capable of phagocytosis (Landsverk, 1988; Landsverk et al., 1987). Furthermore, calf
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M cells in the FAE of jejunal PPs, which are comparable to those of mice in structure
(Landsverk et al., 1987), do not appear to take up latex or parapox virus (Landsverk, 1988).
In lambs, the FAE of the ileal PP, but not of the jejunal PP, secretes small membrane-bound
carbonic-anhydrase-positive particles, which move into the domes and central areas of
underlying follicles (Landsverk et al., 1987; Landsverk et al., 1990). Despite these
differences, the FAE overlying calf and lamb ileal PPs, as well as jejunal PPs, has a well-
developed mechanism for the transcytosis of luminal material (Landsverk et al., 1991), and
does not preclude the possibility that M cells (and homogenous epithelial cells in the ileum
of ruminants) are the portal of entry for prions. Whether these regional and species
differences apply to uptake of prions requires direct investigation.
In PPs, dendritic cells form a dense layer of cells in the subepithelial dome just beneath the
FAE and in close contact with M cells (Kelsall and Strober, 1996). Migratory bone marrow-
derived dendritic cells are centrally involved in transport of proteins both within PPs and to
mesenteric lymph nodes (Banchereau et al., 2000; Huang et al., 1996). It is probable that in
deer (which possibly demonstrate an immunobiology similar to that in sheep), initial uptake
and propagation of PrPRes could occur in the ileal PPs and tonsils and within dendritic cells
that act as a cellular bridge, transporting PrPSc from the gut lumen via the lymphatics to the
lymphoid tissue (Huang et al., 1996) and emigrating via the lymphatic system to the
ileocaecal and retropharyngeal lymph nodes (Sigurdson et al., 1999).
1.1.7.2 The origin and characteristics ofFDCs
FDCs are specialized antigen-trapping cells that have only been detected in the lymphoid
tissue, located within B-cell follicles (Humphrey et al., 1984; Radoux et al., 1984). They
have morphological similarities or critical markers in common with several other cell types
including reticular cells, pericytes, some antigen-transporting cells, mononuclear cells and
endothelial cells, and this has prompted the suggestion that each of these cell types may
represent an FDC precursor and may explain the origin of FDCs (Tew et al., 1982).
However, the origin of this unique cell type has not been unequivocally established. FDCs
may be derived from primary lymphoid tissue and need not develop from local stromal cells
originating in the local secondary lymphoid tissue (Kapasi et al., 1998; Tew et al., 1982).
They can be distinguished from other immune system cells based on their cytoplasmic
extensions (dendrites), which form a dense network in the germinal centre and make contact
with germinal centre B-cells (MacLennan, 1994). Their location is restricted to the light
zones of germinal centres of the lymphoid follicles and FDCs have the ability to trap and
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retain immune complexes on their surfaces for prolonged periods of time (from months to
years) through the presence of complement receptors (CR1, CR2 and CR3) and the Fc
receptor (Fang et al., 1998; Liu et al., 1997; Schriever et al., 1989; Sellheyer et al., 1989;
Tew et al., 1990; Tew et al., 1997). FDCs should not be confused with the typical dendritic-
type cells, which may be found in virtually any area of the body and may be thought of as
sentinels of the immune system (Ibrahim et al., 1995). Dendritic-type cells, rather than
presenting antigens to B-cells, interact with, and process and present antigens to T-cells in a
highly efficient fashion (Cella et al., 1997; Schuler et al., 1997; Shortman et al., 1997;
Steinman, 1996).
FDCs are resistant to high doses of radiation and appear to be very long-lived cells with a
slow turnover, for example, antigen-bearing FDCs are present in murine hosts for more than
a year (Tew et al., 1990; Tew et al., 1982). According to Tew and colleagues (Tew et al.,
1982), this inevitably presents a problem in FDC pathogenesis studies since radiation does
not eliminate FDCs from the system, and host FDCs are likely to be present following
reconstitution with donor bone marrow. Consequently, difficulties may arise when trying to
detect FDCs of donor origin.
1.1.7.2.1 FDCs and their role in TSEpathogenesis
It has been suggested that the host immune system may act as a critical susceptibility factor
(Partanen, 2003) particularly as PrPSc can first be detected in lymphoid tissues on FDCs
(Mabbott and Bruce, 2001). Mature FDCs express high levels of the host PrP (PrPc), which
may be converted to PrPSc (Burthem and Roberts, 2003), and is essential for TSE replication
in lymphoid tissues (Brown et al., 1999). PrPSc usually accumulates on FDCs of lymphoid
tissues of patients with vCJD (Hill et al., 1999), sheep naturally infected with scrapie (van
Keulen et al., 1996) and rodents inoculated with scrapie via the peripheral route (Brown et
al., 1999; Mabbott et al., 2000; McBride et al., 1992) and appears to be critical for
neuroinvasion. The importance of FDCs in TSE pathogenesis has been demonstrated through
several studies. Mabbott et al. (2000) have shown that treatment of mice with lymphotoxin
p-receptor and human immunoglobulin (LTpR-Ig) before or shortly after peripheral scrapie
challenge with the ME7 scrapie strain, significantly extended incubation periods, compared
to that of control mice treated with human immunoglobulin. FDCs depend on expression of
lymphotoxin a/p receptor by B-cells (Endres et al., 1999), and blocking of this signalling
with LTpR-Ig is believed to result in a loss of mature FDCs and consequently, a substantial
slowing of the disease. However, after i/c challenge, treatment with LTpR-Ig had no effect
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on disease development and scrapie pathogenesis in the brain (Mabbott et al., 2000). FDCs
can, therefore, serve as potential targets for therapy in peripherally transmitted TSE diseases
like vCJD. It is worth noting that the authors inoculated mice intraperitoneally and
intracerebrally. These routes are however, not equivalent to natural routes of oral infection,
and the importance of FDCs as an amplifying site for prion infectivity after oral infection
remains unsettled.
1.1.7.2.2 The use of immunodeficient and chimeric mice in determining the role ofFDCs
in TSE pathogenesis
The role of FDCs in TSE pathogenesis has been investigated using SCID mice. SCED mice
lack mature FDCs (Kapasi et al., 1993) and are easily transplanted with a variety of donor
cells. Hence, they provide a useful tool for assessing the role of FDCs in TSE pathogenesis.
In SCID mice, the lack of FDCs is demonstrated by the absence of antigen localization on
FDCs in lymph node and splenic follicles of passively immunized mice, and by the absence
of labelling with the monoclonal antibody FDC-M1 (Kapasi et al., 1993). Kapasi and
colleagues (1993) have shown that FDC networks develop rapidly in SCID mice
reconstituted with B- and T-cells; this indicates that SCID mice have SCID precursors, and
that immature FDCs can be induced to mature by bone marrow grafts from
immunocompetent donors.
In mouse scrapie models, mature FDCs express high levels of the host PrP (PrPc), which is
essential for TSE replication in lymphoid tissues (Brown et al., 1999). Studies using SCID
mice have indicated involvement of FDCs in scrapie pathogenesis of the ME7 scrapie strain.
Brown et al. (1999) used PrP chimeric mice, by "/-irradiating PrP+/+ or PrP' mice (which
destroys lymphocytes, myeloid cells and their progenitors, but not FDCs), and then grafting
bone marrow from PrP-deficient (PrP_/~) knockout mice into PrP-expressing (PrP+/+) mice
and vice versa. It was found that replication of the mouse-passaged ME7 scrapie strain in
spleen involves FDCs with no evidence for any direct involvement of circulating B-cells or
other bone marrow-derived cells. Replication of the scrapie agent did not occur in mice with
PrP-deficient FDCs, even when bone marrow was grafted from PrP-expressing mice, that is,
PrPc on FDCs was seen only when the recipient expressed a functional PrP gene. PrP status
of bone marrow-derived cells did not influence the levels of infectivity measured in the
spleen, nor did it affect the time of development of neurological disease in mice infected
intraperitoneally.
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Tumour necrosis factor-a (TNF-a) signalling from B-lymphocytes is important for the
maturation of FDCs (Mabbott and Bruce, 2001). TNF-receptor 1 (TNF-R1) is expressed on
the FDC and/or its precursor (Tkachuk et al., 1998). Signalling is mediated via this receptor,
and mice deficient in either TNF-a or TNF-R1 lack mature FDCs (Le Hir et al., 1996;
Pasparakis et al., 1996). After peripheral challenge, TNF-a knockout mice either fail to
develop scrapie, or few develop clinical disease after extended incubation periods (Brown et
al., 1999).
1.1.7.2.3 The Rocky Mountain laboratory (RML) scrapie isolate
There are several laboratory mouse-passaged TSE strains that have distinct incubation
periods and neuropathological characteristics; findings suggest that some strains may target
different cell populations in peripheral tissues. For example, studies (Blattler et al., 1997;
Klein et al., 1997) using the Rocky Mountain Laboratory (RML) scrapie isolate have given
remarkably different results from that obtained by Brown et al. (1999). Blattler et al. (1997)
found that replication of the scrapie agent took place in the LRS and could be restored by
PrP-expressing lymphocytes and myeloid cells although the specific lymphohaemopoietic
stem cells or LSC-derived cells involved in prion replication have not been determined
(Raeber et al., 1999). Several authors concluded that mature B-lymphocytes are critical for
neuroinvasion by scrapie after peripheral exposure, and discounted the crucial role of FDCs
in TSE pathogenesis (Klein et al., 1998; Raeber et al., 1999). It has been suggested that B-
lymphocytes may act directly by serving as a "transport vehicle" by delivering prions
physically to the nervous system, or indirectly by promoting neuroinvasion through the
secretion of factors like antibodies or cytokines, or inducing maturation of FDCs, which may
in turn be directly responsible for neuroinvasion (Klein et al., 1998). It appears that the RML
scrapie isolate, unlike the ME7 strain, is able to replicate in bone marrow-derived cells, and
that different scrapie strains may target different cell types in lymphoid tissue (Brown et al.,
1999) as they do in brain tissue (Bruce et al., 1989). Kapasi and colleagues (1998) showed,
however, that bone marrow contains FDC precursors and could therefore, be derived from
primary lymphoid tissue. Pre-FDCs may leave the bone marrow and become dispersed in
tissues throughout the body; the intermediate-type pre-FDC supply could be great enough to
provide precursors for months, resulting in development of new FDC networks (Kapasi et
al., 1998). In an earlier study (Kapasi et al., 1993), it was found that B- and T-cells can
induce host FDC development in SCID mice, suggesting that FDC precursors were present
in these mice. Rather than reconstitute the bone marrow with B-lymphocytes, it has been
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suggested that SCID mice be reconstituted with various kinds of bone marrow cells
including leukocyte precursors.
TNF-R1"'" mice, which apparently lack mature FDCs, were found to be very susceptible to
peripherally administered prions (Klein et al., 1997). However, immunomodulation alters
susceptibility to TSEs in rodent models (Mabbott et al., 1998) and may be in accordance
with the finding that resistance to scrapie of immune-deficient mice may be overcome by
relatively large inocula of prions (Brown et al., 1999) and may directly infect peripheral
endings bypassing the need for replication in peripheral tissues (Fraser et al., 1996;
Lasmezas et al., 1996). It has been suggested that susceptibility of TNF-R1"'" mice to
peripherally administered prions may depend on a population of cells that is not identified by
the FDC markers, FDC-M1 and FDC-M2 (Klein et al., 1998).
Studies using athymic mice indicated that T-lymphocytes were not involved in TSE
pathogenesis (Fraser and Dickinson, 1978; McFarlin et al., 1971). One major point is worth
mentioning with respect to these studies. Recently, new GALT has been described in murine
(isolated lymphoid follicles or ILFs and "cryptopatches") (Ishikawa et al., 1999; Kanamori
et al., 1996) and rat (lymphocyte-filled villi or LFV) (Moghaddami et al., 1998) small
intestine. ILFs have been described as being structurally and functionally similar to the
follicular units that compose PPs and may serve as a complementary system to PP for the
induction of intestinal immune responses. ILFs develop normally in the progeny of
transplacentally manipulated PP-deficient mice and decreased numbers of conspicuously
atrophied ILFs have been found to be present in IL-7Ra"/" ppnu" mice (Hamada et al., 2002).
Researchers investigating the role of PPs in oral TSE pathogenesis need to take these
observations into consideration since previous studies may have examined the role of PPs
without considering the compensatory role of ILFs.
Cryptopatches are tiny areas of lymphoid tissue situated randomly around the circumference
of the intestinal wall of mice (Hamada et al., 2002), and are not detectable until the
fourteenth day post-partum (Kanamori et al., 1996). Murine cryptopatches and rodent LFV
occur in athymic (nude) mice and rats, respectively (Moghaddami et al., 1998). Evidence
shows that large numbers of T-cells develop in the mucosa of the murine small intestine
without passing through the thymus. These T-cells, derived from the intestine, are called
intestinal intraepithelial T-lymphocytes (IELs); IELs are concentrated in cryptopatches
(Ishikawa et al., 1999). Both cryptopatches and rodent LFV have been identified as sites of
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primary extrathymic T-cell differentiation (Moghaddami et al., 1998). The reliability of
studies investigating the role of T-lymphocytes in TSE pathogenesis (Fraser and Dickinson,
1978; McFarlin et al., 1971) remains doubtful since extrathymic T-cell development in
cryptopatches was not considered. Nonetheless, a more recent study (Klein et al., 1997)
using the RML isolate support the finding that T-cell defects do not impair susceptibility to
scrapie.
It will be interesting to determine whether the findings described above are also valid for
other species, including sheep and non-human primates, using oral inoculation, and whether
the development of disease may be accelerated in conditions such as inflammatory bowel
disease, whereby, the number of FDC-containing lymphoid aggregates is increased in the
intestine (Yeung et al., 2000). Most studies have been directed at splenic FDCs. Perhaps
future studies also need to focus on FDCs present in other lymphoid organs, including PPs.
Whether the time of appearance of FDCs in lymphoid tissue, including lymphoid follicles of
PPs helps to determine susceptibility of an individual to TSE infection is well-worth
investigating and forms the basis of this thesis.
1.2 Aims of project
Previous studies using mathematical models suggest that exposure to BSE-contaminated
meat and meat products could not explain the young age distribution of vCJD cases in the
UK and that an additional effect of age-dependent susceptibility was required to fully
account for the age of vCJD cases (Boelle et al., 2004). Susceptibility to vCJD was predicted
to increase during childhood, peak during adolescence and decrease sharply afterwards.
Although the oral route appears to be the most likely route of transmission for natural TSE
infections, including scrapie in sheep (Heggebp et al., 2000) and BSE in cattle (Terry et al.,
2003), little attention has been paid to the gastrointestinal tract and the mechanisms
surrounding its involvement in determining age-related susceptibility to risk of oral TSE
infection. Whether young individuals may be more susceptible to natural TSE infection
because of developmental differences in their gut anatomy has been suggested but remains to
be determined.
This study aims to investigate the potential role of GALT in determining age-related patterns
in incidence of natural cases of TSEs. The main objectives of this project are outlined as
follows:
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i) To determine the effect of age at exposure to the TSE agent on susceptibility and
incubation period of the disease using the NPU experimental scrapie dataset.
ii) To quantify the number of lymphoid follicles and surface area of ileal PP tissue in the
distal ileum of different age groups of Cheviot sheep.
iii) To determine whether a link exists between available measures of PP development and
the estimated risk of infection for an individual of the corresponding age using anatomical
data and estimates of risk of infection in mathematical models for sheep, cattle and humans.
iv) To investigate the ontogeny of FDCs and associated PrP in ileal PP tissue of postnatal
mice and sheep using immunocytochemistry (ICC).
1.3 Overview of thesis
Chapter 2 follows this general introduction (Chapter 1) and employs statistical methods,
including logistic regression and survival analyses, to demonstrate the effect of age at
exposure on scrapie outcome and incubation period of the disease, respectively. Several
other factors related to susceptibility were incorporated into the models simultaneously.
Subsequent to this, a quantitative study was performed to determine the amount of PP tissue
and the lymphoid follicle density in the distal ileum of different age groups of Cheviot sheep
(Chapter 3). The anatomical data obtained from this sheep study were required as part of a
comparative epidemiological study (Chapter 4) that uses anatomical PP data and estimates of
risk of infection (derived using mathematical models) to provide evidence for a link between
PP development and age-related risk of TSE infection in sheep, cattle and humans. Chapter 5
investigates the ontogeny of PrP-associated FDCs in postnatal mice and sheep and examines
how the onset of FDC development may be related to age-dependent susceptibility to TSEs
in these two species. Finally, in Chapter 6, the results from statistical, mathematical and ICC
studies are integrated and interpreted, and implications for future research are discussed.
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Chapter 2: Age at exposure contributes to determining the incidence and
survival times of sheep experimentally infected with the TSE agent
2.1 Introduction
The link between BSE and vCJD, and the recently confirmed case of BSE in a French goat
(Brugere-Picoux et al., 2005) has heightened scientific interest in oral transmission of the
TSEs and has refocused efforts to control scrapie. The majority of TSE cases occurs in sheep
aged 2-4 years (Baylis and Goldmann, 2004). This is in comparison to other natural cases of
TSEs, including BSE and vCJD (Arnold and Wilesmith, 2004; Will et al., 2000) where most
cases occur in adolescents and young individuals. The reasons for the current age
distribution of TSE cases are today, speculative (Ghani et al., 1998) but may be partly
explained by a higher susceptibility of younger animals to TSE infection (Diaz et al., 2005;
Matthews et al., 2001).
In the ovine PrP gene, three codons at positions 136 (A, V), 154 (R, H) and 171 (R, Q, H)
largely influence the incidence and age of onset of natural and experimental scrapie
(Houston et al., 2002; Hunter, 1997b; Hunter, 2003). In many breeds, such as Cheviot, the
VRQ allele and the ARR allele have consistently been associated with the highest
susceptibility or natural resistance to clinical disease in the field, respectively (Goldmann et
al., 1994; Hunter et al., 1996; Hunter et al., 1997; Hunter et al., 2000).
Generally, sheep of genotypes of greatest scrapie risk (VRQ/VRQ and ARQ/ARQ) die, on
average, at the youngest age (Baylis and Goldmann, 2004). In natural scrapie, this manifests
as a difference in the mean ages at death from scrapie for sheep of different PrP genotypes
(Baylis et al., 2002; Bossers et al., 1996). Although host genotypic differences explain much
of this variation, they do not account for all of the observed variation in incubation period
nor do they explain why animals with susceptible genotypes do not always develop disease.
Several studies suggest that a number of other genes may influence the scrapie incubation
period in inbred lines of mice (Manolakou et al., 2001) or sheep (Moreno et al., 2002), and
that non-genetic factors may also be involved in the control of the disease (Elsen et al., 1999;
Manolakou et al., 2001). In sheep, it has been shown that interactions exist between host
genotype and scrapie strain (Goldmann et al., 1994; O'Rourke et al., 1997). Using several
different strains of natural scrapie in mice, the incubation period of the disease was found to
be associated with PrP genotype (Moore et al., 1998) and with the prion strain inoculated
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(Bruce et al., 1991). In general, the incubation period is lengthened when a smaller dose of
agent is administered (Bruce et al., 1991; McLean and Bostock, 2000) or when a peripheral
route of inoculation is employed instead of an i/c route (Bruce et al., 1991). One study
showed that the risk of oral infection of scrapie in mice depended not only on the total dose,
but whether the dose was given as one or a series of challenges (Gravenor et al., 2003).
Because the oral route is the most likely route of natural transmission of scrapie and vCJD,
information about scrapie may be helpful in understanding the current epidemiological trend
of vCJD. However, it is important to remember that extrapolations to vCJD must take into
account the additional complexity of disease development including, for example, the
infectious agent, the host's environment and the species involved as source and recipient of
the infectious agent (species barrier). So far, it is not known whether the age at which sheep
become infected determines to any extent the incubation period of scrapie, or the likelihood
of an animal developing clinical signs, and whether this factor may help to explain the
current age distribution of scrapie and other natural cases of TSEs.
The aim of this study is therefore, to determine the influence of age at exposure on incidence
and incubation period of scrapie/BSE (henceforth, referred to as TSEs), using data from an
experimental NPU Cheviot flock, and taking into account the effect of several other factors
including genetic susceptibility, strain, route and dose of agent.
2.2 Methods
This study comprises data from experiments carried out on NPU Cheviots from 1960 to
2002. These experiments were designed to study, by classical genetic breeding experiments,
the well-established incubation period differences in family lines of the sheep, and to create
'susceptible' and 'resistant' lines of NPU Cheviots (henceforth, referred to as positive and
negative selection lines, respectively) based on differing incubation periods following
inoculation with a source of scrapie called SSBP/1 (Scrapie Sheep Brain Pool number 1)
(Dickinson, 1976). Cheviots that developed disease from s/c inoculation in 150-400 days
were bred as the positive line and those animals, which showed no clinical signs of disease
within their normal lifespan, were grouped in the negative line. Polymorphisms of the PrP
gene have been found to be associated with differences in artificially induced susceptibility.
It has since been discovered that the two lines of sheep differ in PrP genotype frequencies,
the positive line animals encoding at least one copy of the VRQ allele and the negative line
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animals being AXX/AXX (Hunter et al., 1996). The origin and history of the experimental
NPU flock is described in greater detail elsewhere (Hunter, 1997a; Hunter et al., 1996).
This study was based on experiments that commenced in 1960 and comprises several
different experiments. Although experiments were performed with many different
combinations of sheep breeds, TSE strains (including BSE), doses and routes of inoculation
and, therefore, cannot be directly compared on the basis of incubation period or development
of TSE, the method used here of combining data from many different experiments allows the
assembly of such information from existing data archives without committing unreasonable
resources to new experimentation. Similar type datasets have been used to investigate the
effect of several variables on infection probability and incubation period. By adopting the
concept of relative dose (that is, relative to ID5o), McLean and Bostock (2000) were able to
standardize dosing across 117 different titration experiments in the murine scrapie model
thus creating a dataset of sufficient size to address questions on effect of age, sex and dose
on infection probability and incubation period of scrapie; these experiments comprised over
4,000 animals and encompassed over 30 years of experimental work. (See McLean and
Bostock (2000) for full explanation on method used for calculating ID50s).
2.2.1 Data Management
Experiments were performed between 1960 and 2002 on 2367 NPU sheep. All sheep which
were challenged came from the breeding flock. Animals for injection were moved to an
experimental shed where work with experimental TSE had been conducted for many years
(Dickinson and Stamp, 1969). Sheep breeds included the Cheviot, Herdwick, Swaledale and
Cheviot-Herdwick cross. Goats were also used in the experimental studies.
This present study comprises a subset of this experimental dataset and includes only
purebred Cheviots with birth dates ranging from January, 1960 to April, 2002. For each
animal, data included an identification number, sex, date of birth, date of exposure to
infectious agent, selection line, dose and route of inoculation used, strain of agent and date of
death or onset of clinical signs. Confirmation of suspect TSE cases through histopathological
detection of vacuolation of brain tissue was available for 1372 sheep. Animals were not
always kept until their natural death but were culled if they developed any form of
debilitating, intercurrent disease. An animal was also culled if it was suspected of having
TSE based on clinical signs.
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2.2.2 Description of study variables
The different factors included in the models are as follows.
2.2.2.1 Age at exposure (agejexp).
Sheep, with ages ranging from 1 to 3070 days, were classified into two age categories: 0-18
months and >18 months. This grouping was based on epidemiological observations, which
suggest that young ruminants are more susceptible to TSE infections than older ones
(Detweiler and Baylis, 2003).
2.2.2.2 Dose/route ofexposure (d/r).
This factor represents a combined effect of dose and route of exposure. Five levels of the d/r
of exposure effect were defined: i/c injection given at a low dose (0.3, 0.35 or 0.5 ml per
animal); i/c injection given at a high dose (0.9 or 1.5 ml per animal); s/c injection given at a
low dose (0.5, 1.0, 1.5 or 2.0 ml per animal); s/c injection given at a high dose (5 or 15 ml
per animal); and oral infection using 50 ml per animal. I/c and s/c challenges were carried
out using a 10"' dilution of brain homogenate. For oral infection, a dose of 50 ml of a 10%
BSE cow brain homogenate (equivalent to 5 g of infected brain tissue) was used.
2.2.2.3 Strain ofagent (agent).
This factor represents the strain of agent used for inoculation. Four levels of agent were
defined: BSE, CH1641, Half-bred and SSBP/1 (the latter three being sheep-passaged TSE
strains). SSBP/1 has been transmitted by injections of brain material in Cheviot sheep for 25
passage-generations. In some of the passages Scottish Blackface and Half-bred sheep brains
were included as minor constituents of the pool of this agent (Dickinson and Stamp, 1969).
2.2.2.4 Selection line (seln_line)
Genotype information at the PrP gene locus was available for only 154 sheep. Information
on selection lines was more complete, and was therefore expected to provide additional
information. 197 animals had no selection line (n = 156) or were classified as heterozygotes
(n= 41). These animals were included in the analyses to obtain a better estimate of other risk
factors in the model. Hence, three levels of this variable (seln_line) were defined: The
positive selection line, the negative selection line and other.
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2.2.2.5 Definition ofcases
For purposes of analysis, sheep were identified as 'TSE animals' when they showed clinical
signs (including pruritus and incoordination of gait) and/or positive histology. Hence,
suspect TSE cases were not always confirmed by histopathological detection of vacuolation
of brain tissue. Natural scrapie was first recognised in the NPU Cheviot flock in 1968
(Dickinson, 1974) and only affects sheep of the VRQ/VRQ and VRQ/ARQ genotype.
Therefore, if scrapie occurs in these genotypes with an incubation period of less than 150
days (inoculation of SSBP/1 in VRQ/VRQ Cheviot sheep results in the shortest incubation
periods, on average of about 150 days) then cases are always considered to be natural scrapie
(Hunter, 2003; Nora Hunter, personal communication). For purposes of analyses, animals
that showed clinical signs of TSE or died and had positive histology at less than 150 days
following challenge were excluded from the analyses since they may have been preclinically
infected through natural exposure rather than through experimental inoculation.
2.2.3 Statistical Analyses
Descriptive statistics were performed on all variables entered in the model. All statistical
analyses were performed using S-PLUS 2000 for Windows (Mathsoft Inc., USA).
2.2.3.1 Logistic Regression
Conditional logistic regression was used to evaluate the effect of age_exp in 1505 sheep after
adjusting for seln_line, agent and d/r on TSE status ('TSE' or 'no TSE'). First, a univariate
analysis of each variable was performed. Variables significant in the univariate analysis at
the 25 percent level (based on the chi-square test) were eligible for inclusion in the model.
The model building process began with a multivariate model containing all variables
significant in the univariate analysis. Variables in the model that were not themselves
significant (P < 0.05) and did not improve the overall fit of the model (as determined by
likelihood ratios) were rejected. As a final check, all rejected variables were entered
individually into the final model to determine whether they became significant or produced
an "important" change (of about 20 percent) in the coefficients of other variables already
included in the model. Selnjine was always added first to the model because of the known
effect of genotype on TSE outcome. Age_exp was added to the model last in order to obtain
an estimate of the additional effect of this variable, adjusting for other significant covariates.
Two-way interaction terms were selected from the main effects in the model. The
significance of each separate interaction was assessed by adding it to the main effects model
and using the likelihood ratio test statistic (for the current model versus the main effects
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model), the degrees of freedom for this test and its P-value. All interactions significant at the
5 percent level were added jointly to the main effects model. Since the 'd/r x age_exp'
interaction was of major interest it was added last to the model. The model fit was assessed
using deviance residuals.
2.2.3.2 Survival Analysis
Survival analysis is suitable for experimental studies when the time having been at risk is
known for each individual. The results of this type of analysis can also be seen as a
refinement of results of logistic regression, where the occurrence ('yes' or 'no') of the event
is analysed. In this study, survival analysis was used to model the hazard for an animal to
show signs of TSE (or death due to TSE) in an interval after time t, conditional on the
subject not being affected until then. The measure of the effect obtained is called a hazard
ratio (HR) and is expressed in terms of an exponential of a regression coefficient in the
model. Failure time was defined as the time between which an animal was infected and the
date that it developed clinical signs of TSE, or was culled (as a result of intercurrent disease
and without showing clinical signs of TSE) and later confirmed as TSE positive from brain
histology. From henceforth, failure time is referred to as the incubation period or 'time till
death'. In this study, a cut-off point of six years was used since most/all animals are expected
to have developed experimental TSE by then. This resulted in the loss of 263 observations.
In the 1960s, a large number of sheep were culled on the same day after being challenged
with infectious agent. Because this would have biased estimates of survival times of these
sheep they were excluded from this part of the study. Consequently, a further 661
observations were lost. As a result the total number of animals used in the survival analysis
was 581. Of these, 240 did not develop TSE and were recorded as censored observations.
Animals which were still alive at the time of the analysis and showed negative pathology for
TSE or animals that died from causes other than TSE (intercurrent deaths) were also
included as censored observations. Intercurrent deaths were recorded as censored
observations and occurred if: an animal died with clinical signs of TSE and had a negative
pathology result; died with no clinical signs of TSE and had a negative pathology result; or
died with no clinical signs of TSE and had no recorded pathology. Mistaken culls occurred
when an animal showing clinical signs was killed and had a negative pathology result;
mistaken culls were also recorded as censored observations.
Model building began with a bivariate (non-parametric) analysis of the association between
survival time and the variables, age_exp, seln_line, agent and d/r. Median survival times
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(±95% confidence intervals) were obtained and differences between survivorship curves
were tested using the Kaplan-Meier estimator and the log-rank test. Significance was set at P
< 0.05. Cox proportional hazard models were used to determine the effect of age_exp on
survivorship period after adjusting for significant covariates. A multivariate model
containing all variables significant in the bivariate analysis was run. The variable age_exp
was always added to the model last. P-values from the Wald tests of the individual
coefficients were used to identify covariates that might be deleted from the model. Any
variable excluded from the initial multivariate model was added back to the model to
confirm that it was neither statistically significant nor an important confounder. How well
the fit of a model improved when variables were removed or added to it was assessed by
observing changes in the log-likelihood values. Two-way interaction terms were selected
from the main effects in the model using P-values from the likelihood ratio test as a guide to
selecting interactions. The proportional hazard (PH) assumption, which assumes that the
HRs (that is, the conditional relative risks across substrata) are proportional to one another
and this proportionality is maintained over time was assessed numerically and visually using
scaled Schoenfeld residuals (Therneau and Grambsch, 2000). In the final model, adjusted
HRs and 95% confidence intervals (CIs) were reported.
2.3 Results
2.3.1 Logistic Regression
This dataset comprised a total of 1505 sheep (Table 2.1). The factors selnjine, agent, d/r and
age_exp were found to be associated with disease/TSE outcome. Although agent was
significant in the univariate analysis (Table 2.2), it became non-significant (with the
exception of agent3) when combined with the other variables in the multivariate logistic
regression model (Table 2.3). However, it was left in the model because of its confounding
effect on d/r and age_exp. All levels of the variables, age_exp and selnjine, were found to
be significant both in the univariate and multivariate models. Selnjine was strongly
associated with TSE outcome (P < 0.001) and made the largest contribution to explain
differences in risk among animals. Animals belonging to the positive selection line were
about 8 times more likely of being TSE-positive compared to animals in the negative
selection line. There were differences associated with some levels of the variables, agent and
d/r (Table 2.3). Sheep that were challenged with BSE were at an increased risk of being
TSE-positive (OR: 5.518; CI: 1.307-23.303) compared to animals infected with the Half-
bred strain. S/c injection at low dose (d/r3), and oral exposure decreased the risk of
developing TSE (OR: 0.406; CI: 0.235-0.703 and OR: 0.172; CI: 0.060-0.488, respectively)
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relative to the i/c, low dose (d/rl) route. Older animals (> 18 months) had an almost 30%
lower chance of being TSE positive than younger animals (0-18 months) (P < 0.01). All
possible two-way interactions (including the'd/r x age_exp' interaction) were found to be
significant on their own (Table 2.4). When the 'd/r x age_exp' interaction was added last to
the main effects model plus all other interactions found to be significant at the 5 percent
level, it became non-significant (P = 0.098).
Table 2.1 Description of the risk factors for TSE in the experimental NPU Cheviot flock (n = 1505)
used in the logistic regression.
Status Total number of
Variable Category TSE No TSE observations
age_exp 1 < 18 months 251 203 454
2 18 + months 454 597 1051
selnjine 1 negative 125 485 610
2 positive 463 235 698
3 other 117 80 197
agent 1 Half-bred 5 13 18
2 CH1641 43 93 136
3 BSE 18 22 40
4 SSBP/1 639 672 1311
d/r 1 ic, low dose 66 91 157
2 ic, high dose 6 10 16
3 sc, low dose 601 653 1254
4 sc, high dose 20 15 35
5 oral 12 31 43
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Table 2.3 Estimated coefficients, estimated standard errors and P-values for the multivariate model
containing variables (where P < 0.25) identified in the univariate analysis. Significant results are
indicated in red.
Variable p SE(p) OR 95% CI P-value Change in df
deviance
Constant -1.253 0.677
seln_line2 2.101 0.138 8.174 6.262- 10.671 < 0.001 303.773 2
3 1.792 0.184 6.001 4.201 -8.574
agent2 0.419 0.702 1.520 0.410-5.642 0.245 4.154 3
3 1.708 0.777 5.518 1.307-23.303
4 0.947 0.711 2.578 0.688-9.660
d/r2 -0.051 0.610 0.950 0.287-3.147 0.001 17.890 4
3 -0.910 0.289 0.406 0.235 - 0.703
4 -0.312 0.478 0.732 0.293- 1.832
5 -0.762 0.575 0.172 0.060 - 0.488
age_exp2 -0.344 0.129 0.709 0.551-0.913 0.007 7.157 1
Log-likelihood: -2285.461
Table 2.4 P-values for interactions, added individually, to the main effects model. Significant results
are indicated in red.
Interaction P-value Change in deviance Log-likelihood
seln_line x agent <0.001 22.990 on 5 df -2279.785
xd/r <0.001 46.050 on 7 df -2299.576
x age_exp <0.001 22.913 on 2 df -2283.758
agent xd/r <0.01 19.653 on 6 df -2312.211
x age_exp <0.05 9.593 on 3 df -2286.851
d/rxage_exp <0.05 12.470 on 4 df -2288.927
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2.3.2 Survival Analysis
A total of 581 sheep were used in this analysis (Table 2.5). 240 animals were found to be
TSE negative and 341 were TSE positive. Data showed a long-tailed survival distribution
(Figure 2.1), with the majority of TSE deaths occurring around 300 days. There was a
significant difference in the mean ages at death for animals that died from TSE (341/581)
and animals that died from other (non-scrapie) causes (240/581) (two sample t-test, t =
18.139 on df = 579; P = <0.0001. Data (time in days) was log transformed for non-normality.
(The detransformed means were as follows: For animals with no TSE (TSE = 0), mean =
824.1; 95% CI: 755.1 - 899.5). For animals with TSE (TSE = 1), mean = 345.1; 95% CI:
328.9 - 363.1). There was a significant difference (Chi-square (X2) = 10.832 on 1 df; P =
0.001) in the number of intercurrent deaths between young (55/224 or 24.6%) and old
animals (136/357 or 38.1%).
Table 2.5 Estimated median times to development of TSE/death due to TSE, with 95% CIs and log-
rank test P-values for categorical variables in the NPU experimental TSE study (n = 581). Significant
results are indicated in red.
Variable Category No. of observations Median time (95% CI) Log-rank test
P-Value
age_exp 1 <18 months 224 321 (298, 343) < 0.001
2 18 + months 357 691 (500, 1176)
seln_line 1 negative 168 2085 (2027, NA) <0.001
2 positive 363 362 (348, 377)
3 other 50 312(275, 338)
agent 1 Half-bred 18 NA, (1140, NA) < 0.001
2 Chi641 111 2085 (2085, NA)
3 BSE 32 912(663, 1925)
4 SSBP/1 420 361 (343, 376)
d/r 1 ic, low dose 122 1886(1176, NA) < 0.001
2 ic, high dose 14 NA (464, NA)
3 sc, low dose 389 362 (344, 376)
4 sc, high dose 19 305 (234,942)
5 oral 37 1701 (912, NA)
NA: No output provided
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Figure 2.1 Histogram showing distribution of data used in the survival analysis. Status represents
'TSE outcome': 0 = censored observation; 1 = TSE.
All variables were found to be significant (P < 0.05) in the bivariate analysis (Table 2.5). The
PH assumption was tested numerically (Table 2.6) and smoothed scaled Schoenfeld residual
plots for the predictors (Figure 2.2(A-J)) provided a visual interpretation of the non-
proportionality. The PH assumption did not hold for age_exp, the impact of age_exp clearly
changing with time (Figure 2.2J). Because of this violation, a piecewise Cox regression was
used. This involved partition of the time axis at a time point suggested by the residual plots
and the median of the event times (375 days), and running separate Cox regressions on the
two subsets of the data (Therneau and Grambsch, 2000). Estimates for the piecewise Cox
regression are presented in columns 3 and 4 ofTable 2.7. Although age_exp could have been
incorporated into the model as a stratified variable, this method does not provide an estimate
of the impact of the stratified variable (in this case, age_exp, the main variable of interest) on
the hazard rate. Estimated HRs in the multivariate analysis were found to be significant for
selection line, BSE and age_exp (P < 0.05) (Table 2.8). HRs of above one were obtained for
seln_line2 and seln_line3 for each piecewise Cox regression, indicating that incubation
period/'time till death' was considerably shorter compared to the negative selection line
(seln linel) over the entire study.
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Figure 2.2 Graphs of the scaled Schoenfeld residuals to assess the PH assumption for variables in
the main effects model (see Table 2.6) for A. seln_line2; B. seln_line3; C.agent2; D. agent3;
























































































However, the impact of selection line appeared to be greater for longer incubation periods
(time > 376 days). The agent "BSE" had a HR of about eight times that for the reference
level ("Half-bred") for time < 376 days, with the impact of this agent decreasing for longer
incubation periods (HR = 3.420) (for time > 376 days). A HR of 0.438 was obtained for
older animals for time < 376; this indicated that older sheep developed TSE at a rate that was
about 56% lower than for younger sheep for this time period (Table 2.8). The negative
impact of the variable, age_exp, appears to be driven by shorter rather than longer incubation
periods, and there is a complete reversal of sign in the coefficient for age_exp for time > 376
days, with older animals having a HR about twice that for younger animals (Table 2.8).
Coefficients (for age_exp) attained statistical significance in the piecewise Cox models (P <
0.05) (see Table 2.8).
Table 2.8 HRs and 95% CIs and P-values for the Cox PH model containing variables significant at
the 25% level in the bivariate analysis in the NPU experimental TSE study (n = 581). Significant
results are indicated in red.
Variable HR
(95% CI for HR)
Wald Statistic
P-Value
Time < 376 Time > 376 Time < 376 Time > 376
seln_line2 3.016 5.467 <0.01 <0.001
(1.311-6.940) (2.947-10.140)
3 2.764 4.280 <0.05 <0.001
(1.094-6.986) (1.805-10.150)
agent2 2.900 0.652 0.300 0.480
(0.394-21.363) (0.200-2.130)
agent3 8.315 3.420 <0.05 <0.05
(1.377-50.198) (1.208-9.680)
agent4 NA 0.541 NA 0.34
NA (0.154-1.910)
d/r2 1.362 0.625 0.620 0.470
(0.400-4.635) (0.136-2.880)
3 1.966 1.183 0.480 0.690
(0.303-12.746) (0.516-2.710)
4 2.890 1.291 0.280 0.810
(0.422-19.810) (0.167-10.000)
5 0.589 0.504 0.660 0.150
(0.057-6.072) (0.198-1.280)
age_exp2 0.438 2.280 < 0.001 <0.01
(0.330-0.582) (1.312-3.960)
NA: No output provided
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Table 2.9 Testing the PH assumption, numerically, for the final model.
Variable rho Chi-square P-value
Time < 376 Time > 376 Time < 376 Time > 376 Time < 376 Time > 376
seln_line2 -0.107 -0.097 1.426 0.809 0.232 0.368
seln_line3 -0.028 0.054 0.119 0.310 0.731 0.578
agent2 0.057 -0.153 0.644 3.020 0.422 0.082
agent3 -0.090 0.0 4.074 0.0 0.050 0.999
agent4 NA -0.128 NA 1.81 NA 0.179
d/r2 0.027 -0.080 0.180 0.682 0.671 0.409
3 0.023 -0.107 0.121 0.871 0.728 0.351
4 0.036 0.009 0.285 0.007 0.594 0.933
5 0.099 -0.072 3.151 0.545 0.076 0.460
age_exp 0.069 0.034 1.177 0.099 0.278 0.752
NA: No output provided
In the final model, there was no evidence of non-proportionality as none of the P-values
were found to be significant at the conventional 0.05 level (Table 2.9). Although partitioning
of the time axis was effective in removing the problem of non-proportionality, the
disadvantage is that the power of the study is less because of fewer time events. Interaction
terms were not included in the final model because it was uncertain as to whether the model,
comprising 581 cases and four factors (most comprising several levels) could handle all
interactions successfully. However, because the 'd/r x age_exp' interaction was of interest in
this study, to view a non-parametric estimate of the age_exp effect after adjusting for
possible differences in d/r distributions, plots of the stratified fit were produced as shown in
Figure 2.3 and Kaplan-Meier estimates (at P < 0.05) used to determine whether the two age
groups for each route had equal survivor functions. For illustrative purposes, these effects
have been summarized graphically across the entire time frame (time < 376 and time > 376).
There appeared to be a significant difference between the two age groups for 's/c, low dose'
(dr3) route (P < 0.001) and 's/c, high dose' (d/r4) route (P < 0.01), with younger animals
having shorter incubation periods. All young animals developed TSE prior to 350 days when
challenged with a high dose of TSE agent via the s/c route compared to 50% in older
animals. (However, this difference was not significant: Fisher's exact test: P = 0.057). When
challenged with a low dose of agent subcutaneously, the majority (93%) of young and about
half (47%) of old animals developed TSE prior to 350 days (with a significant difference
between young and old animals: Chi-square (X2) = 63.934 on 1 df; P = <0.0001). The effect
of age_exp was found to be non-significant for both the i/c and oral routes (P > 0.05).
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Figure 2.3 Kaplan-Meier plots for the different routes of inoculation, and P-values indicating whether
the two different age groups have equal survivor functions. A. all doses/routes, P < 0.0001; B. ic/low




Variation in susceptibility to TSE can be evaluated by the mortality rate and the incubation
period of the disease (Diaz et al., 2005). This present experimental study investigated the
effect of age at infection on TSE outcome and incubation period/'time till death', taking into
account the effects of several other variables. Experimental challenges revealed a complex
relationship between selection line, age at infection, the strain of agent and the dose/route of
exposure. This is in agreement with results obtained from previous studies.
2.4.1 Effect of selection line
Sheep from the positive selection line appeared to have a higher risk of becoming TSE
animals and had a higher rate of developing the disease than sheep from the negative
selection line. Because selection lines were used in this analysis, the results obtained cannot
be directly compared to results of other studies, which have used genotype information.
However, the two lines of sheep differ in PrP genotype frequencies with positive line
animals encoding at least one copy of the VRQ allele and negative line animals being
AXX/AXX. Thus, VRQ/XXX sheep appeared to have a higher risk for becoming TSE
positive than sheep with the AXX/AXX genotype. The association of TSE status and
incubation period with selection line was expected since susceptibility to experimental TSE
in NPU Cheviots has been shown to be controlled mainly by host genetics (Goldmann et al.,
1994); generally, the shortest incubation periods are associated with the most susceptible
genotypes (Baylis and Goldmann, 2004). This assumption has been a requirement for
successful modelling of a within-flock scrapie epidemic (Matthews et al., 2001). Other
studies in sheep have shown that the average incubation period differs among different
genotypes for Cheviots and Dorsets that were infected subcutaneously with SSBP/1
(Houston et al., 2002). In mice, a relationship also exists between the incubation period and
PrP genotype (Moore et al., 1998).
Although selection line made the largest contribution to explain the differences in risk
among animals, the survival of a number of sheep from the positive selection line and the
wide variation of 'incubation times/times till death' of TSE-affected sheep in this present
study suggest that factors other than host genetics may also govern the risk of infection. The
frequencies of PrP genotypes observed in scrapie-free populations of sheep (Bossers et al.,
1996; Hunter and Cairns, 1998) provide evidence that scrapie is not simply a genetic disease,
and several studies provide initial estimates for the relative risk of developing the disease
taking into account non-genetic factors (Diaz et al., 2005; Elsen et al., 1999; Healy et al.,
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2004). It has been suggested that additional polymorphisms within the PrP open reading
frame or in the flanking regions may modulate incubation times or influence susceptibility
(Hunter et al., 1996). One study in a Romanov flock has shown that polygenic variance was
responsible for 21% of the total genetic variability that was related to susceptibility to
scrapie and that this variation may be important in understanding the existing genetic
susceptibility in many sheep populations (Diaz et al., 2005). Although there is evidence that
other genes may influence the incubation period of TSEs in inbred lines of mice (Manolakou
et al., 2001; Moreno et al., 2003), little is known of their nature and function.
2.4.2 Effect of agent
Susceptibility to ovine TSE is controlled by a combination of host genetics (Belt et al., 1995;
Clouscard et al., 1995; Hunter et al., 1992; Laplanche et al., 1993) and the TSE strain used
to infect the host (Dickinson and Meikle, 1971; Goldmann et al., 1994). In this present study,
different strains of TSE were found to have different incubation periods/'times till death'.
Animals infected with BSE had an increased risk of being TSE-positive and developed the
disease at a rate that was over three times that for animals infected with the Half-bred strain.
This finding demonstrates the degree of pathogenicity of BSE relative to other strains used in
this study. However, the amount of BSE material that constitutes an oral infectious dose for
human beings and the incubation periods resulting from such exposure are unknown,
although this uncertainty has been partly addressed (Herzog et al., 2004; Lasmezas et al.,
2005). Several strains of natural TSE have been identified on the basis of their incubation
periods under standard conditions of experimental infection (Bruce et al., 1994; Bruce et al.,
2002), and some strains appear to attack genotypes differently. In NPU Cheviot sheep,
although the ARQ/ARQ genotype is considered to be resistant to scrapie following challenge
with SSBP/1 (Goldmann et al., 1994), this genotype has been shown to be susceptible to the
CH1641 isolate of scrapie in sheep and goats (Foster et al., 2001). An important limitation of
this present analysis was the absence of genotype information and the inability to examine
the effect of specific strains on different genotypes. There was, however, a significant
interaction between selection line and strain of agent, implying that the effect of agent on
TSE outcome varied for the different selection lines.
2.4.3 Effect of dose/route
The oral route of infection was associated with decreased odds of TSE-positive status and
animals infected via this route developed TSE at a lower rate compared to the i/c and s/c
routes of infection. Evidence from experimental infections in mice indicates that the
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incubation period is a function of the route of infection and the infective dose (Bruce et al.,
1991). Previous studies have shown that BSE is transmitted more efficiently to sheep (and
goats) by i/c inoculation than by oral dosing with the oral route nearly always resulting in
longer incubation periods than the i/c route (Foster et al., 2001). Oral or intragastric infection
of TSE was found to be about 40,000 times less efficient than the i/c route in mice (the
highest effective titre by the intragastric route being 4.3 log]0 LD50 units/g and the average
titre of 139A scrapie brain being 8.9 logio LD50 units/g for the i/c route) (Kimberlin and
Walker, 1989a) while a difference as high as 109 has been reported in hamsters, using 263K
scrapie brain (Prusiner et al., 1985). Although the oral route is relatively inefficient it is
believed to be the most likely route of entry for natural TSE infections including scrapie,
BSE, CWD, TME, Kuru and vCJD (Andreoletti et al., 2000; Gajdusek, 1977; Hadlow et al.,
1982; Marsh and Bessen, 1993; Shmakov and Ghosh, 2001; Williams and Young, 1980).
Also, it is not known whether the TSE agent may behave differently in natural disease and
may be spread more efficiently via peripheral routes. Although oral inoculation studies of
TSEs, including BSE, have been performed in recent years in sheep (Foster et al., 2001;
Jeffrey et al., 2001b; O'Rourke et al., 1997), comparisons between them are difficult because
of differences in method of infection.
Sheep challenged with high doses of the infectious agent via the s/c route succumbed to TSE
after shorter periods than when exposed to lower doses of the agent. For any given route the
dose-response curve has been shown to be consistent, that is, the higher the dose, the shorter
the incubation period (Kimberlin and Walker, 1978). In mice, the average incubation period
was found to increase linearly with logarithmic decrease in dose (McLean and Bostock,
2000). The variations in the incidence of TSE among animals that are naturally exposed to
different levels of infection also provide evidence of a dose-response relationship. An
increase in the incidence of TSE and a decline in the age at which the disease begins have
been reported within affected flocks, and have been attributed to increasing levels of
environmental contamination by the infectious agent (Chatelain et al., 1986; Foster and
Dickinson, 1989; Sigurdarson, 1991).
2.4.4 Age at exposure
The young age distribution of TSE cases can be explained if (i) the incubation period is
shorter in young than in old animals, and (ii) young animals are more susceptible to
infection. That younger sheep (less than 18 months) have an increased risk of becoming TSE
animals and develop the disease at a rate that is about twice that for older animals (for time <
376) is an interesting observation in this study considering the current age distribution of
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natural scrapie cases. This effect remained significant after controlling for other variables.
Similar results have been reported by Diaz and colleagues (2005), whereby it was found that
animals exposed to infection for the first time early in life appear to be more likely to
develop scrapie compared to animals facing infection at older ages. Matthews et al. (2001)
suggest that this age effect may be explained by a greater degree of susceptibility of younger
compared to older animals, and a relationship also appears to exists between age at infection
and age at which clinical signs of scrapie develop (Woolhouse et al., 1998). Results from
this present study imply that if young sheep do not develop TSE by the first year of life then
it is unlikely that they will develop disease later on. Whether the finding by Diaz and
colleagues (2005) may be partly due to intercurrent deaths primarily in older animals is not
known. In this present study, the estimate of the HR for older animals is likely to have been
biased since the number of intercurrent deaths was significantly greater in older animals. For
longer incubation periods/'time till death' (time > 376), older animals appeared to have an
HR about twice that for younger animals. Whether or not older animals may have developed
pre-clinical scrapie and became more susceptible to other disease is not known, although this
remains a possibility.
In mice, i/p injections of 10"2 inocula of the ME7 strain were found to be 100% lethal in
young adults but killed only 80% of neonates, suggesting that neonatal mice probably lack
some cell populations required for the initiation of scrapie pathogenesis (Outram et al.,
1973). On the other hand, neonatal mice have also been shown to be very susceptible to
agent injected by various s/c routes (Outram, 1976). The age of rats at the time of i/c
inoculation with TSE-affected material was found to have little effect on the length of the
incubation period (Chandler and Fisher, 1963) and this is comparable to findings from this
present study. Evidence based on analysis of titration experiments in the murine scrapie
model showed that although there was no age effect on probability of infection, young mice
appeared to have incubation periods that were, on average, longer than seven days (McLean
and Bostock, 2000).
One finding in this study is in contrast to a previous finding where age at challenge was
found to have no significant effect on incubation period in sheep (and goats) infected orally
with the BSE agent (Foster et al., 2001). However, the sample size used by the authors was
small (n = 19) and the majority (85 percent) of sheep challenged were less than 18 months,
making it difficult to determine any age effect in light of confounding variables. Huillard
d'Aignaux et al. (2002) found no evidence that incubation period of vCJD increases with age
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and suggest that the young age of cases of the disease perhaps reflects increased levels of
exposure in young individuals rather than age-dependency in the incubation period.
One interesting finding in this present study is that the majority (93%) of young sheep
succumbed to TSE prior to 350 days after s/c challenge with a low dose of inoculum,
compared to less than 50% of older animals. The s/c route in young sheep appears to be
more efficient compared to animals over 18 months, perhaps because of the level of
maturation of peripheral nerves. This suggests that if high doses of the agent gain access to
the peripheral nervous system, particularly in young animals, then prior amplification in the
lymphoid tissue may not be absolutely necessary and the incubation period may be shortened
considerably. Where the level of infection is lower, amplification in lymphoid tissue may be
required to facilitate TSE pathogenesis, thereby, prolonging incubation periods. It has been
found that, following s/c inoculation of neonates (Outram, 1976), 60% of 0-4 day-old mice
inoculated with ME7 brain homogenate succumbed to scrapie after short incubation periods
(ranging from 150-230 days) and this figure decreased further to 30% in 8 day-old mice and
10% in adult mice.
Various factors contribute to making experimental studies of TSEs difficult. This is largely
due to the long incubation period between infection and the development of clinical signs of
the disease (resulting in intercurrent deaths as a result of disease other than TSE), and the
absence of an ante-mortem diagnostic test (at least during the time at which this
experimental study was performed) to detect infected animals. Nevertheless, analyses are
relatively more difficult in natural TSEs because of uncontrolled variables such as the time
and extent of exposure and the strains of TSE agent encountered throughout the life of the
animal. Because of the difficulty in establishing evidence of pre-clinical infection, this made
it impossible to verify the initial disease status of the experimental animals. Furthermore, the
interval allowed for TSE to develop in the experimental cases was relatively long and this
makes it difficult to distinguish experimental cases from cases that may have developed
naturally later on (bearing in mind that incubation periods may appear more variable than
expected based on genotype/selection line only, and may also reflect the effect of dose and
route of inoculation and agent strain, as observed in this present study). For example, in this
study, 'age at exposure' was not known for all animals and although animals that developed
scrapie at 150 days or less following experimental exposure were excluded from the
analyses, the interpretation of the challenge of positive line animals (encoding at least one
copy of the VRQ allele) with BSE for instance, may still have been possibly confounded by
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the presence of natural scrapie in this line of Cheviots. Foster and others (2001), for
example, have shown that incubation times were similar for BSE and Scr8 (a source of
natural scrapie) following oral inoculation. Ideally, experiments should be repeated in a
scrapie-free environment using scrapie-free sheep from countries (like New Zealand)
considered free of the disease.
The diagnosis of TSE was not always confirmed histopathologically, thus introducing
criticism of the validity of the outcome of unconfirmed or clinically diagnosed cases. For
example, although most sheep exhibit behavioural changes, pruritis, ataxia and weight loss,
clinical signs in sheep experimentally infected with SSBP/1 tend to be shorter and weight
loss is not a prominent feature (Houston and Gravenor, 2003; Wilson et al., 1950).
Nonetheless, even histopathological examination of brain tissue may fail to give positive
results in animals incubating disease caused by the SSBP/1 strain (James Foster, personal
communication). It is important to note that subclinically infected animals may have similar
levels of infectivity as terminally sick animals (Thackray et al., 2002) and, therefore, when
determining susceptibility to TSE infection, it is not sufficient to only monitor for clinical
signs, but also necessary to assay for PrPSc and/or prion infectivity (Hill and Collinge, 2003).
Differential diagnoses like listeriosis, rabies and pneumonia were never notable in the NPU
flock, nor were external parasites. Although toxins are a likely differential, animals were
treated prophylactically for several bacterial infections, including clostridial infections.
Pregnancy toxaemia can be excluded from the list of differentials since animals were not
bred once challenged (James Foster, personal communication). Previous studies
investigating the association between flock and management factors and scrapie in the UK
have used data that include both confirmed and unconfirmed scrapie flocks (Hoinville et al.,
2000a; Hoinville et al., 2000b).
One limitation of this study was the scarcity of genotype information for the sheep used in
this study. It has been shown that during an outbreak, the PrP genotypes of affected animals
are expected to change over time and "although age-at-onset changed over time, the
observed changes were largely, but not exclusively, driven by the time course of the PrP
genotypes of cases" (Mclntyre et al., 2006). Animals with more resistant genotypes are more
likely to live longer (and be present in the flock as older individuals) compared to their
younger counterparts. Therefore, whether the age effect observed in this study was driven
largely by the time course of PrP genotypes of cases is difficult to determine.
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These results show that TSE outcome and incubation period/'time till death' of the disease
can be influenced by, in addition to host genetics, the pathogen strain, the dose and route of
infection as well as the age at exposure to the agent. The apparent age distribution of the
naturally acquired TSEs could perhaps be explained by a shorter incubation period and/or an
increased susceptibility to infection in younger animals. Scrapie is similar to vCJD in having
both genetic polymorphisms in susceptibility and a long incubation period (Zeidler et al.,
1997). However, whether or not findings can be extrapolated to vCJD is questionable.
Although some parallels can be drawn with vCJD, direct comparison cannot be made
because oral transmission and the species barrier have been shown to lengthen and increase
variability in animal experiments (Diringer et al., 1998; Kimberlin and Walker, 1978).
Furthermore, other factors not demonstrable by this present study might nevertheless have a
potentially important role in the development of TSEs (Diaz et al., 2005; Elsen et al., 1999;
Gruner et al., 2004; Healy et al., 2004; O'Rourke et al., 1997), and different host-strain
interactions exist under experimental conditions. Although these findings suggest that
several interactions exist, the sample size (small relative to the number of interactions
incorporated into the model) used in this present study makes it difficult to validate the
absolute importance of these interactions.
Why the peak incidence of vCJD (and the other naturally acquired TSEs) is in young
individuals is a matter of conjecture in the present state of knowledge but various factors
could contribute. This present study raises the possibility of age-related susceptibility,
because of yet to be identified biological factors, and may help to explain the controversy
that has recently arisen over the importance of various cells, including FDCs (see Chapter 5)
and B lymphocytes in the pathogenesis of the TSEs. Furthermore, prediction of the epidemic
size of related TSEs, such as vCJD, is difficult in the absence of good understanding of the
epidemiology and susceptibility factors for the naturally acquired TSEs. In this study,
younger animals appeared to have shorter incubation periods compared to older animals
following s/c inoculation of the infectious agent. As mentioned previously, this may be
attributed to the greater vulnerability of immature nerves to TSE invasion in the young
individual. This observation warrants further investigation of the development of peripheral
nerves and their role in determining incubation period of the disease and TSE pathogenesis
in sheep. Although this effect was not observed for the oral route, this may be attributed to
the small sample size and a difference in the cellular tropism of the respective prion strains,
bearing in mind that the BSE agent was used in the majority of oral inoculations as opposed
to s/c exposure where the SSBP/1 agent was primarily used.
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Nonetheless, oral infection is the most likely route of natural exposure and PPs have been
indicated as the most probable sites for the intestinal uptake of prions after oral exposure to
the infectious agent (Beekes and McBride, 2000). If the gut immune system plays a role in
susceptibility to natural TSE infection it is likely that age will influence susceptibility since
the amount of ileal PP tissue decreases with age. In view of the young age distribution of the
naturally acquired TSEs including scrapie and vCJD, age-dependent differences in PP
development have been investigated, under the assumption that peak development of this
lymphoid tissue in adolescent and young adult years may promote TSE replication and
consequent development of disease thereby, rendering younger individuals more susceptible
to naturally acquired TSEs.
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Chapter 3: Quantification of Peyer's patches in Cheviot sheep for future scrapie
pathogenesis studies
3.1 Introduction
Susceptibility to vCJD and other TSEs, including scrapie in sheep and BSE in cattle, appears
to be age-dependent. This hypothesis is consistent with the observation that sheep first
exposed to infection at older ages appear to be less susceptible to scrapie than animals
encountering infection for the first time early in life (Diaz et ah, 2005; Matthews et ah, 2001;
Chapter 2 of this thesis). Mathematical models using an estimated age risk function have
shown that decreasing age-related susceptibility (with susceptibility peaking in adolescent
years) is required to reproduce the characteristics of the age distribution of vCJD cases and
that dietary exposure alone could not explain the young age of vCJD cases seen in the UK
(Boelle et al., 2004). Although a relation with puberty may be hypothesised, there is, so far,
no clear biological explanation for this peak incidence in young adults.
Oral ingestion is considered to be the main route of natural exposure to TSE agents
(Shmakov and Ghosh, 2001). For example, the consumption of BSE-infected beef and beef
products is most likely to be responsible for the emergence of vCJD (Bruce et al., 1997), and
kuru was likely to be transmitted among the Fore people of Papua, New Guinea by
cannibalistic acts at funeral feasts (Huillard d'Aignaux et al., 2002). Following experimental
oral infection of mule deer fawns with CWD, PrPSc was detected first in the lymphoid
follicles of Peyer's patches (PPs) and the draining mesenteric lymph nodes 45 days post-
inoculation (Sigurdson et al., 1999). When rodents were orally exposed to scrapie, PrPSc
accumulation occurred first in PPs and ganglia of the enteric nervous system (Beekes and
McBride, 2000).
In sheep, the ileal PP has been implicated as a likely primary entry site of the scrapie agent
followed by spread to more proximal and distal segments of the intestinal tract (Andreoletti
et al., 2000). This structure is conspicuous in young animals and can extend up to 2.5 m as a
long, continuous aggregate of lymphoid tissue, comprising about 100,000 tightly packed
lymphoid follicles (Reynolds et al., 1985; Reynolds, 1987). The total weight (120 grams) of
PP tissue is greater than any other single lymphoid organ in the body by 6 weeks after birth
(Reynolds and Morris, 1983). What is particularly interesting about the ileal PP is that it
undergoes involution, and by about 15 to 18 months of age the organised lymphoid elements
of this structure have almost completely regressed. In humans, the number of PPs is greatest
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during adolescent (Cornes, 1965) and young adult (van Kruiningen et al., 2002) years and
then declines with age. The jejunal PPs by contrast remain intact throughout life in both
sheep and humans. An important hypothesis to test was therefore whether this characteristic
feature of ileal PP tissue provides a possible biological explanation for the apparent
increased susceptibility to TSE infection in young individuals.
It has been suggested that the increased number of PPs in younger animals as well as the
increased permeability to macromolecules in the neonatal gut epithelium may contribute to
increased susceptibility to oral TSE infection (Shmakov and Ghosh, 2001). If TSE infection
starts in the lymphoid follicles of PPs, then it can be speculated that variations in the number
and/or surface area of PP tissue in the ileum could explain age-dependent susceptibility to
the TSEs and may influence individual susceptibility to disease. For instance, if the follicle-
associated epithelium (FAE) is considered as a channel for infection, and assuming that
particle uptake capacity is a function of the area of FAE, then reduced gut-associated
lymphoid tissue (GALT) may well be associated with decreased incidence of infection
(Liebler et al., 1988; Shmakov and Ghosh, 2001).
Because it is so inaccessible to experimental manipulation, the GALT has received
considerably less attention than the tonsil or spleen in TSE pathogenesis studies despite the
fact that for part of the animal's life the majority of its lymphoid cells reside within this
specialized tissue (Reynolds, 1980). This study was undertaken because it was felt that
information on the number of lymphoid follicles and surface area of PP tissue in the distal
ileum of sheep and their relationship to subject age was essential before a realistic
assessment could be made of the potential role of this tissue in determining the age-related
incidence of scrapie and the pathogenesis of the disease. This study was not an attempt to
repeat previous anatomical work but to obtain data specific to an experimental flock of
Cheviot sheep for future scrapie pathogenesis studies. The aim of this study was therefore, to
quantify the number of lymphoid follicles and surface area of the ileal PP in different age
groups of Cheviot sheep.
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3.2 Materials and Methods
3.2.1 Animals
This study was carried out from February, 2003 to October, 2005, using sheep from the NPU
Cheviot flock in Edinburgh. The NPU Cheviot flock is a closed flock with endemic natural
scrapie and is maintained by the Institute for Animal Health Neuropathogenesis Unit as a
source of natural scrapie infections. Demographic information and epidemiological data are
available for all sheep (Hunter et al., 1996). Sheep from each of the following age categories
were included in the study: 0-3 months, 3-6 months, 6-12 months, 12-18 months and over 18
months (Appendix A, Table A-l). Specimens of the ileum and distal jejunum were obtained
from sheep that were either euthanized because of severe arthritis in one or more limbs, died
shortly after birth or were culled for flock management reasons. Data including sheep
identification number, sex, PrP genotype, date of birth and cause of death were recorded.
Investigations were largely restricted to material derived from necropsies carried out within a
few hours of death. However, some material (notably from lambs, which were born alive and
died during the night) was not examined immediately. Specimens with any clinical or
pathological evidence of intestinal disease were excluded from the study. One 7 year-old
Suffolk was necropsied at the Easter Bush Veterinary Centre and was used in a preliminary
study to help determine the most appropriate method for identification and quantification of
PP tissue and lymphoid follicles.
3.2.2 Collection and storage of specimens
Animals were euthanized using sodium pentobarbital (at a dosage of 60 mg/kg,
intravenously). A ventral abdominal incision was made, and the caecum exteriorised for
orientation. The ileocaecal junction (see Figure 3.1) was identified, and the terminal portion
of the distal ileum ligated as close to the junction as possible. The ileum was followed up to
2.5 m proximally and excised, to ensure that the entire ileal PP and a small length of jejunum
were included.
Samples of ileal tissue were collected from the caudal end of the distal ileum for histology
and ICC (see Chapter 5). Samples for histology were placed in 10% formaldehyde. All other
samples were stored in liquid nitrogen at -70°C. The remainder of the specimen was placed
in a labelled "zip lock" bag and transported to the laboratory at 4°C.
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3.2.3 Visualisation of PPs and lymphoid follicles
The specimens were opened from their caudal ends along the mesenteric borders (to avoid
transecting the patches, most of which occur on the antimesenteric aspect) and carefully
washed in cold, running water for about 10-15 minutes to help remove mucus and digesta.
Although the ileal and jejunal PPs could be seen, LFs were not clearly visible. Preliminary
experiments were performed to optimise the technique for counting lymphoid follicles and
enhancing the appearance of PPs.
Figure 3.1 Photograph of the caecum (A), ileocaecal junction (B) and distal ileum (C)
For preliminary studies, the intestine of one 7 year-old Suffolk sheep was divided into
several sections (to minimise the number of sheep used). The method used is a modification
of Comes' (1965) method. Segments of intestine were immersed in 2% acetic acid for 24
hours, and then rinsed in cold water (alternatively, specimens may be placed in 50% acetic
acid for 2 minutes). Acetic acid is used for precipitation of nucleoproteins (Ronne, 1989),
and since lymphoid follicles in PPs are virtually masses of nucleoprotein with little
cytoplasm, the lymphoid follicles appear conspicuous. The follicular content of the patches
was enhanced by staining with 0.5% methylene blue for 2-5 minutes. To increase the
contrast between the dark bluish-black PPs and the lighter bluish-green of the rest of the
tissue, specimens were immersed in fresh, dilute (2%) acetic acid for a further 24 hours,
followed by a quick wash in water.
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3.2.4 Area of PP tissue
After trimming of excess mesenteric fat, the terminal ileum (distal 0.6 m of the ileum) was
transilluminated on a horizontal X-ray view box. PP tissue and individual lymphoid follicles
were easily visualised using this technique. Digital images were obtained. Image analysis
software (Image-Pro Plus®) was then used to calculate the areas of intestine and of PP tissue.
The area of PP tissue was recorded as a percentage of the total area of intestinal tissue.
Repeatability of results was determined based on paired measurements of percentage of PP
tissue for each tissue specimen.
Samples were collected for histology to confirm that the patches were in fact collections of
lymphoid follicles, and that this method succeeded in staining the lymphoid follicles and no
other structure of the same size and shape. Jejunal PPs were collected for comparative
purposes.
3.2.5 Quantification of lymphoid follicles
In young lambs (less than 6 months old), the serosal surface of the intestine was removed to
allow for easy quantification of lymphoid follicles. This was done by carefully slitting the
serosal tissue at right angles to the long axis of the intestine and stripping away the serosa
with a pair of forceps. With practice, it is quite easy to remove the serosal membrane. To
determine the number of lymphoid follicles, the stained intestine was placed between two
glass slides, the upper of which was etched in square centimetres. Individual lymphoid
follicles appeared as bright blue spots against a faintly blue background when viewed on the
X-ray box. The number of lymphoid follicles in 6 different sections along the length of the
terminal ileum was counted by naked eye, starting at 5 cm from its caudal end and selecting
4 cm2 sections at every 10 cm thereon, proximally. In older sheep (over 6 months), lymphoid
follicles were smaller in size and more difficult to visualize. In these animals, follicles were
counted from the mucosal surface of the intestine using a dissecting microscope
(magnification of X4). Results were recorded as the average number of lymphoid follicles
per cm2 of ileum. Repeatability of results was determined based on two separate counts for
each of the 6 tissue sections.
3.2.6 Techniques
Throughout the investigation, every attempt was made to obtain tissues within one or two
hours of death followed by immediate refrigeration. Samples that were obtained several
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hours after death were friable and difficult to handle. They stained poorly and failed to
demonstrate PPs in autolytic areas of the intestine.
To optimise results, the following points were noted during the course of this study. Fresh
intestinal tissue (obtained at least within one or two hours of death) should be used and
washed in cold, running water. Water should not be forced through the lumen in an attempt
to flush out digesta since there is the risk of damaging lymphoid follicles and disrupting villi.
Formalin was not appropriate for this study since it resulted in shrinkage and discolouration
of the tissue making it difficult to visualise patches altogether (not shown). Therefore, for a
more detailed gross morphologic study, the specimen should be placed in dilute acetic acid
and not formalin.
3.2,7 Statistics
The repeatability of a method evaluates the extent to which the same observer obtains the
same results under identical circumstances. In this study, repeatability of the two methods
used was determined based on two separate estimates for each specimen. To assess
repeatability of the methods used, the difference between the pair of measurements for each
individual was calculated and the limits of agreement (that is, the limits within which most
of the differences lie) calculated (Petrie and Watson, 2001). Assuming the differences follow
a normal distribution, the limits are calculated as:
d + 2sdiff, where
d is the mean of the differences, and
Jdiff is the standard deviation of the differences
To check that the relationship between the differences and the magnitude of the
measurement is constant, the difference in the two measurements in a pair against their
average is plotted. A random scatter of points around the line of zero difference with no
funnel effect as the mean of the two measurements increases indicates a constant
relationship. Lines that denote the upper and lower difference values that enclose 95% of the
points are added to the plot. Hence the name limits of agreement plot (or Bland-Altman plot)
(Bland and Altman, 1986).
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The Spearman rank correlation coefficient (Petrie and Watson, 2001) was used as a measure
of association between the anatomical data and the corresponding age of an individual.
3.3 Results
A total of 41 tissue specimens were examined. Eight of these specimens were excluded from
the study because of evidence of parasitism, or because lambs had died during the night and
the intestines had undergone post-mortem changes.
3.3.1 Area of PP tissue and lymphoid follicle density
The ileal PP was continuous in younger animals (0-6 months) and was found to extend up to
1.39 m proximally (Appendix A, Table A-l). In old animals, the ileal PP was found to have a
"moth-eaten" appearance when stained with methylene blue. This is consistent with
involution and associated loss of follicles from PP tissue. PP tissue was present largely on
the anti-mesenteric aspect of the small intestine. After puberty (about 12 months), a drastic
decrease in the area of ileal PP tissue was observed (Figure 3.2). The area of ileal PP tissue
ranged from a mean of 49.8 to 60.3 % in 0-3 month-old lambs to 0 to 7.0 % in the oldest
animals (18 months and over). The percentage of ileal PP tissue was negatively correlated
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Figure 3.2 Percentage of PP tissue and the average number of lymphoid follicles per cm" in sheep of
various ages (n=33).
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Lymphoid follicle number is represented as the average number of lymphoid follicles per
cm2 of terminal ileum as shown in Figure 3.2. Lymphoid follicles were most numerous near
the ileocaecal junction. Compared to the area of ileal PP tissue, a similar drastic decrease in
lymphoid follicle density was observed after puberty (Figure 3.2). There was some variation
in the number of follicles between individual animals in each age group; however, variation
between the respective age groups was striking. Lymphoid follicle density ranged from a
mean of 224 to 355 in 0-3 month-old lambs to 0 to 17 in the oldest animals (18 months and
over). Lymphoid follicle density was negatively correlated with age of the animal (rs = -
0.943; n=33, PcO.OOOl). Area of ileal PP tissue and lymphoid follicle density were found to
be highly concordant (rs = 0.899, n=33, P<0.0001). The partial correlation coefficient for the
two variables after adjusting for the effect of age was 0.440, n=33, P=0.01.
3.3.2 Follicular pattern
The macroscopic appearance of lymphoid follicles in young lambs (0-6 months) was
characteristic (Figure 3.3). Once the serosal surface of the intestine was removed, lymphoid
follicles appeared as tiny, raised white plaques (of about 0.5 mm in diameter) (Figure 3.3A).
The follicles were numerous and appeared to be evenly distributed throughout the entire ileal
PP. When the specimen was transilluminated on an X-ray box, the follicles appeared as dark
blue nodules (Figure 3.3B), indicating uptake of methylene blue stain. Placing the specimen
in water (or 2% acetic acid) appeared to remove the colour from surrounding tissues more
quickly than from the follicles. Lymphoid follicles were less obvious from the serosal
surface and far less numerous in older (over 18 months) animals. Follicles in these animals
were more easily observed on the mucosal surface as tiny, light blue nodules present among
the villi of the intestine (not shown).
Lymphoid follicles were characterised microscopically as well defined focal cellular
aggregates of lymphoid cells (lymphocytes and lymphoblasts) with variable numbers of
associated tingible body macrophages. A morphologic difference in lymphoid follicles
between young and older animals was apparent. In young (0-6 month-old) animals, the
follicles were more numerous and larger, and tended to extend throughout the entire lamina
propria of the intestine (Figure 3.4A). Coccidia were found to be present in association with
the mucosal epithelium in some samples; these specimens were excluded from the study.
Few lymphoid follicles were found in animals aged 18 months and older (Figure 3.4C).
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Lymphoid follicles in these animals were less extensive compared to those seen in younger
animals (Figure 3.4A and B). Figure 3.4C shows one lymphoid follicle from a section of
ileal tissue in a 30 month-old ewe. The lymphoid follicle has undergone involution and may
not be visible macroscopically from the mucosal surface.
Figure 3.3 Lymphoid follicles in a 4-month old lamb. The serosal membrane (S) was partly stripped
to reveal the underlying lymphoid follicles. A. No transillumination has been used, and the lymphoid
follicles appear as tiny, white nodules. B. The tissue section has been transilluminated and the follicles
appear as dark, greenish-blue nodules. P= ileal Peyer's patch.
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Figure 3.4 Comparison of PP lymphoid follicles in the ileum of NPU Cheviot sheep at: A. 3 months;
B. 7 months, and C. 30 months. Lymphoid follicles undergo involution and are fewer in number with




The Bland and Altman plot was used to assess the repeatability of each method (that is, using
lymphoid follicle counts and area of PP tissue) by comparing repeated measurements for
each method on 33 sheep. Plots were used to determine whether the variability or precision
of each method is related to the size of the characteristic (lymphoid follicle counts or area of
PP tissue) being measured.
Repeatability of the methods used for quantifying area of PP tissue and number of lymphoid
follicles was satisfactory and paired measurements per individual animal can be used with
reasonable confidence. Limits of agreement (Figure 3.5) were obtained in order to determine
if the relationship between the differences and the magnitude of the measurement (whether
large or small) is constant. With the exception of a small cluster of points at the extreme left
of the line of zero differences (representing sheep with very few or no lymphoid follicles or
PP tissue), the relationship between the differences and the magnitude of the measurement is
more or less constant for both methods as can be seen from the random scatter of points
around the line of zero differences (Figure 3.5). We expect 95% of differences to lie within
the limits -143 to 181 (19 + 162) and -1.15 to 1.49 (0.17 ± 1.32) for lymphoid follicle density
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Figure 3.5 Bland and Altman plots for assessing the repeatability of methods used for quantifying
lymphoid follicles and area of PP tissue. A. The difference between two lymphoid follicle counts
plotted against their average, and B. The difference between two measurements of percentage of PP
tissue plotted against their average.
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3.4 Discussion
Young sheep have distinctly more follicles and PP tissue than adults. Although there was
some individual variation in the measures (surface area of PP tissue and number of follicles),
the general tendency was a rapid falling off in follicle number and patch area immediately
after 12 months of age. For purposes of comparison between different cases, the average
number of follicles per cm2 and average PP surface area are obviously better measures than
the total number of follicles and total PP surface area because of the different dimensions of
the ileum in different sized individuals. Direct comparisons with previous studies proved
difficult primarily because of different aged animals and measures used for quantifying PP
tissue and follicular content. One study (Reynolds and Morris, 1983) showed that the weight
of ileocaecal PP tissue and the associated number of follicles were greatest for 9 week-old
lambs. However, in this study, cases ranged from 120 days gestation to 9 weeks post-partum
and did not always account for differences in intestinal length in different sized individuals.
Also, the breed of sheep used in the study was not stated.
Several factors may influence the number of PPs in the intestine, for example, diet (and
hence the antigenic load in the intestine), the frequency of food consumption as well as the
time taken between ingestion and evacuation may well be important factors (Poskitt et al.,
1984). Whether or not variations in PP tissue area and lymphoid follicle number arise
depending on exposure to amount and type of antigen, or whether the development of
lymphoid follicles is embryologically pre-determined for the breed or the individual animal
(Liebler et al., 1988) remains unknown.
In sheep, natural scrapie infection occurs most likely by the oral route via infection of PPs
followed by replication in the GALT (Andreoletti et al., 2000). Replication in the intestine
and lymphoid organs usually occurs for many months, even years, before reaching the CNS
via the blood or nerve fibres innervating lymphoid tissues (Andreoletti et al., 2000). FDCs
have been implicated as the cells of the lymphoid system that sustain replication of the TSE
agent in laboratory rodents (Brown et al., 1999; McBride et al., 1992). Studies in sheep have
shown the presence of PrPSc, which is strongly associated with disease (Bolton et al., 1982),
in cells of the FAE (Heggebp et al., 2000), and this is consistent with PrP uptake from the
gut lumen occurring across this specialised intestinal epithelium. This transport function is
thought to be mediated by M cells, which as shown in one study, are able to mediate
transepithelial transport of prions (Heppner et al., 2001). Transcytosis of pathological agents
across the FAE has been implicated in several diseases including Yersinia infections,
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salmonellosis and paratuberculosis (Gleason and Patterson, 1982; Landsverk et al., 1990;
Momotani et al., 1988; Wolf and Bye, 1984) which are all known to originate in PPs.
Natural infection with the scrapie agent is thought to occur mainly in young sheep less than 9
months old (Hourrigan et al., 1979). During this period of high susceptibility to infection, the
ileal PP serves as the main GALT comprising an extensive area of FDCs and specialised
FAE actively engaged in the uptake and transcytosis of macromolecules from the gut lumen
(Heggebp et al., 2000). Involution of the ileal PP at puberty and the accompanying drastic
reduction in the number of follicles (and FDCs as well as FAE) may well contribute to
reduced susceptibility to scrapie infection observed in older animals (Diaz et al., 2005;
Hourrigan et al., 1979) and may influence individual susceptibility to disease. A number of
other factors including PrP genotype, strain of agent and environmental factors such as
artificial or natural rearing (Elsen et al., 1999; Hunter et al., 1996) have been linked with
susceptibility to scrapie. The incubation period and pathogenesis of scrapie varies according
to the interaction of a number of these factors (as demonstrated in Chapter 2). Hence, it is
becoming clear that there is great heterogeneity in the control of susceptibility to scrapie, and
the association made here suggests that the amount and distribution of ileal PP tissue may
represent an additional contributory factor.
One study showed that sheep parasitized with Teladorsagia circumcincta were at a greater
risk of becoming infected with the scrapie agent. However, results were inconclusive
because of improper controls, and the possibility that subclinical scrapie may have already
been present in the flock (Elsen et al., 1999). Specifically, it has been suggested that
infection with Teladorsagia circumcincta may be a cofactor of scrapie infection, facilitating
penetration of the infectious agent through lesions due to larvae in the gastrointestinal tract
(Laplanche et al., 1996). It has been hypothesised that nematodes may serve as vectors of the
disease, but this hypothesis has, so far, been tested with no success (Fitzsimmons and
Pattison, 1968). Another possibility is that PP numbers are perhaps increased in parasitic
infections and bearing in mind that these lymphoid structures most likely act as a primary
replication site and reservoir of the scrapie agent (Andreoletti et al., 2000) results in
parasitized individuals becoming more susceptible to scrapie infection. Further studies of
ileal PP tissue in different age groups of sheep with disease conditions are therefore needed
in order to obtain more information about the functional significance of this specialized gut
tissue and its role in scrapie pathogenesis.
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Chapter 4: Comparative evidence for a link between PP development and
susceptibility to TSEs
4.1 Introduction
The incidence of natural cases of TSEs or prion diseases is related to age: scrapie incidence
in sheep typically peaks between 2 and 3 years of age (Detweiler and Baylis, 2003), BSE
incidence in cattle peaks at around 5 to 7 years of age (Defra, 2004); and vCJD incidence in
humans peaks at 25 to 30 years (Will, 2003). Age-related patterns in incidence will reflect
the incubation period of the disease (typically long relative to host life expectancy), the
magnitude of the risk of infection and any age dependency in the risk of infection. Analyses
of epidemiological data for scrapie (Matthews et al., 2001), BSE (Ferguson et al., 1997) and
vCJD (Boelle et al., 2004) have suggested that there is significant age dependency in the risk
of infection for all these TSEs. Available evidence suggests that these patterns cannot be
fully accounted for by changes in exposure, in which case changes in susceptibility must also
play a role. However, to date, there has been no indication of why susceptibility might
change with age.
Age dependency in the risk of infection by TSEs will reflect any age dependency in exposure
to infection and/or in susceptibility to infection for a given level of exposure. Both of these
are likely to be linked to the route of transmission. Although other transmission routes may
exist (see below), oral exposure appears to be the most important route of transmission for
natural TSE infections in sheep, cattle, deer and mink and for vCJD and kuru in humans
(Detweiler and Baylis, 2003; Heggebp et al., 2000; Sigurdson et al., 1999; Terry et al., 2003;
Will, 2003). There is evidence for the involvement of Peyer's patches (PPs), part of the gut-
associated lymphoid tissue (GALT), in orally transmitted TSE infection. Experimental
studies in cattle have demonstrated staining for PrPSc (the abnormal prion protein) in PP
follicles in the distal ileum throughout much of the course of the disease following oral
exposure to the BSE agent (Terry et al., 2003). In sheep, oral infection with scrapie is
thought to occur mainly via the ileal PP, followed by replication in GALT (Heggebp et al.,
2000). In mule deer fawns, lymphoid follicles of PPs have been shown to accumulate PrPSc
within a few weeks following oral exposure to CWD (Sigurdson et al., 1999). After oral
infection of nonhuman primates with BSE-infected material, PrPScis initially detected in PPs
(Bons et al., 1999). In experimental infections, mice deficient in both tumour necrosis factor
(TNF) and lymphotoxin or in lymphocytes, in which PPs are decreased in number, are highly
resistant to oral challenge and their intestines are virtually devoid of infectivity at all times
82
post-challenge (Prinz et al., 2003). These facts collectively suggest a key role for PPs in the
infection dynamics of a range of TSEs.
Early presence of PrPSc in mouse PPs after oral exposure to scrapie {Beekes and McBride
2000) has indicated these structures as being the most probable sites for the intestinal uptake
of the TSE agent. Various cell types present in this lymphoid tissue have been implicated as
important elements in the uptake and propagation of the infectious agent. PrPSc staining in
the follicular dendritic cells (FDCs) of patients with vCJD (Hill et al., 1999) and of sheep
naturally infected with scrapie (van Keulen et al., 1996), as well as staining associated with
the luminal border of cells in the follicle-associated epithelium (FAE) of sheep suggest
uptake of the TSE agent from the intestinal lumen to the underlying lymphoid tissue
(Heggebp et al., 2000). Although important functional differences exist between PP in sheep
ileum and those in the duodenum and jejunum, the FAE overlying jejunal and ileal PPs has
an efficient mechanism for the transcytosis of luminal material (Griebel and Hein, 1996; Lie
et al., 2005), including prion proteins, to the underlying lymphoid tissue.
The development of GALT is known to be related to age. In young sheep, cattle and humans,
ileal PPs are the major component of GALT possessing an extensive bed of FDCs and FAE.
The involution of ileal PPs occurs at around puberty in sheep, cattle and humans (Carlens,
1928; Cornes, 1965; Reynolds and Morris, 1983). However, the age-related changes in PP
development are not identical across these three species, providing an opportunity for a
comparative study. Our hypothesis is that although the relationships between PP
development and age and between susceptibility to TSE infection and age differ in sheep,
cattle and humans, there should still be a correlation between PP development and
susceptibility for each species.
4.2 Methods
4.2.1 Anatomical studies
Specimens of ileum were collected from 33 sheep of different ages (0-1 year, 1-2 years and
>2 years) from a flock of Cheviot sheep maintained by the Institute for Animal Health NPU
(Hunter et al., 1996). The study was limited to animals with no clinical or pathological
evidence of intestinal disease. Specimens were obtained from sheep that were either
euthanised because of severe arthritis in one or more limbs, died shortly after birth or were
culled for flock management reasons. The specimens were opened along their mesenteric
borders, and rinsed in cold water. PP tissue and lymphoid follicles were visualised by
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immersing the intestines in 2% acetic acid for 24 hours, and the follicular content of the
patches enhanced by staining with 0.5% methylene blue for 2-5 minutes. PP tissue and
lymphoid follicles were easily visualised using this technique.
The terminal ileum (distal 0.6 m of the ileum) was transilluminated on a horizontal X-ray
view box and digital images were obtained. Image analysis software (Image-Pro Plus®) was
then used to calculate the areas of intestine and of PP tissue. The area of PP tissue was
recorded as a percentage of the total area of intestinal tissue.
To determine the number of lymphoid follicles, the stained intestine was placed between two
glass slides, the upper of which was etched in square centimetres. Individual lymphoid
follicles appeared as bright blue spots against a faintly blue background when viewed on the
X-ray box. The number of lymphoid follicles in 6 different sections along the length of the
terminal ileum was counted by naked eye, starting at 5 cm from its caudal end and selecting
4 cm2 sections at every 10 cm thereon, proximally. Results were recorded as the average
number of lymphoid follicles per cm2 of ileum.
Results are described in terms of area of PP tissue and lymphoid follicle density in the sheep
ileum; analyses indicate that these two measures are closely correlated (rs=0.899, n=33, P<0
.001). PP data for cattle and humans were obtained from earlier studies (Carlens, 1928;
Cornes, 1965). These studies used different measures to quantify PP tissue from those we
obtained here for sheep. The cattle data (Carlens, 1928) refer to weight of PP tissue in the
small intestine of 94 German beef cattle. The human data (Cornes, 1965) refer to number of
PPs in the normal small intestine of 46 individuals between 0 and 40 years of age. The study
was limited to necropsies performed within a few hours of death, and to patients with no
clinical history or pathological evidence of gastrointestinal tract disease. A second, smaller
study of human PPs indicates that, in humans, number of PPs and area of PP tissue in the
distal ileum were correlated across age classes (r=0.415, n=55, P<0.01) (van Kruiningen et
al, 2002). As far as I am aware, there are no other quantitative data on PP development with
respect to age available for these species but, where direct comparisons are possible, it
appears that the different measures reflect the same underlying relationship with age.
4.2.2 Scrapie incidence data
The NPU Cheviot flock, a closed flock maintained explicitly as a source of natural scrapie
infections, has been comprehensively documented and demographic information and
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epidemiological data on all sheep are available (Hunter et al., 1996). In this study, analyses
were based on data obtained from an outbreak of scrapie, which spanned the years 1985 to
1994 affecting cohorts born between 1983 and 1992. This represents a total of 1,473 sheep of
which 34 developed clinical scrapie. In this flock, scrapie occurs in two PrP genotypes,
VRQ/VRQ and VRQ/ARQ (Hunter et al., 1996). (There is no evidence that PrP genotype
influences PP development). Further details of the outbreak are given elsewhere (Hunter et
al., 1996).
4.2.3 Age-susceptibility function for sheep
The method follows that of Boelle et al. (Boelle et al., 2004) used to derive the age risk
function for vCJD. The occurrence of cases in genotype G sheep is modelled by a Poisson
process in the (age, time) plane with intensity %(«,?) given by:
a
71G (a,t) = fiGrGS(a) J"exp - jA(u,t -a + u)du A(a',t-a + a)hG (a - a')da'
where J3C is the birth rate and rc is the relative susceptibility of genotype G individuals, S(a)
is the probability of survival (in the absence of scrapie) until age a, hc is the probability
density function for the incubation period for genotype G individuals, M,a,t) is the per capita
rate of infection for individuals of age a at time t. The expression sums the contribution to
the incidence of infection at age a and time t from animals infected when at age a', taking
into account the fact that the number of animals available at age a' to become infected is
reduced by those already infected at age u. The low incidence of scrapie in this flock
(Matthews et al., 2001) permits modelling of the age and timing of cases as a Poisson
process because the course of the outbreak does not significantly impact on the demography
of the susceptible sheep.
The survivorship function S{a) is a Weibull function with mean age of death of 2.99 years
(Matthews et al., 2001). The incubation period distribution is a gamma distribution with a
mean of 1.9 years (Matthews et al., 2001). The birth rate J3C is selected to give the average
numbers of sheep of different genotypes born per year. The per capita rate of infection, Ma,t)
has two parts: a time dependent component g(t) which is assumed here to be proportional to
an exponential function fitted to the incidence of infection; and an age-dependent component
/(a) which represents the relative susceptibilities of different age classes:
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fx for 0 < a < 1
f(a) f2 for 1 < a < 2
/3 for 2 < a < 9
where the maximum value taken by f, f2 or f3 is equal to 1. Standard theory on point
processes (Cox and Isham, 1980), gives the log-likelihood of the observed age-of-case data
to be:
The subscript i denotes actual case data; deaths are known to occur at age a, and a time t,
after the start of the outbreak. Maximum likelihood methods were used to estimate the
constant of proportionality, which determines the magnitude of the per capita rate of
infection and the age-dependent susceptibility function as defined by fi,f2, and f3. This was
done for (i) the 34 cases over the 10 year period assuming no differences between genotypes,
and (ii) for the 28 genotyped cases allowing the 8 VRQ/ARQ cases to have either a lower
susceptibility to infection or (iii) a longer incubation period than the 20 VRQ/VRQ cases.
We found that models (ii) and (iii) produced a significant improvement in fit at the 95%
level over model (i), but that the shape of the age-dependent susceptibility function was
robust to the choice of model. Results are shown for model (ii).
For cattle, estimates of risk of BSE infection were made from n=158,550 BSE cases in
British cattle and were calculated from the cumulative distribution function, defined by
Ferguson et al. (1997), corresponding to the age-exposure/susceptibility curve (fitted using
maximum likelihood methods).
For humans, estimates of risk of vCJD infection were obtained from a previous study that
comprised n=129 vCJD cases in British people, and were fitted using maximum likelihood
methods by Boelle et al. (2004).
4.2.4 Concordance between susceptibility data and anatomical data
For each combination of anatomical data and risk of infection estimates we calculated the
Spearman's rank correlation coefficient, rs, between the value of the available measure of PP
development (area, weight or number) and the risk of infection for an individual of the
G
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corresponding age. Sample sizes were n=33, n=94 and n=46 for sheep, cattle and humans,
respectively. Correlation coefficients were calculated using S-PLUS 2000 for Windows.
4.3 Results
For sheep, cattle and humans alike, a strong correlation was found between risk of TSE
infection and the development of lymphoid tissue in the gut which can explain both the
relationships between age and disease incidence within species and differences in this
relationship between species.
For sheep there is a marked fall in both the surface area of ileal PP tissue and lymphoid
follicle density between approximately 12 and 24 months old, and both measures remain
very low throughout adulthood (Figure 4.1 and 4.2A). Analysis of data on the incidence of
natural scrapie over a 10 year period in the sheep flock providing the anatomical data
indicates that the risk of infection is highest in the first year of life and is lowest in sheep >2
years old (Figure 4.2A). The two distributions peak in the same age class and are highly
concordant (see Methods): surface area of ileal PP tissue vs risk of infection, rs=0.887 (n=33,
P<0 .001); lymphoid follicle density vs risk of infection, rs=0.882 (n=33, PcO.001).
For cattle, previous work (Carlens, 1928) has shown that the weight of PP tissue in the small
intestine increases in the first year of life, peaks at 12-18 months old, declines thereafter, and
is low throughout adulthood (Figure 4.2B). Available estimates of age-related risk of
infection of the British cattle population with BSE up to 1996 (given a mean incubation
period of 5 years; published estimates range from 4.5 to 5.5 years (Arnold and Wilesmith,
2004)) indicate that the risk is initially low, peaks at about 12 months, and declines rapidly
thereafter (Figure 4.2B). Again, the two distributions peak at similar ages and are
concordant: rs=0.693 (n=94, P<0.001).
For humans, previous work (Cornes, 1965) has shown that the number of PPs in the small
intestine increases during childhood, peaks at 10-15 years old, and declines thereafter,
although the PPs persist throughout adulthood (Figure 4.2C). Recent estimates of age-related
risk of infection of the British human population to vCJD (Boelle et al., 2004) indicate that
the risk is initially low, peaks between 5 and 20 years, and declines thereafter (Figure 4.2C).
Here too, the two age-related patterns are concordant: rs=0.38 (n=46, P=0 .008). The same
study (Boelle et al., 2004) provides estimates of age-related susceptibility having allowed for
changes in putative exposure associated with consumption of bovine carcass meat (see
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below). This is also concordant with the number of PPs: rs=0.360 (n=46, P=0.014).
Importantly, these correlations occur despite the markedly different patterns of age-related
development of GALT in humans as compared with sheep and cattle.
Figure 4.1 Comparison of PP lymphoid follicles in the ileum of NPU Cheviot sheep at: A. 4 months;
B. 15 months, and C. 6 years, using haematoxylin and eosin staining. Lymphoid follicles (F) undergo
involution and are fewer in number with increasing age. L=intestinal lumen. Bar = 200 pm.
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Figure 4.2 Comparison of age-related changes in PP development and estimated risk of TSE infection
relative to the most susceptible age class, for sheep, cattle and humans. A. PP areas for n=33 Cheviot
sheep of mixed genotypes in 3 age classes (left hand axis, open circles), compared with estimates of
risk of scrapie infection relative to the most susceptible age class (solid line) (+50 percentiles-dashed
lines) from field data on n=34 cases in mixed PrP genotype (VRQ/VRQ and VRQ/ARQ) Cheviot
sheep (see Methods) in the same age classes (right hand axis). B. PP tissue weight against age for
n=94 cattle (open points, data from Carlens, 1928), compared with estimates of risk of BSE infection
relative to the most susceptible age class (solid line) as a function of age made from n=158,550 BSE
cases in British cattle (taken from Ferguson et al., 1997). C. Numbers of PPs in the small intestine in 8
age classes of humans (open circles, data taken from Cornes, 1965), compared with estimates of risk
of vCJD infection relative to the most susceptible age class (solid line, ±50 percentiles-dashed lines)
from n=129 vCJD cases in British people for the same age classes (redrawn from Boelle et al., 2004).
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4.4 Discussion
Results show that, whilst both age-related changes in the development of PP tissue and
estimated risks of TSE infection differ between sheep, cattle and humans, in each case the
two are associated. However, these results do not distinguish effects of age-related changes
in exposure to TSE infection from age-related changes in susceptibility. To make this
distinction we need to consider how oral exposure to TSE infection might change with age
for each species.
For BSE in cattle, epidemiological studies have implicated meat and bone meal (MBM)
containing recycled infected cattle tissues (Wilesmith et al., 1988). MBM used to be
incorporated as a protein source in concentrated feedstuffs and fed to both calves and adult
cattle. However, there is no clear correlation with the estimated age-infection function
(Figure 4.2B): almost all calves were exposed to MBM by 6 weeks of age; exposure then
fluctuated up to 24 months old but, especially for dairy cows, rose again in adulthood
(Anderson et al., 1996; Wilesmith et al., 1997). This route of BSE transmission is thought
now to have been eliminated by feed production regulations introduced in 1988 and 1996.
For vCJD in humans, the most likely vehicle for exposure is food products containing BSE-
contaminated cattle tissues (Cooper and Bird, 2002). Humans consume solid foods from 4-6
months of age with average consumption of bovine carcass meat peaking during childhood
and tending to fall thereafter (see Figure 3 in Boelle et al., 2004). This route of transmission
is thought now to have been eliminated by food production regulations introduced in the UK
in 1996. Here, putative exposure is more closely aligned with PP development (Boelle et al.,
2004) but, as reported above, when age-related exposure is taken into account, there remains
an association between PP development and estimated susceptibility.
For scrapie in sheep, the vehicle(s) of oral exposure is (are) less well understood, but are
likely to include grazing on pasture contaminated with scrapie, possibly by infected foetal
membranes (Pattison et al., 1972). Lambs typically begin to graze at 6-14 weeks and
continue to do so throughout their lives. Exposure by this route would not be correlated with
the estimated age-infection function (Figure 4.2A).
The importance of other transmission routes is less clear. Transmission from mother to
offspring in utero or via breast milk (self-evidently age-dependent) is thought to play a minor
role, if any: currently available estimates of the fraction of cases due to maternal
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transmission are 0-8% for scrapie in sheep (Matthews et al., 2001), 0-14% for BSE in cattle
(Gore et al., 1997), and 0% for vCJD in humans (Will et al., unpublished data). Other
suggested routes include skin scarification (as demonstrated experimentally in mice (Taylor
et al., 1996)), food-borne infection via oral lesions (Bartz et al., 2003), for scrapie possibly
even mechanical transmission involving arthropods (Lupi, 2003), and for vCJD, iatrogenic
transmission (Will, 2003). However, there is no evidence that exposure via any of these
routes varies with age in a manner corresponding to the estimated risk of infection functions
(Figure 4.2)
The measures of PP development (area, weight or number) used in this study are crude
indicators of lymphoid tissue development; alternative measures in PP development may be
at least as appropriate (for example, in sheep, counts of functionally mature FDCs).
Moreover, this analysis assumes that both the anatomical data and the age-susceptibility
estimates available are representative of each host species in general and not just the specific
populations examined. Similarly, it is assumed that the associations studied have not been
distorted by other factors (example, history of exposure to gut pathogens) which might
influence PP development and/or susceptibility to TSEs.
Given these caveats, it is nonetheless striking that an association between PP development
and susceptibility to TSEs is seen not just in one host species but in three host species with
different relationships between these variables and age. This kind of comparative study is
especially useful in cases such as this where experimental manipulations (example, of PP
development) are not feasible.
Taken together, the epidemiological, anatomical and pathological evidence are consistent
with the hypothesis that PP development or a close correlate of PP development is a major
determinant of the observed age distribution of natural cases of TSEs in sheep, cattle and
humans. This implies that the age groups most at risk of TSE infection (given that the
individuals are exposed and have a susceptible PrP genotype) are indicated by the
development of PPs in the gut.
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Chapter 5: Ontogeny of PrP-associated follicular dendritic cells in postnatal
mice and Cheviot sheep
5.1 Introduction
Prion protein (PrP), the product of the PrP gene, has been linked to TSE infection and
disease progression based on the findings that the scrapie agent is unable to replicate in PrP
knockout mice (Biieler et al., 1993), and when PrP levels are increased by insertion of
multiple PrP gene copies the disease progresses more rapidly (Prusiner, 1991). PrPSc deposits
are associated with TSE pathogenesis and immunocytochemical detection of this
pathological PrP isoform is routinely used as a hallmark of these diseases (Kitamoto et al.,
1987; Lantos et al., 1992). After oral inoculation of rodents with scrapie, infectivity and
PrPSc accumulate first in PPs and ganglia of the enteric nervous system before their detection
in the central nervous system (CNS) (Beekes and McBride, 2000; Maignien et al., 1999). In
natural and experimental scrapie in sheep, PrPSc is often found to accumulate in PPs prior to
detection within the CNS (Andreoletti et al., 2000; van Keulen et al., 1999). Within the gut-
associated lymphoid tissue (GALT) of orally infected rodents (Beekes and McBride, 2000)
and sheep (Andreoletti et al., 2000; Hcggebp et al., 2000) with scrapie and mule deer
inoculated with CWD (Sigurdson et al., 2002), disease-specific PrP accumulations occur in
association with FDCs. High levels of PrP have also been detected on FDCs in uninfected
mice (Brown et al., 2000a; Ritchie et al., 1999). Although the precise identity of the
gastrointestinal tract tissues and cells in which TSE infectivity is either supported or
replicated remains to be established, the FDC appears to be the most likely candidate for
prion replication.
FDCs are a unique population of accessory cells localized to primary and secondary nodules
of lymphoid tissues (Heggebp et al., 2002) and have been implicated as the likely sites for
prion replication in lymphoid tissues as they appear to express high levels of abnormal PrP in
patients with vCJD (Bruce et al., 2001; Hill et al., 1999), sheep with natural scrapie (van
Keulen et al., 1996) and mice experimentally infected with BSE (McBride et al., 1992). Sub¬
lethal whole body y-irradiation of mice before or after peripheral infection has no effect on
scrapie incubation periods, suggesting involvement of non-proliferating, radioresistant cells
in the lymphoreticular phase of prion propagation (Fraser and Farquhar, 1987). Amongst the
best candidates for cells of this nature are FDCs. Signalling through TNF-R1 and LTpR is
required for the development and maintainance of mature FDCs (Mabbott and Bruce, 2001).
In spleens of TNFa-/- mice challenged with the ME7 scrapie strain, the absence of detectable
infectivity and PrPSc in the spleen and reduced disease susceptibility coincide with the
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absence of mature FDCs (Brown et al., 1999; Mabbott et al., 2000). Inhibition of LTp
signalling pathway with a soluble receptor that depletes FDCs (Mackay and Browning,
1998), prolongs the latency of scrapie after intraperitoneal (i/p) challenge (Mabbott et al.,
2000; Montrasio et al., 2000), and B cell-deficient pMT mice (Kitamura et al., 1991), which
bear a deletion of the transmembrane p-immunoglobulin exon, are resistant to i/p inoculation
with prions (Klein et al., 1998) perhaps because of impaired FDC maturation (Klein et al.,
1998; Montrasio et al., 2000). SCID mice, which lack mature FDCs, are fully susceptible to
TSE infection when challenged via the intracerebral (i/c) route, but are relatively resistant
when exposed peripherally (Fraser et al., 1996; Kitamoto et al., 1991). Hence, although
FDCs appear to play a major role in i/p infection, their contribution may not be essential in
i/c route transmission (Kitamoto et al., 1991).
In spite of oral exposure being a likely transmission route not only for vCJD but also for
other TSEs, the majority of experiments that suggest involvement of PrPSc replication in
FDCs have been performed using i/p routes of infection. Direct i/p inoculation is a
potentially misleading model of natural TSE infection, and the role of FDCs following oral
infection remains unsettled. For instance, the role of the spleen and of FDCs in amplification
of prion infectivity following oral inoculation remains unclear, since, although splenectomy
prolongs the incubation time of scrapie in intraperitoneally-infected animals (Fraser and
Dickinson, 1970), it has no effect after oral or intragastric inoculation (Kimberlin and
Walker, 1989a). Although the role of PrPc-expressing mature splenic FDCs is well
characterised at least in the FDC-dependent ME7/C57BL mouse scrapie model, the ontogeny
of PrPc-expressing FDCs in PPs and how this might affect susceptibility to TSE infection is
not known. Previous studies have shown that neonatal mice are less susceptible to scrapie
challenge compared to adults (Outram et al., 1973). Although a proportion of neonates
survived i/p infection, their ability to survive scrapie challenge disappeared in the first week
of life and by 10 days post-partum, susceptibility to scrapie resembled that of the adult
(Ierna, 2001). Because sheep are born with more developed lymphoreticular responses
relative to mice, and possess an extensive bed of FDCs in the ileal PP at a time when they
are considered to be most susceptible to infection (Heggebp et al., 2000; Hourrigan et al.,
1979), this may help to explain the apparent increased susceptibility of young lambs and the
decreased susceptibility observed in mice soon after birth. It is interesting to speculate that
neonatal mice perhaps lack a mature cell population required for scrapie pathogenesis
(Outram et al., 1973) and when these cells undergo differentiation, susceptibility to scrapie is
restored after a certain postnatal age. Because there is an intrinsic requirement for FDCs in
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ME7 scrapie pathogenesis, this may suggest that maturation of FDCs may affect neonatal
scrapie pathogenesis with this strain. Although previous studies suggest that FDCs are in an
immature state during the first month of life because of immaturity of B cells (Marshall-
Clarke et al., 2000) and the inability of FDCs to trap immune complexes (Holmes et al.,
1984), other studies suggest that immature FDCs may be partially functional (Karrer et al.,
2000).
The majority of studies have focussed on the distribution of PrP in the spleen, lymph nodes
and tonsil, easily accessible sites in comparison to the ileal PP. The aim of this chapter is,
therefore, to investigate using immunocytochemical techniques the earliest age at which PrPc
can be detected in uninfected developing PP tissue in the ileum of C57BL mice and Cheviot
sheep, and to verify its association with FDCs during ontogeny to determine any correlations
with the onset of scrapie susceptibility in sheep and mice. Data obtained from this study may
aid in explaining the apparent decreased susceptibility of neonatal mice and increased
susceptibility in young sheep and whether this could be attributed to an absence of PrP-
associated FDCs within PPs.
5.2 Materials and Methods
5.2.1 Mice
All mice used in this study were uninfected with scrapie and were bred in the NPU, Institute
for Animal Health, Edinburgh. C57BL and PrP"'" mouse strains were used. The C57BL strain
expresses normal levels of PrPc and is used routinely at NPU for investigating the role of the
lymphoreticular system (LRS) in scrapie peripheral pathogenesis and was used in
experiments described in this chapter. PrP"'" mice, which do not produce PrP protein, were
produced by insertion of an MT/Neo cassette into exon 3 of the PrP gene in 129/Ola mice
(Manson et al., 1994), and were used as a negative control in the ICC experiments.
5.2.1.1 Harvesting ofmouse tissues
C57BL and PrP"'" mice of various age groups (2, 7, 14, 28 and 35 days) were culled using
cervical dislocation. The small intestine was harvested and frozen sections prepared (see
below). Each group comprised six mice for each of the two strains (Table 5.1). Because the
intestine is a long organ, transverse sections are not sufficient and the organ is best studied
longitudinally. A technique referred to as the 'Swiss roll', which has been described
previously (Moolenbeek and Ruitenberg, 1981; Reilly and Kirsner, 1965), was used for
examining the full length of the mouse ileum (Figure 5.1). The entire small intestine was
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removed from the abdomen and dissected longitudinally. Faecal contents were removed and
the intestine divided into three segments (the duodenum, jejunum and ileum) to facilitate
easy handling. Each segment was rolled up longitudinally with the mucosa facing outwards.
The 'Swiss roll' was snap frozen in liquid nitrogen (at -70°C) for cryostat sectioning. The
'Swiss roll' preparation necessitates rapid and careful removal of the intestine because
within 10 minutes of killing the animal, there is considerable sloughing of the intestinal
epithelium and loss of muscular tone.
Table 5.1 Mice used for investigation of PrP and FDC onset in ileal PP tissue.
Age of mice
Mouse Strain
2 days 7 days 14 days 28 days 35 days
Number of C57BL 6 6 6 6 6
animals PrP-/- 6 6 6 6 6
5.2.1.2 Preparation offrozen tissue
Snap frozen rolls of ileum were embedded in Tissue-Tek ®. Cryostat sections (7 pm) were
cut at -20°C (see Appendix B-l for full description of method) using electrostatically
charged glass slides (Superfrost Plus glass®) that attracts frozen (and formalin fixed) tissue
sections, binding them to the slide. The slides were dried overnight at room temperature, and
then stored at -20°C in airtight boxes containing silica gel to help minimise humidity.
5.2.1.3 Double immunolabellingfor PrP and FDCs
Cryostat sections were incubated with normal goat serum to block non-specific binding sites.
Washing steps were performed with TBS. Sections were immunolabelled with a rabbit
polyclonal anti PrP antibody, 1B3. 1B3, raised by inoculating rabbits with PrPSc fibrils from
the brains of Sincs7 (PrP a/a) mice terminally affected with ME7 (Farquhar et al., 1994;
Farquhar et al., 1989), recognises 4 distinct sites along the PrP peptide sequence including
one site in the N-terminus region (Farquhar et al., 1989; Korth et al., 1997).
1B3 was applied at a 1:1000 dilution overnight at room temperature. To ensure antibody
specificity, adjacent serial sections from the same tissue sample were incubated with normal
rabbit serum in place of primary antibody. Immunolabelling was visualised using fluorescent
goat anti-rabbit alexa 488 (1:200 dilution) (Invitrogen).
95
Figure 5.1 Preparing a 'Swiss roll' using the small intestine of the mouse. A. Materials for preparing
'Swiss roll'; B-C. Small intestine is slit open longitudinally with scissors from the caudal end; D.
Divided intestine (duodenum, jejunum and ileum) with caudal ends nearest the investigator; E. Faeces
are removed with a wooden stick. Segments are kept in normal saline to prevent desiccation; F.
Cleaned segment is rolled onto stick with the mucosa facing outwards; G. 'Swiss roll' is snap frozen
in liquid nitrogen (-70°C); H. 'Swiss roll' is carefully removed from stick and placed in a cryostat
tube for ICC studies.
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For FDC networks, sections were blocked with normal mouse serum and immunolabelled
using a biotinylated monoclonal rat antibody, FDC-M2 (AMS Biotechnology Oxon,
Abingdon, UK).
Recent studies have identified the antigen recognized by the FDC-specific antiserum FDC-
M2 as complement component C4 (Taylor et al., 2002). Normal rat serum was used for
controls. Immunolabelling was visualised using streptavidin-alexa 594 diluted 1:200 in TBS
(Invitrogen). Slides were mounted in fluorescent mounting media (DAKO) and examined
under a confocal microscope. Immunolabelled slides were stored at 4°C to prevent photo-
bleaching. The specificity of the double immunocytochemical labelling procedure was
evaluated using healthy mouse spleen. (Full method described in Appendix B-2).
Double immunolabelled sections were analysed using confocal microscopy to determine
areas of co-localisation between PrPc and FDC markers. Co-localization analysis, based on
intensity profiles, was used to further characterize double immunolabelling. Sections were
viewed with green and red excitation/emission settings to detect PrP and FDCs, respectively.
Immunolabelling intensity profiles were obtained by plotting the intensity (pixel intensity) of
immunolabelling detected through the green and red channels versus the position of the
labelling along a user defined line (XY position). The same process was repeated for PrP7
mice. Superimposition of profiles for each channel was obtained for analysis. Merged green
and red images appear yellow and indicate areas of co-localization.
5.2.2 Sheep
Thirty-three sheep (NPU Cheviots) aged 0-3, 3-6, 6-12, 12-18 and over 18 months were used
in this study (see Appendix A, Table A-2). Their PrP genotypes were designated according
to the major disease-linked polymorphisms at codons 136 (alanine/valine), 154
(arginine/histidine) and 171 (glutamine/arginine) (Hunter et al., 2000). Genotype
information was available for only 23 sheep. None of these sheep had any clinical evidence
of disease. Sheep tissues were collected (as described in Chapter 3) for ICC and histoblot
analysis from the ileum (that included several sites containing grossly identified PP tissue),
and stored at -70°C in liquid nitrogen until use.
5.2.2.1 Single ICC using cryostat sections
Serial tissue sections were immunolabelled separately for PrP and FDCs. Cryostat sections
(7 pm thick) were incubated with normal rabbit serum to block non-specific binding sites.
97
Staining for detection of PrP was carried out using the BG4 (primary) antibody (at a 1:100
dilution), a mouse monoclonal antibody (Jeffrey et al., 2001a). Washing steps were
performed with TBS. Streptavidin biotinylated alkaline phosphatase (1:100 dilution) was
applied and colour development performed using Vector Red. To ensure antibody
specificity, adjacent sections were incubated with normal mouse serum in place of primary
antibody. (Full method is described in Appendix B-2). Images were taken using a Nikon
E800 microscope linked to a Kodak Polaroid camera.
Immunolabelling for FDCs was carried out similarly on cryostat sections using the D62
(primary) antibody. (Full method is described in Appendix B-2). D62 was obtained from
Bryan Charleston at Compton, Institute for Animal Health. The antibody has not yet been
fully characterised.
5.2.2.2 Histoblots
Frozen sections of 10 pm in thickness were mounted on nitrocellulose membranes (0.45
micron pore size: Bio-Rad laboratories, Hemel Hempstead, Herts, England), and dried flat
overnight at room temperature. After washing in TBS with 0.05% Tween, sections were
digested with proteinase K (PK) solution (25 pg/ml) in PK buffer (lOmM/L Tris HC1, pH
7.6; lOOmM/L NaCl; 0.1% [w/v] Brij 35) for 3 hours at 37°C. After rinsing in distilled water,
the samples were incubated in 3 mM Tris-buffered saline (with Tween) phenyl-
sulphonylfluoride (TBST-PMSF) (at room temperature to stop PK activity), followed by
denaturation in 3M guanidine isothiocyanate to denature PrPc. 10% BSA was added to the
membranes to block non-specific binding sites. Immunostaining was carried out using rabbit
polyclonal antibody, 521.7 (van Keulen et al., 1996) (at 1:30,000 dilution) to label PrP, and
NBT/BCIP to visualise the reaction product. The control tissues were tonsil and mesenteric
lymph node of a sheep with verified scrapie (positive control) and ileal PP tissue from an
animal confirmed not to have scrapie (negative control). (Full method is described in
Appendix B-2). Histoblots were analysed using a dissecting microscope.
5.3 Results
5.3.2 Mouse tissues
Using the 1B3/Alexa 488 system, PrP was found to be located within follicles of PPs and
was first detected at 7 days in all six mice. No PrPc was detected in PPs of 2-day old mice
(not shown). Staining for PrP was also obtained in PP follicles of 14-, 28- and 35-day old
mice and was more extensive compared to 7 day olds (with immunolabelling occurring most
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extensively in 35-day old mice) (Figures 5.2 and 5.3). Not all PP follicles stained for PrP in
some of these animals. PPs were difficult to locate in neonates (2-day olds).
Cells expressing FDC-M2 antigen, an epitope related to mouse C4 (Balogh et al., 2001) were
first observed at 7 days after birth, corresponding to the onset of detectable levels of PrPc in
developing PP follicles. FDC-M2+ cells appeared as well-defined networks and were
localized to the follicular region. Although the morphology of FDC-M2 labelling at 7 days
was very similar to that in the adult, staining appeared to be more diffuse in 35-day olds and
covered a wider area of the follicle. None of the 2-day old mice demonstrated FDC-M2
reactivity in follicles (not shown). Although the immunolabelling technique was optimised to
reduce background staining, FDC-M2 appeared to stain structures that resembled blood
vessels (Figure 5.30) in the lamina propria. No staining was observed in follicular regions
sections incubated with normal rat serum suggesting that labelling was due to the presence of
FDCs.
Confocal imaging of double stained sections showed some co-localisation between PrP and
FDCs within follicles, surrounded largely by areas of single labelling for both PrP and FDCs.
Yellow labelling was indicative of co-localization. In the case of 7-day old tissue for
example, labelling detected through the green and red channels match each other closely
between XY positions 150 and 210 pm (Figure 5.4A) but this corresponds to a minute area
of co-localization as demonstrated by the yellow colour (Figure 5.2C). Overall, for each age
group, the majority of PrPc did not co-localise with FDC-M2, and there were many single
labelled FDC-M2+ cells not expressing PrPc. For example, the two red arrows in Figure
5.5G indicate two peaks of medium to high intensity in the red channel indicating PrPc
negative/FDC-M2+ cells. Co-localization appeared to be greatest for 35-day old mice
(Figure 5.30). There was little variation in the level of staining for each age group based on
pixel density.
Age-matched controls (PrP_/*) showed no staining for PrP in PPs (Figure 5.2(D and H) and
Figure 5.3(L and P) as confirmed by line profile analysis (Figures 5.4 (B and D) and 5.5 (F
and H). However, the overall intensity of FDC-M2 labelling in PrP_/" controls was lower
compared to that observed for C57BL mice in all age groups (Figures 5.2 and 5.3), and this
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Figure 5.4 Co-localization analysis of 7 (A and B) and 14-day old (C and D) ileal PPs in mice, double-
immunolabelled for FDCs (red) and PrP (green). Pixel intensities for FDC and PrP labelling
correspond to FDC/PrP co-localization in Figures 5.2 for C57BL (C and G) and PrP_/" (D and H).
Immunolabelling intensity profiles were obtained as described previously (section 5.2.1.3). Areas of
co-localization are indicated by close matching of XY positions for red and green labelling. Red
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Figure 5.5 Co-localization analysis of 28 (E and F) and 35-day old (G and H) ileal PPs in mice,
double-immunolabelled for FDCs (red) and PrP (green). Pixel intensities for FDC and PrP labelling
correspond to FDC/PrP co-localization in Figures 5.3 for C57BL (K and O) and PrP"'" (L and P).
Immunolabelling intensity profiles were obtained as described previously (section 5.2.1.3). Areas of
co-localization are indicated by close matching of XY positions for red and green labelling. Red




The PrP genotypes of sheep used in this part of the study are given in Appendix A, Table A-
2. PrP genotypes are designated according to the major disease-linked polymorphisms at
codons 136 (alanine/valine), 154 (arginine/histidine) and 171 (glutamine/arginine). Whether
or not patterns of staining were similar for different genotypes within each age group could
not be determined because of small sample size.
5.3.3.1 ICC
5.3.3.1.1 Staining for PrP and FDCs using cryostat sections
Consecutive ileal sections were labelled with the BG4 and D62 antibodies because
simultaneous staining had not succeeded. Staining for PrP was detected in all age groups
investigated. The level of staining, however, differed between follicles and between
individuals. There were accumulations of PrP in most nodules of PPs in the ileum and the
distribution of staining was similar in all age groups of sheep (Figure 5.6). Staining was
observed primarily in the light central zone of follicles with little/faint or no staining present
in the dark peripheral zone adjacent to the capsule.
Figure 5.6 Distribution of PrP in
a cryostat section of ileal PP
tissue of an uninfected 9 month-
old sheep using the BG4 antibody.
Staining is confined mainly to the
central region of the lymphoid
follicle in the region of the FDC
networks (N). Some faint
background staining is also visible
in the interfollicular regions
(arrows).
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There was a diffuse pattern of staining observed (using the D62 antibody) within the light
zone of follicles, corresponding to the localization of FDCs and characterized by a reticular-
like pattern (Jeffrey et al., 2000b). Staining was detected in all age groups investigated
(Figure 5.7). However, staining in old sheep (over 18 months) was found to be less diffuse
and less intense (Figure 5.8). Dense staining was sometimes observed in the luminal border
of the epithelial cells in the FAE (Figure 5.8). Dense, large, punctuate-type staining was
sometimes found to be present in the dome and interfollicular regions of some follicles
(Figure 5.7). However, similar staining was also observed in control sections using normal
serum, and was most likely the result of artefact/non-specific staining.
U
Figure 5.7 Distribution of FDCs in
a cryostat section of ileal PP tissue
of an uninfected 9 month-old sheep
using the D62 antibody. Note the
reticular-like network of these cells
in the central region of the follicle
(N). Dense punctuate areas of
labelling represent non-specific
staining (arrows).
Figure 5.8 Distribution of FDCs in
a cryostat section of ileal PP tissue
of an uninfected 6 year-old sheep
using the D62 antibody. The FDC
network appears to have
degenerated with age (N). Areas of
dense staining are visible in the




The antibodies BG4 and D62 tended to produce relatively high background staining in
frozen tissue sections despite the fact that the immunolabelling technique was repeated and
optimised to minimise cross-reactivity. Staining, though faint, was also observed in similar
regions of control sections incubated with normal serum and suggests that labelling was not
entirely specific for PrP and FDCs.
5.3.3.1.2 Histoblots
Immunocytochemical techniques, using cryostat sections, did not differentiate between the
cellular (PrPc) and disease-associated isoform (PrPSc) of the protein. The histoblot technique
is useful for differentiating between PrPSc andPrPc. The technique has the advantage in that it
preserves the tissue anatomy to some degree thereby revealing the distribution of PrPSc
within tissues {Heggebp et al., 2003) as observed in this study. Staining was more intense
for PK-positive samples compared to PK-negative samples (Figure 5.9). Based on histoblots,
only one sheep of PrP genotype VRQ/VRQ was found to be subclinically infected with
scrapie. Uninfected sheep had the genotypes ARR/ARR, ARR/AHQ, VRQ/AHQ or
AHQ/AHQ. In this study, PrPSc was detected in ileal PPs in one 9-month old sheep (Figure
5.9D). Proteinase K-resistant PrP was detected in the lymphoid nodules and was localized
mainly to the light central zone and neck region of the nodules. The dark peripheral zone
showed little staining and there were scattered foci of strong staining in nodules perhaps
corresponding to tingible body macrophages (Appendix C, Figure C-l). This was in contrast
to staining observed in uninfected animals which appeared to be less intense and which
showed no specific punctuate-type pattern in lymphoid nodules or extranodular regions
(Figure 5.9B). Histoblot and immunocytochemical examination of negative control animals
showed no PrPSc in the ileal PP tissue (Figure 5.9F). There was dark, granular staining in the
germinal centres in the mesenteric lymph node of positive controls (Figure 5.9H).
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Figure 5.9 Histoblots of ileal PP tissue and mesenteric lymph node. Magnification X10. Histoblots
from an uninfected animal in TBS (PK negative) (A) and PK solution (PK positive) (B). Histoblot
analysis of PrP accumulation in ileal PP tissue from a VRQ/VRQ sheep (9 months old) with natural
scrapie infection (C and D). Histoblot of the ileal PP in an uninfected animal, used as a negative
control in this study (E and F). Histoblot of the mesenteric lymph node from a scrapie-infected animal,
used as a positive control in this study (G and H). ( See also Appendix C, Figure C-l for explanation




Double immunofluorescence was used to investigate the co-localisation of PrP and FDCs in
frozen sections of ileal tissue in uninfected mice. This study does not assume that cells
associated with the cellular expression of PrP (PrPc) necessarily participate in TSE
replication (although it would seem likely that PrPSc accumulations in specific cell types may
indicate their involvement in TSE pathogenesis).
In this study, it was possible to identify FDCs in PPs of the mouse ileum using a specific
monoclonal antibody (FDC-M2). PrP labelling was present in all age groups of mice, except
the 2-day old category, in the centre of lymphoid follicles. Other authors have used the FDC-
M2 antibody in determining the association between PrP and FDCs in splenic mouse tissue
(Brown et al., 1999; Kosco et al., 1992). The overall intensity of FDC-M2 labelling in PrP"'
PPs was found to be lower than that of C57BL PP tissue and is in accordance with findings
from a previous study using splenic tissue from mice (Ierna, 2001). This finding suggests
that FDCs may undergo a different rate of maturation in PrP'and C57BL mice perhaps
because of their genetic backgrounds. Further investigation will be required in order to
determine whether or not this is a significant finding.
Previous studies have shown that by day 10, few splenic follicles contain cells expressing the
FDC-M2 antigen. However, the earliest FDC marker displayed was the antigenic
determinant recognized by the FDC-M1 monoclonal antibody, which was detectable by day
3 prior to follicle formation in splenic cells (Balogh et al., 2001). The FDC-M1 marker was
not used in this study because it also stains tingible body macrophages which are most likely
of haemopoietic origin (Aguzzi et al., 2003). Although FDC-M 1 has been cited as a
maturational marker for FDCs (van den Berg and Dijkistra, 1995), it has not been sequenced
and its function has not yet been determined.
In this study, FDCs were detected significantly earlier than in other lymphoid structures
using the FDC-M2 marker (Ierna, 2001). The appearance of FDC-M2+ cells at 7 days old
may suggest that FDCs are functionally mature at this age or are reaching functional
maturity. It is interesting that the onset of FDC-M2 labelling follows the onset of detectable
levels of PrP, an observation perhaps suggestive of the intricate involvement of PrP in FDC
maturation. However, there was little co-localisation between PrP and FDCs in ileal PP
tissue suggesting that, in addition to FDCs, other cells like macrophages or interdigitating
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dendritic cells (Andreoletti et al., 2000) may also be involved in oral scrapie pathogenesis in
mice. Little co-localization between PrP and FDCs may also suggest that PrP-expressing
FDCs are at different maturational levels, with single labelled FDCs not having acquired full
maturational status. Findings in this study are in contrast to the findings of a previous study
where it was found that in adult (30-day old) mice, most of the PrPc labelling within splenic
follicles co-localized with FDC-M2+ cells and no single FDC-M2+ cells were observed. A
significant degree of co-localization between PrP and FDC-M2+ cells was also found in
splenic follicles of 7-, 10- and 14-day old mice (Ierna, 2001). Similar findings (in splenic
tissue) were reported using the FDC-M1 antibody (Brown et al., 1999; Ritchie et al., 1999).
Differences between observations made in this present study and previous studies suggest
that splenic FDCs may play a potentially more important role in TSE pathogenesis than
FDCs that reside in follicles of PPs based on association of these cells with PrP.
Alternatively, infectivity may reside in other cell types (like macrophages) until FDCs have
reached a certain maturation state. The possibility that other cells present in PPs may play a
more intricate role in TSE pathogenesis exists and may render FDCs less critical (or not
absolutely essential) for propagation of the agent.
In this study, the distribution of FDC-M2 indicates that, in addition to FDCs, uncharacterized
reticular and perivascular cells may also be involved in the capture and possibly also the
retention of immune complexes and antigens (Taylor et al., 2002). This question may be
addressed by using other markers to investigate the co-localization of PrP and leukocyte
populations, including macrophage and dendritic cell lineages in extra-nodular tissue.
Results from previous studies exclude the idea that FDCs (or B cells) are absolutely
necessary for infection (including oral infection) and spread to the brain, and suggest that
other cell types, including isolated lymphoid follicles (ILFs) (see Chapters 1 and 6)
macrophages or dendritic cells, may play a more important role in TSE pathogenesis than is
generally appreciated (Shlomchik et al., 2001). In this present study, cells located at the
periphery of lymphoid follicles could not be considered as FDCs since they did not exhibit
the typical dendritic shape nor were they located within germinal centres (Imai et al., 1998).
Similar observations have been made using the FDC-M1 antibody, used to identify murine
FDCs, and that cross-reacts with some macrophages (Montrasio et al., 2000) as mentioned
previously. FDCs have also been identified functionally by their ability to trap intravenously
injected immune complexes (van Rooijen and Streefkerk, 1976) and it has been found that
the ability of FDC-M1 positive cells to trap immune complexes coincides with the
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appearance of CD21/35 (complement receptor Type 2 and 1, CR1.2) receptors on cells with
a follicular location in spleen tissue (Balogh et al., 2001).
At 35 days, labelling was not confined to the central region of the germinal follicle but was
relatively diffuse and covered a wide area of the follicle. The diffuse nature of this staining
may suggest morphological differences between the dendritic processes of FDCs of young
mice (i.e. 7 days) and older mice (35 days). Ultrastructural studies have shown that mature
mouse spleen FDCs residing within the light zone of the follicles appear to have long
cytoplasmic extensions, and could be distinguished from FDCs residing within the dark
zone, which have less pronounced extensions (Jeffrey et al., 2000a). Imai et al. (1986) have
shown that the transition between immature and mature FDCs with labyrinthine structures
occurred between 28 and 35 days after birth. It is possible, however, that the route, type and
amount of environmental antigenic stimulation and the type of lymphoid tissue studied may
affect the development of germinal centres.
It has been reported that young mice become fully susceptible to peripheral scrapie infection
around the time at which FDCs in splenic tissue are detected and that FDC-M2 may detect
FDCs at a critical stage in maturation required for TSE pathogenesis (Ierna, 2001). Future
studies need to be performed to determine if young mice also become fully susceptible to
oral TSE infection around the time in which FDC-M2 labelling is observed in the PPs of the
ileum. If so, it may be speculated that immaturity of FDC networks in PPs may hamper or
delay scrapie replication or prevent it completely, following oral inoculation of the agent. It
has been suggested that quantitative differences may also exist between the amount of PrPc
in young and adult spleens (Ierna, 2001), based on the area of tissue that was
immunolabelled for the protein. A similar observation was also made for PP tissue in this
present study and may be partly responsible for the greater susceptibility to peripheral
scrapie infection observed in adult mice. Mice used in this study were not infected and
whether or not the distribution of PrP labelling is the same in PP tissue from scrapie-infected
and uninfected mice is not known. Previous immunocytochemical studies have shown,
however, that host PrP is localised to FDCs in the spleen of normal and scrapie infected mice
(McBride et al., 1992; Ritchie et al., 1999) and strong, granular staining has been reported
within germinal centres (where FDCs reside) in spleen tissue of infected mice (Ritchie et al.,
1999). Studies in mice have also shown that PrP-expressing FDCs are needed for disease
without any direct involvement of bone-marrow derived cells such as lymphoid or myeloid
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cells (Brown et al., 1999). However, these studies were performed using peripheral routes of
infection and only spleen tissue was examined in young adult mice.
It is important to bear in mind that cellular mechanisms of TSE pathogenesis and the
importance of lymphoreticular amplification could differ depending upon the species, dose
and strain of infecting agent and the route of inoculation used. It has been found, for
instance, using a murine scrapie model, that splenectomy had no effect after oral challenge,
although infectivity was found in PPs (Kimberlin and Walker, 1989a). Hence, although the
spleen appears to be a major site of TSE replication and an important route of entry into the
CNS following peripheral infection (Kimberlin and Walker, 1989a), its role in oral TSE
pathogenesis may not be as well established.
5.4.3 Sheep
This study yields further insight into the distribution of PrP in PP tissue of the ileum of
sheep. PrPc was found to be associated with the light zone of lymphoid nodules.
Conventional immunocytochemical approaches are a useful tool in this type of investigation
but wider application of these approaches to methods like histoblotting and PET-blotting
(Schulz-Schaeffer et al., 2000a; Schulz-Schaeffer et al., 2000b) are necessary to distinguish
between the normal cellular form of PrP (PrPc) and the abnormal isoform associated with
scrapie (PrPSc). Conformational changes associated with PrPSc confer a relative resistance to
proteinase digestion, which is used as a basis for distinguishing between PrPc and PrPSc.
Furthermore, histoblots are useful since they retain some degree of preservation of tissue
anatomy and are therefore able to demonstrate the distribution of PrPScin tissues.
Interestingly, staining in histoblots appeared to be more intense in PK positive samples
compared to PK negative samples. However, the significance of this staining is at present
uncertain. It may be attributed to more epitope sites on the peptide chain being exposed for
binding by primary antibody following protein kinase treatment, it may represent a non¬
specific binding feature of antibodies to macrophages (which may be enhanced during
infection) or it may signify a specific up-regulation of PrPc-bearing cells in disease
(Heggebp et al., 2002). Histoblots showed that PrPSc (proteinase K-resistant PrP) was
confined mainly to the follicles/lymphoid nodules and more precisely in the light zone where
FDCs are localized. Staining appeared as a granular punctate pattern confined to follicular
regions. In uninfected animals, no punctuate-type staining was found to be associated with
follicles. The reason for this variation in staining is not known, although it suggests, most
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likely, involvement of the scrapie agent and its association with the follicular region.
Interpretations, however, cannot be made based solely on observations from one infected
sheep. Whether the variation in staining observed between individuals was also the result of
differences in PrP genotype is unknown.
In sheep, specific antibodies recognising FDCs are lacking. D62, which has been previously
shown to be able to identify FDC populations in other species (including humans) using
secondary lymphoid tissue (Bryan Charleston, unpublished), was used to identify FDCs in
sheep ileum. However, the antibody has not as yet been fully characterised. In this study,
labelling for FDCs (which occurred as fine, diffuse, reticular staining) and PrP occurred in
the majority of follicles of the distal ileum of all age groups of uninfected sheep investigated
and was confined largely to the centre of lymphoid nodules. Labelling varied in intensity
within and between individual follicles and between individual sheep. A relatively high level
of background staining was observed in frozen sections stained with BG4 or D62. Since
cryostats preserve the antigenicity of PrP, background staining may be attributed to cross-
reactivity between BG4 (and D62) and non-PrP (and non-FDC) epitopes present on other
cells or tissue structures such as blood vessels. Although an association between PrP
accumulation and FDC network in lymphoid follicles in PPs was not specifically
demonstrated through double immunolabelling, this association can only be presumed on the
basis of similarities between PrP immunolabelling and morphology and localization of FDCs
in lymphoid follicles (Andreoletti et al., 2000; van Keulen et al., 1996). Findings in this
present study suggest that FDCs may be a significant site of accumulation of PrP in sheep
and is in agreement with results from previous studies (Heggebp et al., 2002). Furthermore,
the presence of mature FDC networks in the gut of newborn lambs raises the question of
maternal transmission of the infectious agent from ewe to lamb as a result of exposure to
infected placental tissue.
It has been shown that lymphocyte function decreases with age, and this will result in
degeneration of FDC networks (Kosco-Vilbois, 2000). In older sheep (over 18 months of
age) all follicles had undergone involution, and although visible, appeared to be hypocellular
and shrunken as described in Chapter 3 in this thesis and by other authors (Reynolds and
Morris, 1983). Whether or not degeneration of FDC networks (Figure 5.8) can be correlated
to their ability to accumulate and replicate prions is not known. However, if the number of
functional FDCs is significantly reduced in older animals, this may well contribute to
reduced susceptibility to TSE infection observed in older animals.
112
Co-localization and immunocytochemical staining in tissues is informative, but they are not
the most sensitive or quantitative methods of protein detection. Furthermore, whether PrPc
location and distribution are wholly or partially indicative of the extensiveness of this PrP
during disease is not known. To determine whether FDCs and (other cells) are plausible
candidates for infectious PrP replication, in vitro experiments that maintain these cells in
culture are required (Sy and Gambetti, 1999). Furthermore, because PrPcis expressed at high
levels in human leukocytes (including T cells, B cells, monocytes and dendritic cells)
compared to murine leukocytes (Liu et al., 2001), it is possible that these cells may well have
different roles in TSE pathogenesis in the two species. Whether or not observations made in
murine models are directly relevant to human prion disease can only be determined through
additional studies. Until then, the identity of cell types responsible for prion replication will
remain controversial.
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Chapter 6: General discussion
The emergence of vCJD in humans, most likely due to consumption of BSE-contaminated
meat and meat products (Bruce et al., 1997), and the young age distribution of vCJD cases
has provided renewed impetus to understanding the pathogenesis of oral transmission of the
naturally occurring TSEs (including scrapie, BSE and CWD) and the apparent age-
dependent susceptibility to these diseases. For natural scrapie, incidence in sheep flocks
tends to peak in young adult years despite different forces-of-infection and considerable
differences in disease incidence (Detweiler and Baylis, 2003; Redman et al., 2002). A
similar age distribution has been observed for BSE in cattle with the majority of cases
occurring in animals aged 5 to 7 years (Anderson et al., 1996), and data on prevalence of
CWD suggest that an age-specific peak exists for CWD in free-ranging cervids in Colorado
and Wyomming (Heisey and Joly, 2004; Miller et al., 2000).
That young people were more exposed to BSE-contaminated beef and beef products is not
sufficient to explain the strikingly high proportion of vCJD cases among adolescents and
young adults, and to account for the current age distribution of vCJD cases, an additional
effect of age-dependent susceptibility is required (Boelle et al., 2004). Although natural TSE
infection occurs most likely via the oral route (Detweiler and Baylis, 2003; Heggebp et al.,
2000; Sigurdson et al., 1999; Terry et al., 2003; Will, 2003), the intraperitoneal (i/p) and
subcutaneous (s/c) routes of infection have been used in the majority of susceptibility studies
and may provide potentially misleading models of natural oral infection. In intracerebral (i/c)
challenge experiments, TSE infection may bypass the immune system portal, including
Peyer's patches (PPs), which are known to play a key role in the infection dynamics of a
range of TSEs, making it difficult to assess disease risk if the gut immune system is involved
in oral TSE pathogenesis.
The main aim of this thesis was, therefore, to investigate the potential role of PP tissue in
determining age-dependent susceptibility to natural TSE infection. Here, results from the
preceding chapters are discussed in the context of age-dependent susceptibility to the TSEs
and implications for future research are considered.
Because oral inoculation has been recognised as a relatively inefficient mechanism of TSE
transmission, this may help to explain why a relatively small number of individuals have so
far developed clinical signs of vCJD despite the possibility that a large proportion of the UK
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population may have been exposed to BSE-contaminated material. However, complexities
arise because infection via the oral route may not necessarily result in clinical signs of
terminal disease, and knowledge of host factors does not always make it possible to predict
with certainty which individuals will develop disease. For example, not all sheep from the
positive selection line and comprising susceptible genotypes developed disease following
oral TSE exposure in this study (Chapter 2). This observation parallels findings in other
studies where only a proportion of genetically susceptible sheep were found to develop
scrapie following oral dosing or when residing in naturally infected flocks (Foster et al.,
2001; Jeffrey et al., 2001b; O'Rourke et al., 1997). Findings imply that, in addition to genetic
factors (Hunter et al., 1996), other factors including agent characteristics (Goldmann et al.,
1994), as well as environmental factors (Elsen et al., 1999; Healy et al., 2004), route of
exposure, level of infectious challenge (Jeffrey et al., 2001b) and age at infection (Diaz et
al., 2005) may well be involved in the control of natural and experimental disease.
Age at exposure to the TSE agent was found to be a potentially important factor in
determining whether an animal developed scrapie and the incubation period of the disease.
Because younger animals appear to be more susceptible to scrapie and seem unlikely to
develop the disease if they have not already done so by one year post-infection (Chapter 2),
this may explain the age distribution of scrapie cases. One interesting finding in this present
study was that younger sheep infected subcutaneously with a high or low dose of the TSE
agent generally had shorter incubation periods compared to older animals (over 18 months)
infected via the same route (Chapter 2).
Experiments carried out by Outram in the 1970s (Outram et al., 1973) have shown that
following s/c challenge, a high proportion of neonatally infected mice developed scrapie
after incubation periods that were significantly shorter than that of adults. Although the
involvement of the LRS could not be excluded since experiments were performed using
immunocompetent mice, similar results were obtained more recently using ME7 infection of
SCID mice in which the LRS component is impaired. In addition, the number of cases with
short incubation periods decreased significantly following s/c inoculation of mice of 14 days
or older (Ierna, 2001). These findings imply that immature nerves may be vulnerable to
scrapie infection. Peripheral innervation is greater in neonates compared to 14 day old mice
(Brown et al., 1976; Lichtman, 1977) and PrPc levels are also high in developing axons and
during synaptogenesis (Sales et al., 2002), either of which may facilitate uptake and
transmission of infectivity. Interestingly, peripheral nerves remain under-developed until two
weeks after birth (Jessen and Mirsky, 1999) during which time myelinating Schwann cells,
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which encircle and protect the axon from damage and infection (Mirsky and Jessen, 1999)
are immature and not yet fully functional. This is consistent with previous findings, which
have shown that incapacitated nerves result in shortened scrapie incubation periods
(Kimberlin et al., 1983a; Kimberlin et al., 1983b). In support of this observation, Glatzel et
al. (2001) showed that mice with hyperinnervated lymphoid organs developed scrapie more
readily following peripheral challenge with the RML strain. The enteric nervous system is
suggested as the site of initial neuroinvasion for the scrapie agent (Heggebp et al., 2000; van
Keulen et al., 1999; Van Keulen et al., 2000). Evidence implies that the ileal PP may be a
significant portal of entry for the TSE agent from the alimentary tract and that accumulation
of the agent in these lymphoid organs may facilitate neuroinvasion (Lasmezas et al., 1996).
Although studies have suggested that lymphoid nodules are poorly innervated structures
(Balemba et al., 1998), a recent investigation of the distribution of the enteric nervous
system in PP of scrapie-affected Suffolk sheep showed an extensive network of nerve fibres
within many lymphoid nodules (Heggebp et al., 2003) that were found to be in close
association with FDCs and tingible body macrophages harbouring abundant PrPSc. This close
association suggests that PP nodules are the sites of neuroinvasion and may preclude the
need for non-neuronal PrPSc transport away form germinal centres (Press et al., 2004).
Specific strains of the TSE agent may preferentially affect specific cell types. In Chapter 2,
BSE was used in the majority of oral inoculations. Interestingly, young and old animals
displayed similar incubation periods when inoculated with this agent via the oral route. In
contrast, SSBP/1 was primarily used for s/c exposure, and in this instance, young animals
showed shorter incubation periods relative to older sheep. Findings suggest that, for SSBP/1,
neuroinvasion may occur from highly innervated peripheral tissues like the skin, with
infection and replication facilitated by immature nerves. Whether or not this finding can be
extrapolated to the BSE agent is intriguing. A marked difference in incubation periods in
young and old sheep following s/c inoculation of the BSE agent will help demonstrate this
cell tropism. The paucity of the BSE agent in the LRS following experimental oral exposure
of calves to BSE (Somerville et al., 1997; Wells et al., 1998; Wells et al., 2005) suggests that
the role of the LRS may not be absolutely essential in BSE neuroinvasion and that there may
be an alternative route of TSE neuroinvasion such as nerves supplying lymphoid tissue.
Based on this observation, it will be interesting to determine whether or not young and old
sheep display similar incubation periods following oral exposure to strains other than BSE.
Whether or not the network of nerve fibres in PP nodules is detectable only at a certain age
and/or stage of involution of lymphoid tissue is not known and requires future investigation.
Furthermore, if mature nerves are less vulnerable to scrapie infection in sheep (as in mice),
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neuroinvasion by the TSE agent may be either delayed or absent following oral inoculation
and this may help to explain why older sheep tend to develop the disease less readily. It must
be remembered, however, that the relative importance of different routes of spread of the
TSE agent within the body is determined not only by agent-dependent factors but also by a
number of host-dependent factors and, therefore, generalizations from an experimental
model to natural disease across a species barrier may not be appropriate.
In this study, sheep infected with the BSE agent generally had an increased risk of becoming
TSE animals and also developed disease after shorter incubation periods (Chapter 2).
Previous findings have established that the vagus and splanchnic nerves are involved in
routing of the 263K scrapie strain from the gastrointestinal tract to the brain and spinal cord
in hamsters (Beekes and McBride, 2000). This pattern of spread is very similar to that
reported for sheep with natural scrapie (Van Keulen et al., 2000). However, it is by no means
certain that these neural pathways are ubiquitous to all TSE strains or are the only avenues
involved in peripheral spread. While TSE infection of the LRS is necessary for
neuroinvasion in many TSE diseases, the possibility remains that the BSE agent may utilise
other, hitherto unknown, routes to facilitate its more rapid spread to the CNS following
peripheral exposure resulting in quicker onset of disease. This is based on the observation
that in natural cases of BSE, TSE infectivity has not been detected in lymph nodes or spleen,
and PrPSc was not found in the distal ileum in cattle (Terry et al., 2003). This is in sharp
contrast to what is observed during scrapie in sheep, hamsters and mice, whereby the agent is
easily detectable in spleen, tonsils and other lymphatic tissues (Andreoletti et al., 2000;
Schreuder et al., 1998) even during the preclinical stage. Furthermore, in contrast to cattle
with BSE, most sheep infected orally with BSE-infected brain tissue showed disease-specific
PrP accumulations in the LRS (Jeffrey et al., 2001b). However, following experimental oral
exposure of calves to the BSE agent, BSE infectivity was found in the distal ileum and a
single sample of tonsil, but not in spleen or lymph nodes (Somerville et al., 1997; Wells et
al., 1998; Wells et al., 2005). In cattle, the absence of infectivity in the LRS in natural cases
of BSE suggests that alternate routes of neuroinvasion may exist and could involve direct
infection of the nervous system. One may claim that experimental studies with cattle
following oral exposure to the BSE agent may not be representative of the natural situation
of GALT in cattle. In Chapter 4, it is assumed that TSE infectivity occurs in PPs of cattle and
this may require justification. A recent study using an experimental model of TME provides
support for TSE neuroinvasion via cranial nerves from highly innervated peripheral tissues
like the tongue, in the absence of LRS infection in natural TSEs of livestock (Bartz et al.,
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2005). However, absence of infectivity in lymphoid organs may also be the result of low
levels of exposure to the BSE agent in natural cases of the disease, and BSE infectivity being
present in these tissues at concentrations low enough to be undetectable. One study used
transgenic mice over-expressing bovine PrPc (Tgbov XV mice) and provided further
evidence that the pathogenesis of BSE in cattle is fundamentally different from that of
scrapie in sheep and mice, and that the spread of BSE infectivity in cattle may be largely
neurotropic (Buschmann and Groschup, 2005). Tgbov XV mice were challenged with
various tissues from cattle with end-stage clinical BSE and although BSE infectivity was not
found in the spleen or mesenteric lymph nodes of terminally BSE-diseased cattle, infectivity
was detected in the PPs of the distal ileum, which are the most likely sites of entry for the
BSE agent. The latter study indicates that Tgbov XV mice serve not only as a more sensitive
mouse model for BSE infectivity, but also that BSE infectivity propagates poorly in bovine
PPs and from there, spread to the CNS via nonlymphatic tissue, such as those of the enteric
nervous system and the PNS (Buschmann and Groschup, 2005). Several authors have
suggested that variations in PrPc molecular features in peripheral lymphoid organs and more
specifically on FDCs may not be detectable by commonly used methods and could be related
to the absence of detectable infectivity in the LRS in BSE-affected cattle (Flechsig et al.,
2000; Thielen et al., 2001).
Dose and route of exposure were analysed as a combined category in this study (Chapter 2).
Hence, effects of these individual factors were not evaluated. However, in general, the oral
route resulted in longer incubation periods and was less efficient in transmitting scrapie
compared to other routes of infection. This is in accordance with findings from other studies
involving the transmission of BSE to Cheviot sheep via similar routes (Goldmann et al.,
1994). Experimental evidence in hamsters and mice also indicates that the incubation period
is a function of the route of infection and the infective dose. In general, the incubation period
is lengthened (McLean and Bostock, 2000) and the attack rate decreased (Baier et al., 2003)
when a smaller dose of agent is given. An increase in scrapie incidence in sheep and a
decline in age at which disease ensues have been reported within infected flocks, and have
been attributed to increasing levels of environmental contamination (Foster and Dickinson,
1989; Sigurdarson, 1991). Exposure to a high dose of agent may result in direct spread to
peripheral nerves without prior amplification of infectivity in lymphoreticular tissues
resulting, most likely, in overt clinical signs of disease. Oral inoculation with increased
dilutions of scrapie-infected brain homogenate resulted in subclinical infections in hamsters
that remained as apparently healthy survivors at 520 days post-infection (Baier et al., 2003).
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It is likely from these observations that the importance of lymphoreticular amplification may
vary with the route of inoculation, infective dose and perhaps the strain of infecting agent
thus determining to some extent whether or not an individual may develop clinical signs of
disease.
The presence of PrP-expressing FDCs in lymphoid tissue of newborn sheep raises the
possibility that sheep could well be susceptible to TSE infection before birth and that
transmission of the agent may occur. Studies in sheep have shown that FDCs in lymph nodes
can be detected as early as day 120-130 of gestation and acquire mature morphology at about
42 days post-partum (Halleraker et al., 1994). In humans, FDC networks in spleen have been
detected by 22 weeks of gestation and exhibit mature lymphoid morphology at one year after
birth (Timens et al., 1987). Because FDCs are present prenatally in foetal humans and sheep,
sheep scrapie models may serve as a potentially useful model for investigating maternal
transmission of vCJD and BSE in humans (Ierna, 2006). Although claims of vertical
transmission have been reiterated frequently in the literature, re-examination of the source
data reveals that these data are extremely sparse, non-reproducible and probably subject to
ascertainment bias. Amniotic fluid and caruncle samples that were tested using a sensitive
TgBov XV mouse bioassay were found to be free of detectable BSE infectivity providing
further evidence that maternal transmission from cow to calf probably does not play an
important role in the epidemiology of BSE (Buschmann and Groschup, 2005). However, this
does not rule out the possibility that young lambs are born with relatively developed
lymphoreticular responses, which makes them highly susceptible to TSE infection upon
exposure to their surrounding environment and may explain the presence of PrPSc in
lymphoid tissues, including ileal PPs, in animals as young as 5 and 9 months old (Van
Keulen et al., 2000); This thesis).
There is ample evidence that within lymphoreticular tissue, FDCs play a potentially
important role in amplification and spread of the TSE agent in some peripheral models of
infection (Brown et al., 1999; Mabbott et al., 2000; McBride et al., 1992). After oral
inoculation with TSE-infected material, PrPSc is initially detected on FDCs in PPs of mice
(Beekes and McBride, 2000) and sheep (van Keulen et al., 1996). PrPSc is also found in
lymphoid follicles of PPs following oral infection of non-human primates with BSE-infected
material (Bons et al., 1999). Mice with genetic defects resulting in reduced numbers of PPs
are resistant to oral challenge with the TSE agent (Prinz et al., 2003) and provide additional
evidence supporting a key role of these structures in oral TSE infection. Golovkina et al.
(1999) investigated the organogenic role of B lymphocytes in mucosal immunity and found
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that the development of PPs, FAE and M cells was impaired in mice that had no B cells, and
that transgenic expression of membrane-bound immunoglobulin M restored B cells and FAE
development (Golovkina et al., 1999). Since members of the TNF-R family have been
implicated in organogenesis of lymphoid tissue, including GALT (Debard et al., 1999), they
are likely to be involved in the B cell-dependent development of FAE, similar to B-cell
dependent generation of FDCs (Fu et al., 1998). Therefore, care should be taken when
interpreting studies that implicate indirect effects of B-cells on solely FDCs in peripheral
scrapie pathogenesis.
Experimental mouse scrapie models have shown that mature FDCs, expressing the host prion
protein (PrPc), are critical for replication of infection in lymphoid tissues and subsequent
neuroinvasion in some (Brown et al., 1999; Mabbott et al., 2000; McBride et al., 1992) but
not all (Shlomchik et al., 2001) i/p models of infection. The overwhelming body of evidence
in support of the role of FDCs in TSE pathogenesis in adult mice has raised the suspicion
that neonatal mice are perhaps less susceptible to scrapie due to a lack of PrPc-expressing
FDCs. Previous studies in splenic tissue of mice have detected PrPc-expressing FDCs as
early as 10 and 14 days post-partum using the FDC-M1 and FDC-M2 markers, respectively
(Ierna, 2001). Although this coincides with the time at which neonates appear to acquire full
adult susceptibility to scrapie, animals were inoculated intraperitoneally and results of this
study may be less relevant to oral pathogenesis (Ierna, 2001). The majority of susceptibility
studies have used the i/p and s/c routes of infection in mice. Although age-dependent
susceptibility to peripheral scrapie infection in mice may offer a framework with which to
investigate the reasons for the current age distribution of vCJD cases, scrapie is not a natural
disease of these animals. Furthermore, the role of the spleen and of FDCs in neuron transfer
of TSE infectivity following oral infection is unclear, since, although splenectomy prolongs
the incubation period of scrapie in animals infected intraperitoneally (Fraser and Dickinson,
1970), it has no effect after oral or intragastric inoculation (Kimberlin and Walker, 1989a).
Hence, i/p inoculation in mice is a potentially misleading model of natural oral infection, and
the role of FDCs after oral infection with the TSE agent remains to be settled. This makes it
difficult to discuss results in relation to susceptibility studies that have used i/p routes of
infection.
In an attempt to partly address this issue, PP development and co-localization with PrP was
investigated. In mice, PrPc-expressing FDCs were detected as early as 7 days post-partum. It
will be interesting to determine whether neonatal mice, challenged orally, develop full adult
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susceptibility to scrapie at around 7 days after birth. If mice are found to be more susceptible
to scrapie around this period, then this may be attributed to the development of LRS and may
imply that neonatal mice are less able to support scrapie replication in PPs. However, it is
important to note that different scrapie strains appear to target different cell types to support
their replication, for example, the RML scrapie isolate, unlike the ME7 scrapie strain, may
require both PrP-expressing FDCs and lymphocytes (Brown et al., 1999; Prinz et al., 2003),
and neuroinvasion by some strains, like the DY TME agent, may not require agent
replication in the LRS (Bartz et al., 2005). Further complexity arises because replication of
infectivity in lymphoid organs may be more extensive in some species than in others
(Baldauf etal., 1997).
In the present study, double immunofluorescence indicated co-localization of PrP and FDCs
in PP tissue. In mice, co-localization occurred to a lesser extent compared to results obtained
in previous studies that examined spleen tissue (Brown et al., 1999; Ierna, 2001; Ritchie et
al., 1999), and may suggest that other cells, in addition to FDCs, may be involved in the
replication of TSE infectivity in PPs follwing oral exposure. This issue may be addressed by
using other markers to investigate the co-localization of PrP and leukocyte populations,
including macrophage and dendritic cell lineages in extra-nodular tissue. Results from
previous studies exclude the idea that FDCs (or B cells) are absolutely necessary for
infection (including oral infection) and spread to the brain and suggest that other cell types,
including macrophages or dendritic cells, may play a more important role in TSE
pathogenesis than is generally appreciated (Shlomchik et al., 2001). In some cases,
neuroinvasion can occur following oral exposure in the absence of significant
lymphoreticular involvement. However, it remains unknown whether an exclusively neural
or mixed lymphoreticular-neural pathway is involved in oral TSE infection taking into
account strain differences.
Although it is important to investigate the cells that express PrPc in order to determine where
the agent most likely replicates and spreads, competency of expression does not necessarily
indicate that a cell is receptive to infection. Events that lead to an increased expression of
PrPc in peripheral compartments, such as gastrointestinal inflammation (Pammer et al.,
2000) may also lead to a greater efficiency of neuroinvasion by TSE agent that enters via the
oral route. It has also been shown that in inflamed human ileal mucosa, M cells are damaged
and increased in number, leading to interruption of the gut epithelial lining and allowing
luminal contents access to the underlying lymphoid tissue (Cuvelier et al., 1993). This
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scenario fits well with results showing shortened incubation periods in parasitized sheep
(Elsen et al., 1999) and in animals with peripheral inflammation (Thackray et al., 2002) and
suggests that the physiological state of the gastrointestinal tract may be a contributing factor
to susceptibility to TSEs. In this thesis, ileal PP tissue was collected and quantified from
sheep with no clinical signs or pathological evidence of intestinal disease (Chapter 3).
However, it will be interesting to investigate further oral TSE pathogenesis for example in
mice with gastrointestinal inflammation.
Many gaps exist in our knowledge and understanding of the structural elements involved in
oral TSE pathogenesis and most studies raise at least as many questions as they answer.
Recently, new GALT, referred to as ILFs, has been described in the murine small intestine
(Hamada et al., 2002). ILFs occur as tiny lymphoid aggregations aligned along the
antimesenteric wall of the mucosa. ILFs are structurally and functionally similar to the
follicular units that comprise PP and are believed to be an equivalent, failsafe and/or
complementary system to PP for the maintenance of intestinal immune surveillance. The
findings of Hamada and colleagues (2002) are important because researchers have been
investigating the role of PPs in the pathogenesis of TSEs using various manipulated
laboratory mice, including mice that lack PP but possess ILFs. If ILFs serve as a failsafe
system to PPs, it is not surprising that in the absence of PPs, neuroinvasion by the TSE agent
following oral infection may occur from FDCs in mature ILFs, rendering mice deficient in
PPs to be just as susceptible to TSE infection as their controls. Transgenic mice lacking
FDCs and/or ILFs will serve as a good model for ascertaining the role of FDCs in future oral
TSE pathogenesis studies. However, because the histogenesis and the molecular
characteristics of FDCs remain ill-defined, a definitive assessment of the contribution of
these cells to TSE pathogenesis continues to be problematic (Aguzzi et al., 2003). Although
FDCs express S-100 proteins, as well as complement receptors 2 (CD35) and 4 (identical to
the marker FDC-M2), these markers are also expressed by other cell types including those
residing within lymphoid organs (Bofill et al., 2000). The FDC-M1 marker, although it
seems to be more specific, also stains tingible body macrophages, which are most likely of
haematopoietic origin. For this reason, the FDC-M1 marker was not used in this study.
The young age distribution of natural cases of TSEs, including vCJD, BSE and scrapie may
reflect age-related exposure, age-dependent incubation periods or age-related susceptibility.
Results of this study (Chapter 2; Section 2.3.1) suggest that sheep facing infection early in
life seemed more likely to be scrapie positive animals compared to animals facing infection
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at older ages, providing further evidence for greater susceptibility to natural TSE infection in
young individuals. However, because natural scrapie was first recognised in the NPU flock
in 1968 and experiments were carried out from 1960 to 2002 (as well as the unavailability of
a preclinical test for the disease) the 'age at exposure' was not always known and the study,
therefore, does not provide sound evidence to support the hypothesis of age-dependent
susceptibility to TSEs. Nonetheless, similar observations have been made using a model of
population dynamics of scrapie where the authors suggest that the effect of age at first
exposure may be explained by a higher degree of susceptibility per se of younger, compared
with older animals (Matthews et al., 2001). Diaz et al. (2005) have also found that sheep
exposed to infection for the first time early in life seemed more likely to show signs of
scrapie than animals exposed to infection for the first time at older ages. For the human
population, analysis has provided evidence that exposure alone could not explain the young
age of vCJD cases seen in the UK and decreasing age-related susceptibility had to be
assumed to reproduce the characteristics of the age distribution of vCJD cases (Boelle et al.,
2004).
In this present study, younger sheep appeared to have shorter incubation periods when
infected by the s/c route only (Chapter 2; Figure 2.3); no similar effect of the oral route was
observed. However, plots of the stratified fit and Kaplan-Meier estimates (used to help
determine whether young and old animals had equal survivor functions for the different
routes of inoculation) provide non-parametric estimates and do not take into account the
confounding effect of the other variables. In addition, the sample size for oral inoculation
was small with the majority of inoculations (32/37) comprising the BSE agent (as opposed to
s/c inoculations where the SSBP/1 agent was used in the majority of cases (408/420)).
Different agents may also behave differently (for example, different TSE strains may
demonstrate significant differences in cellular tropism) depending on the route of inoculation
and the amount of inoculum used. It has been shown that, following inoculation through
scarified skin, a functional immune system is critical for the transport of scrapie to the brain
as SCID mice were found to be refractory to infection (Mohan et al., 2004). This is
consistent with the hypothesis that scrapie infectivity is unlikely to reach the CNS from the
skin by direct capture of infectivity by nerves within the skin or by direct transport via the
bloodstream (Mohan et al., 2004). Hence, any conclusive statements regarding the observed
effect of the oral route and associated lymphoid tissue in the gut in the two age groups of
animals would therefore, be 'premature'. A major drawback of this study is that animals
exposed at older ages may have been culled or died for non-scrapie reasons (intercurrent
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deaths); this may have biased the estimation of the hazard assigned to older animals (Chapter
2) making the reliability of these results questionable.
As mentioned previously, oral infection is the most likely route of natural exposure and PPs
are the most probable sites for intestinal uptake of prions following exposure. It is becoming
clear that there is great heterogeneity for susceptibility to natural TSE infection, and the
association made between PP tissue development and susceptibility to disease suggest that
the amount of GALT may represent an additional factor (Chapter 4). Biological processes
involved in the maturation of GALT, more specifically PP tissue, may contribute to higher
susceptibility to TSE infection in young sheep. This possibility was explored using relatively
crude measures of lymphoid tissue development in sheep (Chapters 3 and 4), cattle and
humans (Chapter 4) and an association between PP development and susceptibility to natural
TSE infection was established. (Alternative measures in PP development may be at least as
appropriate (for example, in sheep, counts of functionally mature FDCs, but see below)).
Age-related changes in PP development appear less obvious in humans compared to that
observed in sheep and cattle (Chapter 4; Figure 4.2). For humans, anatomical data was
obtained from Cornes (1965). Cornes used different criteria for defining a PP. He counted
patches throughout the entire small intestine, and defined a patch as comprising five or more
follicles. It is possible that Comes may have underestimated PP counts and may have
assumed that follicles may function in synergy as an integrated unit rather than each follicle
retaining its ability to function independently. Nonetheless, the variation in the number of
PPs in the human small intestine in different individuals of various ages (as seen form Figure
4.2 in Chapter 4) is obviously greater than is often appreciated and may influence individual
susceptibility to TSE disease (and the occasional occurrence of vCJD in an old individual),
which centres on these structures. In addition, for both human and cattle anatomical data, the
total weight and total number of PP tissue were used as anatomical measures of PP tissue,
respectively, both of which are obviously less accurate measures because of the different
length of the small intestine in different sized individuals. In this present study, the
percentage of PP tissue and the average number of lymphoid follicles per cm2 of ileum were
used as an anatomical measure of PP tissue in sheep because of the various dimensions of
the ileum in different sized animals. Despite the different measures used, however, it appears
that the quantitative data on PP development for the three species still reflect the same
underlying relationship with age.
The percentage of PP tissue is a relatively crude measure and within a species, the diet, and
thus the expected antigenic load in the intestine, the fluidity of the intestinal contents, the
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frequency of food intake and the time taken between ingestion and evacuation may be
important factors in determining the number of PPs in the intestine (Poskitt et al., 1984).
This present study study assumes that both measures of PP development and estimates of
age-susceptibility are representative of each host species in general and not just the specific
populations examined. In addition, it is assumed that the associations investigated have not
been distorted by other factors (like antigenic load and frequency of food intake) which
might influence PP development and/or susceptibility to TSEs. Given these caveats, it is
nonetheless striking that an association between PP development and susceptibility to TSE is
evident not just in one species but in three host species (sheep, cattle and humans) with
different relationships between these variables and age.
One may argue that in this study (Chapter 4) PPs may not necessarily (and accurately)
represent structures capable of accumulating and replicating the TSE agent, and that the
number of functional FDCs in young and old sheep for example, may be the reason for the
difference in susceptibility to TSE infection. However, staining for FDCs (using the D62
antibody) was found to be less diffuse and less intense in old sheep (over 18 months)
compared to younger animals (Chapter 5, Figures 5.7 and 5.8) and perhaps may be an
indication of the degree of involution and functional activity of lymphoid nodules and their
associated follicles. Age-related declines in humoral and cellular components of the immune
system have been demonstrated in both in vitro and in vivo animal and human studies (Burns
and Leventhal, 2000). For example, in old mice of about 23 months, FDCs appeared to be
functionally and structurally impaired compared with younger animals; the cells appeared
atrophic and only a small fraction of antigen transport sites developed (Szakal et al., 1992).
It is therefore possible that senescence of immune system function may have a similar effect
on TSEs as has been observed due to dedifferentiation of FDCs in mice (Mabbott et al.,
2003). Nevertheless, in this present study, the precise role of FDCs was not central in
demonstrating age-dependent susceptibility in sheep, cattle and humans (Chapter 4), and all
that was required was merely uptake of material, including prion proteins, at PPs in the ileum
as well as in other parts of the gut. As discussed later in this chapter, cells other than FDCs
(including M cells and dendritic cells) that reside in PPs and/or bear a close association to
these lymphoid structures may well play an important role in the pathogenesis of naturally
acquired TSE infection. It therefore appears more reasonable to investigate PPs as an entity
rather than limiting the epidemiological study (Chapter 4) to only one cell type. What is
important to remember is that similar correlations (between PP development and risk of TSE
> infection) were found in different species with different patterns of PP development and
different age-susceptibility relationships (Chapter 4). Had the study (Chapter 4) simply
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investigated PP development and scrapie susceptibility in sheep only, a correlation may have
been found but, at least theoretically, other factors could have been involved. The
comparative approach adopted in this study (Chapter 4) is a well recognised and useful tool
for investigating such relationships (Woolhouse et al., 1991; Grassly et ah, 2005) particularly
since there is no feasible way of determining this experimentally (as one would need to
manipulate the age-PP relationship) and experimentation in humans is not possible.
In conclusion, whether the age of vCJD cases is increasing and, if not, whether it should be
expected to do so will depend upon an improved understanding of the age-susceptibility
relationship of the naturally occurring TSEs which will be of immense value in interpreting
current epidemiological trends and making projections for the future. This thesis seeks to
explain an epidemiological pattern - the relationship between age and susceptibility to
natural TSE infection - and suggests that age at exposure to the TSE agent and development
of PP tissue play a potentially important role in determining the incubation period of disease
and whether an individual develops disease, and may help to explain the age distribution of
the naturally acquired TSEs. The work in this thesis provides a framework for future oral
TSE pathogenesis and age susceptibility studies and brings to light the developmental
differences in PrP-expressing FDCs in PPs that exist between the species. Further
investigations are clearly needed to further understand these pathways and to evaluate the
interactive role of agent and host factors and age specificity of disease risk.
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Appendix A: Data used for quantification of lymphoid tissue in NPU Cheviot sheep
Table A-l: Description of variables for Table A-2
Variable Description of variable
Sheep ID sheep identification
Sex Male or female
Seln/genotype* Where genotype (genotype) information was not available, selection
line (Selnjine) (positive or negative) is provided
DOB Date of birth of animal
Cull Date Day on which animal was culled
Days
Ileal PP (m)
Age of animal (in days) at death (Cull Date - DOB)
Length of ileal PP in metres. The length of the ileal PP was not
recorded in animals over 12 months of age because of the patchy
appearance of the structure in older sheep
LF1 First lymphoid follicle (LF) count (for repeatability study)
LF2 Second LF count (for repeatability study)
LF per cm" Average lymphoid follicle LF count per cm" of ileal PP tissue
Area 1 Area of ileal PP tissue calculated as a percentage of total ileal tissue
(first count for repeatability study)
Area 2 Area of ileal PP tissue calculated as a percentage of total ileal tissue
(second count for repeatability study)
% PP tissue Average area of ileal PP tissue ([Area 1 + Area 2]/2) calculated as a
percentage (%) of total ileal tissue
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Appendix B: Immunocytochemistry methods and reagents
B-l Cutting cryostat sections
1. Place blade in holder.
2. Take piece of tissue trimmed to manageable size.
3. Cover chuck in Tissue-Tek (let it get tacky). Put tissue on chuck and surround with Tissue-Tek.
4. Once Tissue-Tek is dried, place chuck in holder and set cryostat to cut sections at 20 pm.
5. Trim without roll plate until tissue is visible.
6. Alter cryostat to cut about 10 pm. First, cut a couple of sections without roll plate then put roll plate
down.
7. Collect sections sequentially.
8. Air dry sections overnight.
B-2 Immunocytochemistry methods
Double immunolabelling for PrP and FDCs in mouse tissues using crvostat sections
1. Prepare wash buffer (TBS) (see below).
2. Defrost slides for 30 minutes at room temperature.
3. Fix slides in acetone for 10 minutes in fume hood.
4. Air dry slides for 15 minutes.
5. Quick wash in TBS for 2 X 5 minutes.
6. Block in normal goat serum at 1/20 for 20 minutes.
7. Tap off serum and apply primary antibody 1B3 at 1/1000 overnight at room temperature. For controls,
use normal rabbit serum at 1/1000.
8. Wash 3X5 minutes in TBS.
9. Incubate in secondary antibody, goat anti-rabbit alexa 488 (15 pg/ml) for 1 hour at room temperature.
10. Wash 3X5 minutes in TBS.
11. Incubate in second block, normal mouse serum at 1/20 for 20 minutes.
12. Tap off serum and apply second primary antibody, FDCM2 biotin at 1/500 for 1 hour. For controls,
use normal rat serum at 1/2000.
13. Wash 3X5 minutes in TBS.
14. Apply streptavidin-alexa 694 (2.5 pg to 5 pg/ml) for 1 hour.
15. Mount sections in fluorescent mounting media (DAKO).
156
Immunolabelling for PrP in sheep tissues using cryostat sections
1. Prepare wash buffer (TBS) (see below).
2. Defrost slides for 30 minutes at room temperature.
3. Fix slides in acetone for 10 minutes in fume hood.
4. Air dry slides for 15 minutes.
5. Quick wash in TBS for 3 X 5 minutes.
6. Block in normal rabbit serum at 1/20 for 15 minutes.
7. Tap off serum and apply primary antibody, BG4 at 1/100 for 1 hour at room temperature. For controls,
use normal mouse serum at 1/600.
8. Wash 3X5 minutes in TBS.
9. Prepare streptavidin biotinylated alkaline phosphatase (SBAP) at 1/100, 30 minutes before use.
10. Add SBAP to each slide for 45 minutes.
11. Wash 3X5 minutes in TBS.
12. Prepare substrate solution (see below) for Vector Red.
13. Add Vector Red to each slide for 5 minutes.
14. Immerse in tap water to stop reaction.
15. Counter stain with haematoxylin for 1 minute. Wash in water and then place in Scott's tap water for 1
minute.
16. Dehydrate in alcohol, clear in xylene and mount slides in DPX.
Immunolabelling for FDCs in sheep tissues using crvostat sections
1. Prepare wash buffer (TBS) (see below).
2. Defrost slides for 30 minutes at room temperature.
3. Fix slides in acetone for 10 minutes in fume hood.
4. Air dry slides for 15 minutes.
5. Quick wash in TBS for 3 X 5 minutes.
6. Block in normal rabbit serum at 1/20 for 15 minutes.
7. Tap off serum and apply primary antibody, D62 at 1/100 for 1 hour at room temperature. For controls,
use normal mouse serum at 1/600.
8. Wash 3X5 minutes in TBS.
9. Prepare streptavidin biotinylated alkaline phosphatase (SBAP) at 1/100, 30 minutes before use.
10. Add SBAP to each slide for 45 minutes.
11. Wash 3X5 minutes in TBS.
12. Prepare substrate solution (see below) for Vector Red.
13. Add Vector Red to each slide for 5 minutes.
14. Immerse in tap water to stop reaction.
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15. Counter stain with haematoxylin for 1 minute. Wash in water and then place in Scott's tap water for 1
minute.
16. Dehydrate in alcohol, clear in xylene and mount slides in DPX.
Method for immunohistoblotting
1. Cut 10 pm frozen tissue sections and apply to PVDF membrane.
2. Air dry for 18-24 hours (time is approximate and not critical).
3. Store at room temperature in box with silica gel until use.
4. Rehydrate membranes for 1 hour in TBST at room temperature.
5. Split samples into + (proteinase K) PK and -PK.
6. Incubate -PK samples 1 hour at room temperature in 100 mM NaOH.
7. Place +PK samples in PK solution (25, 50 and 100 pg/ml) at 37°C. Place in incubator at 37°C and
incubate for 3 hours. Gently shake samples at intervals of 15-20 minutes. Do not use the belly dancer.
8. Wash +PK samples 10x2 minutes in distilled or de-ionized water at room temperature.
9. Incubate +PK samples in TBST-PMSF (3mM) 20 minutes at room temperature to stop PK activity.
10. Wash +PK samples 10x2 minutes in distilled or de-ionized water at room temperature.
11. Incubate +PK samples in tris HCL pH 7.6/GndSCN for 10 minutes at room temperature.
12. Wash +PK samples and -PK samples 10x2 minute washes in TBST.
13. Block membranes in 10% BSA in TBS for 1 hour at room temperature.
14. Add primary antibody, R521 at 1/30,000 (diluted in TBST) and incubate overnight at room
temperature.
15. Wash membranes 10x2 minutes in TBST.
16. Add goat anti-rabbit alkaline phosphatase-conjugated secondary goat anti-rabbit antibody at 1/3000
(diluted in TBST) for 90 minutes at room temperature.
17. Wash membranes 10x2 minutes in TBST.
18. Apply NBT/BCIP substrate for 5-30 minutes at room temperature. Do not shake or use belly dancer
during incubation.
19. Wash membranes 2x5 minutes in distilled or de-ionized water at room temperature (timings are not
critical).
20. Air dry sections overnight on blotting paper or filter paper.




232 ml methanol + 8 mis H202
PBS/BSA wash buffer
Dissolve 5g BSA (bovine serum albumin) in 250 mis stock PBS (lOx PBS)
Top up to 2599 ml with distilled water
lOx PBS
400 g sodium chloride
10 g potassium chloride
57.5 g disodium hydrogen orthophosphate
10 g potassium dihydrogen orthophosphate
5 litres of deionised water
Scott's tap water
8.75 g sodium hydrogen carbonate
50 g magnesium sulphate
2500 ml tap water
Substrate solution for Vector Red
0.343 g tris HCL pH 8.2
25 ml distilled water
TBS/BSA wash buffer










7.45 g Tris pH 7.6
8.76 g NaCl
1 ml Tween 20
Make up to 1.0 L in distilled or de-ionized water
PK digest buffer (100 ml)
0.148 g Tris pH 7.6
0.58 g NaCl
333 pi of 30% stock Brij 35
Make up to 100 ml in distilled or de-ionized water
Proteinase K (PK) solutions
[final PK] [pi stock PK]
25 pg/ml 12.5 pi PK
50 pg/ml 25 pi PK
100 pg/ml 50 pi PK
For each PK solution, add the corresponding amount of PK to 10 ml in PK digest buffer and pre-warm to
37°C in a water bath.
100 mM NaOH (100 ml)
NaOH = 0.4 g made up to 100 ml in distilled or de-ionized water
Block buffer (20 ml)
2.0 g BSA made up to 20 ml in TBS
GndSCN (5 ml)
0.149 g Tris pH 7.6 to 100 ml distilled or de-ionized water
Add 1.77 g GndSCN to 5 ml of above
PMSF solution
0.3 M PMSF in propan-l-ol
5-bromo-4-chloro-3-indolvl phosphate/nitro blue tetrazolium (NBT/BCIP) tablets
1 tablet per 10 ml distilled or de-ionized water
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Appendix C: Histoblot analysis
Figure C-l Higher magnification (X50) (A) of the same section of ileal PP tissue in Figure 5.10D
showing dense accumulation of staining in nodules (N). Arrow indicates pin-point areas of staining that
may represent macrophages. Higher magnification (B) of same section of mesenteric lymph node Figure
5.10H showing several nodules (N) with intense staining.
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Abstract
Background: Epidemiological analyses indicate that the age distribution of natural cases of transmissible spongiform
encephalopathies (TSEs) reflect age-related risk of infection, however, the underlying mechanisms remain poorly understood.
Using a comparative approach, we tested the hypothesis that, there is a significant correlation between risk of infection for
scrapie, bovine spongiform encephalopathy (BSE) and variant CJD (vCJD), and the development of lymphoid tissue in the gut.
Methods: Using anatomical data and estimates of risk of infection in mathematical models (which included results from
previously published studies) for sheep, cattle and humans, we calculated the Spearman's rank correlation coefficient, rs, between
available measures of Peyer's patch (PP) development and the estimated risk of infection for an individual of the corresponding
age.
Results: There was a significant correlation between the measures of PP development and the estimated risk of TSE infection;
the two age-related distributions peaked in the same age groups. This result was obtained for each of the three host species:
for sheep, surface area of ileal PP tissue vs risk of infection, rs = 0.91 3 (n = 19, P < 0.001), and lymphoid follicle density vs risk
of infection, rs = 0.933 (n = 19, P < 0.001); for cattle, weight of PP tissue vs risk of infection, rs = 0.693 (n = 94, P < 0.001); and
for humans, number of PPs vs risk of infection, rs = 0.384 (n = 46, P = 0.008). In addition, when changes in exposure associated
with BSE-contaminated meat were accounted for, the two age-related patterns for humans remained concordant: rs = 0.360 (n
= 46, P = 0.014).
Conclusion: Our findings suggest that, for sheep, cattle and humans alike there is an association between PP development (or
a correlate of PP development) and susceptibility to natural TSE infection. This association may explain changes in susceptibility
with host age, and differences in the age-susceptibility relationship between host species.
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Background
The incidence of natural cases of transmissible spongi¬
form encephalopathies (TSEs) or prion diseases is related
to age: scrapie incidence in sheep typically peaks between
2 and 3 years of age [1], bovine spongiform encephalopa¬
thy (BSE) incidence in cattle peaks at around 5 to 7 years
of age [2] and variant Creutzfeldt-Jakob disease (vCJD)
incidence in humans peaks at 25 to 30 years [3]. Age-
related patterns in incidence will reflect the incubation
period of the disease (typically long relative to host life
expectancy), the magnitude of the risk of infection and
any age dependency in the risk of infection. Analyses of
epidemiological data for scrapie [4], BSE [5] and vCJD [6]
have suggested that there is significant age dependency in
the risk of infection for all these TSEs. Available evidence
suggests that these patterns cannot be fully accounted for
by changes in exposure, in which case changes in suscep¬
tibility must also play a role. However, to date, there has
been no indication of why susceptibility might change
with age.
Age dependency in the risk of infection by TSEs will reflect
any age dependency in exposure to infection and/or in
susceptibility to infection for a given level of exposure.
Both of these are likely to be linked to the route of trans¬
mission. Although other transmission routes may exist
(see below), oral exposure appears to be the most impor¬
tant route of transmission for natural TSE infections in
sheep, cattle, deer and mink and for vCJD and kuru in
humans [1,3,7-9]. There is evidence for the involvement
of Peyer's patches (PPs), part of the gut-associated lym¬
phoid tissue (GALT), in orally transmitted TSE infection.
Experimental studies in cattle have demonstrated staining
for PrPSc (the abnormal prion protein) in PP follicles in
the distal ileum throughout much of the course of the dis¬
ease following oral exposure to the BSE agent [7]. In
sheep, oral infection with scrapie is thought to occur
mainly via the ileal PP, followed by replication in GALT
[8]. In mule deer fawns, lymphoid follicles of PPs have
been shown to accumulate PrPSc within a few weeks fol¬
lowing oral exposure to chronic wasting disease (CWD)
[9]. After oral infection of nonhuman primates with BSE-
infected material, PrPScis initially detected in PPs [10]. In
experimental infections, mice deficient in both tumour
necrosis factor and lymphotoxin or in lymphocytes, in
which PPs are decreased in number, are highly resistant to
oral challenge and their intestines are virtually devoid of
infectivity at all times post-challenge [11]. These facts col¬
lectively suggest a key role for PPs in the infection dynam¬
ics of a range ofTSEs.
Early presence of PrPSc in mouse PPs after oral exposure to
scrapie [12] has indicated these structures as being the
most probable sites for the intestinal uptake of the TSE
agent. Various cell types present in this lymphoid tissue
have been implicated as important elements in the uptake
and propagation of the infectious agent. PrPSc staining in
the follicular dendritic cells of patients with vCJD [13]
and of sheep naturally infected with scrapie [14], as well
as staining associated with the luminal border of cells in
the follicle-associated epithelium (FAE) of sheep suggest
uptake of the TSE agent from the intestinal lumen to the
underlying lymphoid tissue [8]. Although important
functional differences exist between PP in sheep ileum
and those in the duodenum and jejunum, the FAE overly¬
ing jejunal and ileal PPs has an efficient mechanism for
the transcytosis of luminal material [15,16], including
prion proteins, to the underlying lymphoid tissue.
The development of GALT is known to be related to age.
In young sheep, cattle and humans, ileal PPs are the major
component ofGALT possessing an extensive bed of follic¬
ular dendritic cells and follicle-associated epithelium. The
involution of ileal PPs occurs at around puberty in sheep,
cattle and humans [17-19]. However, the age-related
changes in PP development are not identical across these
three species, providing an opportunity for a comparative
study. Our hypothesis is that although the relationships
between PP development and age and between suscepti¬
bility to TSE infection and age differ in sheep, cattle and
humans, there should still be a correlation between PP
development and susceptibility for each species.
Methods
Anatomical studies
Specimens of ileum were collected from 19 sheep of dif¬
ferent ages (0-1 year, 1-2 years and >2 years) from a flock
of Cheviot sheep maintained by the Institute of Animal
Health Neuropathogenesis Unit (NPU) [20], The study
was limited to animals with no clinical or pathological
evidence of intestinal disease. Specimens were obtained
from sheep that were either euthanized because of severe
arthritis in one or more limbs, died shortly after birth or
were culled for flock management reasons. The specimens
were opened along their mesenteric borders, and rinsed in
cold water. PP tissue and lymphoid follicles were visual¬
ised by immersing the intestines in 2% acetic acid for 24
hours, and the follicular content of the patches enhanced
by staining with 0.5% methylene blue for 2-5 minutes.
PP tissue and lymphoid follicles were easily visualised
using this technique.
The terminal ileum (distal 0.6 m of the ileum) was transil-
luminated on a horizontal X-ray view box and digital
images were obtained. Image analysis software (Image-
Pro Plus®) was then used to calculate the areas of intestine
and of PP tissue. The area of PP tissue was recorded as a
percentage of the total area of intestinal tissue.
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To determine the number of lymphoid follicles, the
stained intestine was placed between two glass slides, the
upper ofwhich was etched in square centimetres. Individ¬
ual lymphoid follicles appeared as bright blue spots
against a faintly blue background when viewed on the X-
ray box. The number of lymphoid follicles in 6 different
sections along the length of the terminal ileum was
counted by naked eye, starting at 5 cm from its caudal end
and selecting 4 cm2 sections at every 10 cm thereon, prox-
imally. Results were recorded as the average number of
lymphoid follicles per cm2 of ileum.
Our results are described in terms of area of PP tissue and
lymphoid follicle density in the sheep ileum; analyses
indicate that these two measures are closely correlated (rs
= 0.958, n = 19, P < 0.001). PP data for cattle and humans
were obtained from earlier studies [18,19]. The studies
used different measures to quantify PP tissue from those
we obtained here for sheep. The cattle data [18] refer to
weight of PP tissue in the small intestine of 94 German
beef cattle. The human data [19] refer to number ofPPs in
the normal small intestine of 46 individuals between 15
and 96 years of age. The study was limited to necropsies
performed within a few hours of death, and to patients
with no clinical history or pathological evidence of gas¬
trointestinal tract disease. A second, smaller study of
human PPs indicates that, in humans, number ofPPs and
area of PP tissue in the distal ileum were correlated across
age classes (r = 0.415, n = 55, P < 0.01) [21]. As far as we
are aware, there are no other quantitative data on PP
development with respect to age available for these spe¬
cies but, where direct comparisons are possible, it appears
that the different measures reflect the same underlying
relationship with age.
Scrapie incidence data
The NPU Cheviot flock, a closed flock maintained explic¬
itly as a source ofnatural scrapie infections, has been com¬
prehensively documented and demographic information
and epidemiological data on all sheep are available [20].
In this study, analyses were based on data obtained from
an outbreak of scrapie, which spanned the years 1985 to
1994 affecting cohorts bom between 1983 and 1992. This
represents a total of 1,473 sheep of which 34 developed
clinical scrapie. In this flock, scrapie occurs in two PrP
genotypes, VRQ/VRQ and VRQ/ARQ [20]. (There is no
evidence that PrP genotype influences PP development).
Further details of the outbreak are given elsewhere [20].
Age-susceptibility functions
The method for calculating the age susceptibility function
for sheep follows that ofBoelle et al. [6] used to derive the
age risk function for vCJD. The occurrence of cases in gen¬
otype G sheep is modelled by a Poisson process in the
(age, time) plane with intensity nG(a,t) given by:
: PGrCS(a)Jp exp -jX(u,t-a + u)du X(a',t-a + a')hc (a -a)da
where (3C is the birth rate and rG is the relative susceptibil¬
ity of genotype G individuals, S(a) is the probability of
survival (in the absence of scrapie) until age a, hc is the
probability density function for the incubation period for
genotype G individuals, and X(a,t) is the per capita rate of
infection for individuals of age a at time t. The expression
sums the contribution to the incidence of infection at age
a and time t from animals infected when at age a', taking
into account the fact that the number ofanimals available
at age a' to become infected is reduced by those already
infected at age u. The low incidence of scrapie in this flock
[22] permits modelling of the age and timing of cases as a
Poisson process because the course of the outbreak does
not significantly impact on the demography of the suscep¬
tible sheep.
The survivorship function S(a) is aWeibull function with
mean age of death of 2.99 years [23]. The incubation
period distribution is a gamma distribution with a mean
of 1.9 years [23]. The birth rate pG is selected to give the
average numbers of sheep of different genotypes bom per
year. The per capita rate of infection, X(a,t) has two parts:
a time dependent component g(t) which is assumed here
to be proportional to an exponential function fitted to the
incidence of infection; and an age-dependent component
/(a) which represents the relative susceptibilities of differ¬
ent age classes:
/(«) =
where the maximum value taken byf1f2 or f3 is equal to 1.
Standard theory on point processes [24], gives the log-
likelihood of the observed age-of-case data to be:
i® v r r
X iogCttq (flj, (,)) -X J J (a,t)dadt
i G
The subscript i denotes actual case data; deaths are known
to occur at age a, and a time t, after the start of the out¬
break. Maximum likelihood methods were used to esti¬
mate the constant of proportionality, which determines
the magnitude of the per capita rate of infection and the
age-dependent susceptibility function as defined by fv f2
and f3. We did this for (i) the 34 cases over the 10 year
period assuming no differences between genotypes, and
(ii) for the 28 genotyped cases allowing the 8 VRQ/ARQ
cases to have either a lower susceptibility to infection or
(iii) a longer incubation period than the 20 VRQ/VRQ
k for 0 < A < 1
fl for 1 < a < 2
h for 2 < fl < 9
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Figure I
Comparison of Peyer's patch lymphoid follicles in the ileum
of NPU Cheviot sheep at (A) 4 months, (B) 15 months, and
(C) 6 years, using haematoxylin and eosin staining. F, lym¬
phoid follicles undergo involution and are fewer in number
with increasing age; L, intestinal lumen. Bar = 200 pm.
cases. We found that models (ii) and (iii) produced a sig¬
nificant improvement in fit at the 95% level over model
(i), but that the shape of the age-dependent susceptibility
function was robust to the choice of model. Results are
shown for model (ii).
For cattle, estimates of risk of BSE infection were made
from n = 158,550 BSE cases in British cattle and were cal¬
culated from the cumulative distribution function,
defined by Ferguson et al. [5], corresponding to the age-
exposure/susceptibility curve (fitted using maximum like¬
lihood methods).
For humans, estimates of risk of vCJD infection were
obtained from a previous study that comprised n = 129
vCJD cases in British people, and were fitted using maxi¬
mum likelihood methods by Boelle et al. [6],
Concordance between susceptibility data and anatomical
data
For each combination of anatomical data and risk of
infection estimates we calculated the Spearman's rank cor¬
relation coefficient, rs, between the value of the available
measure ofPP development (area, weight or number) and
the risk of infection for an individual of the corresponding
age. Sample sizes were n = 19, n = 94 and n = 46 for sheep,
cattle and humans, respectively. Correlation coefficients
were calculated using S-PLUS 2000 for Windows.
Results
For sheep, cattle and humans alike, a strong correlation
was found between risk ofTSE infection and the develop¬
ment of lymphoid tissue in the gut which can explain
both the relationships between age and disease incidence
within species and differences in this relationship
between species.
For sheep there is a marked fall in both the surface area of
ileal PP tissue and lymphoid follicle density between
approximately 12 and 24 months old, and both measures
remain very low throughout adulthood (Figure 1 and
2(A)). Analysis of data on the incidence of natural scrapie
over a 10 year period in the sheep flock providing the ana¬
tomical data indicates that the risk of infection is highest
in the first year of life and is lowest in sheep >2 years old
(Figure 2(A)). The two distributions peak in the same age
class and are highly concordant (see Methods): surface
area of ileal PP tissue vs risk of infection, rs = 0.913 (n =
19, P < 0.001); lymphoid follicle density vs risk of infec¬
tion, rs = 0.933 (n = 19, P < 0.001).
For cattle, previous work [18] has shown that the weight
ofPP tissue in the small intestine increases in the first year
of life, peaks at 12-18 months old, declines thereafter,
and is low throughout adulthood (Figure 2(B)). Available
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Figure 2
Comparison of age-related changes in Peyer's patch (PP) development and estimated risk of TSE infection relative to the most
susceptible age class, for sheep, cattle and humans. (A) PP areas for n = 19 Cheviot sheep of mixed genotypes in 3 age classes
(left hand axis, open circles), compared with estimates of risk of scrapie infection relative to the most susceptible age class
(solid line) (± 50 percentiles-dashed lines) from field data on n = 34 cases in mixed PrP genotype (VRQ/VRQ and VRQ/ARQ)
Cheviot sheep (see Methods) in the same age classes (right hand axis). (B) PP tissue weight against age for n = 94 cattle (open
points, data from ref. 18), compared with estimates of risk of BSE infection relative to the most susceptible age class (solid line)
as a function of age made from n = 158,550 BSE cases in British cattle [5] (C) Numbers of PPs in the small intestine in 8 age
classes of humans (open circles, data taken from ref. 19), compared with estimates of risk of vCJD infection relative to the
most susceptible age class (solid line, ± 50 percentiles-dashed lines) from n = 129 vCJD cases in British people for the same age
classes (redrawn from ref. 6).
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estimates of age-related risk of infection of the British cat¬
tle population with BSE up to 1996 (given a mean incuba¬
tion period of 5 years; published estimates range from 4.5
to 5.5 years [25]) indicate that the risk is initially low,
peaks at about 12 months, and declines rapidly thereafter
(Figure 2(B)). Again, the two distributions peak at similar
ages and are concordant: rs = 0.693 (n = 94, P < 0.001).
For humans, previous work [19] has shown that the
number of PPs in the small intestine increases during
childhood, peaks at 10-15 years old, and declines thereaf¬
ter, although the PPs persist throughout adulthood (Fig¬
ure 2(C)). Recent estimates of age-related risk of infection
of the British human population to vCJD [6] indicate that
the risk is initially low, peaks between 5 and 20 years, and
declines thereafter (Figure 2(C)). Here too, the two age-
related patterns are concordant: rs = 0.38 (n = 46, P =
0.008). The same study [6] provides estimates of age-
related susceptibility having allowed for changes in puta¬
tive exposure associated with consumption ofbovine car¬
cass meat (see below). This is also concordant with the
number ofPPs: rs= 0.360 (n = 46, P = 0.014). Importantly,
these correlations occur despite the markedly different
patterns of age-related development of GAFT in humans
as compared with sheep and cattle.
Discussion
Our results show that, whilst both age-related changes in
the development of PP tissue and estimated risks of TSE
infection differ between sheep, cattle and humans, in each
case the two are associated. However, these results do not
distinguish effects of age-related changes in exposure to
TSE infection from age-related changes in susceptibility.
To make this distinction we need to consider how oral
exposure to TSE infection might change with age for each
species.
For BSE in cattle, epidemiological studies have implicated
meat and bone meal (MBM) containing recycled infected
cattle tissues [26]. MBM used to be incorporated as a pro¬
tein source in concentrated feedstuffs and fed to both
calves and adult cattle. However, there is no clear correla¬
tion with the estimated age-infection function (Figure
2(B)): almost all calves were exposed to MBM by 6 weeks
of age; exposure then fluctuated up to 24 months old but,
especially for dairy cows, rose again in adulthood [27,28].
This route of BSE transmission is thought now to have
been eliminated by feed production regulations intro¬
duced in 1988 and 1996.
For vCJD in humans, the most likely vehicle for exposure
is food products containing BSE-contaminated cattle tis¬
sues [29]. Humans consume solid foods from 4-6
months of age with average consumption of bovine car¬
cass meat peaking during childhood and tending to fall
thereafter (see Figure 3 in [6]). This route of transmission
is thought now to have been eliminated by food produc¬
tion regulations introduced in the UK in 1996. Here, puta¬
tive exposure is more closely aligned with PP
development [6] but, as reported above, when age-related
exposure is taken into account, there remains an associa¬
tion between PP development and estimated susceptibil¬
ity.
For scrapie in sheep, the vehide(s) of oral exposure are
less well understood, but are likely to include grazing on
pasture contaminated with scrapie, possibly by infected
foetal membranes [30], Lambs typically begin to graze at
6-14 weeks and continue to do so throughout their lives.
Exposure by this route would not be correlated with the
estimated age-infection function (Figure 2(A)).
The importance of other transmission routes is less clear.
Transmission from mother to offspring in utero or via
breast milk (self-evidently age-dependent) is thought to
play a minor role, if any: currently available estimates of
the fraction of cases due to maternal transmission are 0-
8%forscrapie in sheep [23], 0-14% for BSE in cattle [31],
and 0% for vCJD in humans (Will et al„ unpublished
data). Other suggested routes include skin scarification (as
demonstrated experimentally in mice [32]), food-bome
infection via oral lesions [33], for scrapie possibly even
mechanical transmission involving arthropods [34], and
for vCJD, iatrogenic transmission [3]. However, there is
no evidence that exposure via any of these routes varies
with age in a manner corresponding to the estimated risk
of infection functions (Figure 2)
The measures of PP development (area, weight or
number) used in this study are crude indicators of lym¬
phoid tissue development; alternative measures in PP
development may be at least as appropriate (for example,
in sheep, counts of functionally mature FDCs). Moreover,
this analysis assumes that both the anatomical data and
the age-susceptibility estimates available are representa¬
tive of each host species in general and not just the specific
populations examined. Similarly, it is assumed that the
associations studied have not been distorted by other fac¬
tors (e.g. history of exposure to gut pathogens) which
might influence PP development and/or susceptibility to
TSEs.
Given these caveats, it is nonetheless striking that an asso¬
ciation between PP development and susceptibility to
TSEs is seen not just in one host species but in three host
species with different relationships between these varia¬
bles and age. This kind of comparative study is especially
useful in cases such as this where experimental manipula¬
tions (e.g. of PP development) are not feasible.
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Conclusion
Taken together, the epidemiological, anatomical and
pathological evidence are consistent with the hypothesis
that PP development or a close correlate of PP develop¬
ment is a major determinant of the observed age distribu¬
tion of natural cases ofTSEs in sheep, cattle and humans.
This implies that the age groups most at risk ofTSE infec¬
tion (given that the individuals are exposed and have a
susceptible PrP genotype) are indicated by the develop¬
ment of Peyer's patches in the gut.
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